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Abstract
The mycobacterial cell wall metabolites have always imposed great challenges to researchers due to their
unusual complexity and structural diversity. A lot of research efforts have been directed towards the
evaluation of these metabolites and the role they play in the pathogenesis and virulence of different
serious human pathogens including Mycobacterium tuberculosis the causative agent of tuberculosis
(TB). In the genomic era, it is crucial to develop new methodologies to analyze these components from a
global perspective in a comprehensive and well-validated manner.
Towards this end, we developed a rapid NMR-based approach to produce metabolic profiles in the form of
2D1H-13C HSQC maps. Due to NMR low sensitivity, we used 13C-isotope enrichment strategy to improve
the detection threshold of NMR. We developed and investigated the use of three NMR-based profiles. The
first is for the cell wall associated lipids, the second is for covalently bound mycolic acids and the third
deals with the complex cell wall polysaccharides. Key structural features and major lipid species were
readily identifiable using this technique. This approach can be used for observing changes in the cell wall
due to drug treatment, gene mutation and changes in the physiological environment, species
characterization and screening for virulence factor expression. It also allows for rapid comparative
analysis of several cell wall metabolites within the same sample.
We have used this approach to evaluate the structural diversity displayed in the cell wall metabolites
among different Mycobacteria from different clades. We have successfully used the same technique to
monitor changes in the carbohydrate and lipid pools from Mycobacteria grown under laboratory
conditions that simulate latency and resuscitation from latency. Moreover, we were also able to use such
technique to screen for virulence factor in severalM. tuberculosis clinical isolates.
Although we have successfully developed and used an NMR approach for metabolite analysis, NMR
however remains less sensitive than other spectroscopic techniques like mass spectroscopy (MS). The
high sensitivity of MS makes it one of the best candidates for metabolomic studies. However in case of
cellular lipids, the low polarity and the variable ionization potential deter its routine use for lipid analysis.
Certain metabolites that have low cellular abundance and good ionizability are better analyzed through an
MS-based approach. Mycolactones of M. ulcerans and other closely related species are good examples
for such metabolites and in this work we have demonstrated the utility of MS as a tool for screening for
mycolactones from both bacterial culture and tissue samples.
Metabolomics is currently a rapidly growing field and many researchers have directed their attention in
developing the right research tools to explore it. Spectroscopic methods along with chromatographic
methods have been in the front of this vigorous research effort. The work presented here represents an
innovative attempt to utilize such
techniques to investigate the metabolome of some of the most serious human pathogens and discusses
the potential area where the application of these techniques can be the most useful.
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ABSTRACT
The mycobacterial cell wall metabolites have always imposed great challenges to
researchers due to their unusual complexity and structural diversity. A lot of research
efforts have been directed towards the evaluation of these metabolites and the role they
play in the pathogenesis and virulence of different serious human pathogens including
Mycobacterium tuberculosis the causative agent of tuberculosis (TB). In the genomic era,
it is crucial to develop new methodologies to analyze these components from a global
perspective in a comprehensive and well-validated manner.
Towards this end, we developed a rapid NMR-based approach to produce metabolic
profiles in the form of 2D1H-13C HSQC maps. Due to NMR low sensitivity, we used
13
C-isotope enrichment strategy to improve the detection threshold of NMR. We
developed and investigated the use of three NMR-based profiles. The first is for the cell
wall associated lipids, the second is for covalently bound mycolic acids and the third
deals with the complex cell wall polysaccharides. Key structural features and major lipid
species were readily identifiable using this technique. This approach can be used for
observing changes in the cell wall due to drug treatment, gene mutation and changes in
the physiological environment, species characterization and screening for virulence factor
expression. It also allows for rapid comparative analysis of several cell wall metabolites
within the same sample.
We have used this approach to evaluate the structural diversity displayed in the cell
wall metabolites among different Mycobacteria from different clades. We have
successfully used the same technique to monitor changes in the carbohydrate and lipid
pools from Mycobacteria grown under laboratory conditions that simulate latency and
resuscitation from latency. Moreover, we were also able to use such technique to screen
for virulence factor in several M. tuberculosis clinical isolates.
Although we have successfully developed and used an NMR approach for metabolite
analysis, NMR however remains less sensitive than other spectroscopic techniques like
mass spectrometry(MS). The high sensitivity of MS makes it one of the best candidates
for metabolomic studies. However in case of cellular lipids, the low polarity and the
variable ionization potential deter its routine use for lipid analysis. Certain metabolites
that have low cellular abundance and good ionizability are better analyzed through an
MS-based approach. Mycolactones of M. ulcerans and other closely related species are
good examples for such metabolites and in this work we have demonstrated the utility of
MS as a tool for screening for mycolactones from both bacterial culture and tissue
samples.
Metabolomics is currently a rapidly growing field and many researchers have directed
their attention in developing the right research tools to explore it. Spectroscopic methods
along with chromatographic methods have been in the front of this vigorous research
effort. The work presented here represents an innovative attempt to utilize such
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techniques to investigate the metabolome of some of the most serious human pathogens
and discusses the potential area where the application of these techniques can be the most
useful.
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CHAPTER 1. INTRODUCTION
Mycobacterium, the single genus of the family Mycobacteriaceae, is described as rodshaped Gram positive aerobic to microarophilic bacilli with GC- rich DNA.
Taxonomically, it is placed in the same suborder Corynebacterianeae with Corynbacteria,
Nocardia and Rhodoccoci which are all referred to as Actinomycetales.1 In general,
Mycobacteria are ubiquitous organisms that can be isolated from tap water, house dust
and soil but few are clinically important pathogens that are associated with serious health
problems.2-5 Others are emerging as opportunistic pathogens and are increasingly
imposing new health challenges.6 For many years, the diagnostic feature that was used to
describe Mycobacteria was its “acid-fastness”, a phrase that refers to the ability of the
stained bacilli to resist decolorization by acidic ethanol when exposed to cationic
triphenyl methane dyes such as fuschin.7 The chemical nature of this interaction has been
widely speculated but with contradicting evidence pointing in different directions, it
remains a debatable research point.8-10
Historically, several classifications of Mycobacteria have been used and most have
relied on a specific morphological feature or a biochemical reaction. The most acceptable
nowadays is the traditional classification of Mycobacteria into slow growers and fast
growers subgroups1 (excluding the uncultivable M. leprae). This traditional classification
is surprisingly in agreement with modern 16S rRNA-based classification.11 In addition,
most pathogenic Mycobacteria fall in the slow growers subgroup with few exceptions.1
Other classic descriptions such as atypical Mycobacteria and chromogenic Mycobacteria
have become increasingly outdated and clinically irrelevant as they are biased to a single
feature like the frequent association with mammalian diseases or the ability to produce
certain pigments.7
In the clinic, the most important mycobacterium is that of M. tuberculosis, the
causative agent of tuberculosis (TB), a disease that consumes around two million lives
every year.12 Other common mycobacterial human pathogens are M. leprae the causative
agent of leprosy, M. marinum an intracellular pathogen that causes granulomateous skin
infection13 and M. ulcerans a pathogen responsible for the Buruli ulcer endemic in some
tropical regions.14 However, with an expanding population of immunocompromised
patients, infections with environmental Mycobacteria that do not cause diseases to human
under normal conditions have been on the rise.15 Diseases caused by these opportunistic
Mycobacteria have contributed to the mortality and morbidity of thousands of cases of
HIV patients. Such infections happen through unavoidable routine activities and can
result in either tuberculosis like pulmonary symptoms, lymphaniditis or more severe
systemic mycobacteriosis.16 Most common among these infections are infections with
Mycobacterium avium complex (MAC) which includes mainly M. avium and M.
intracellulare.12,17
Some fast growers, like members of M. fortuitum complex, M. abscessus and M.
chelonae, have also been isolated from the sputum of immunocompromised patients.18
Most other fast growers, however, are saprophytic species like M. smegmatis and M.
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phlei that rarely cause diseases in humans but are used in the laboratory as surrogates to
Mycobacterium tuberculosis which can only be handled in biosafety level-3 facilities to
provide maximum protection to researchers and laboratory workers and limit the spread
of this infectious agent.
1.1 History of Mycobacteria
Mycobacteria pathogens were among the first microorganisms to be discovered as the
causative agents of human diseases. Indeed, the first human pathogen to be described was
that of Mycobacterium leprae the etiological cause of leprosy when in 1873 Gerhard
Hansen reported the presence of rod shaped “infectious substance” in the tissue of
infected patients without identifying it as bacteria.19 It was not until 1880 that Albert
Neisser have stained and identified the bacilli as the etiological cause of leprosy. During
the time of Neisser’s successful characterization, the work that led to the ground breaking
discovery of Mycobacterium tuberculosis as the causative agent of tuberculosis was also
taking place. On March 24, 1882, Robert Koch, the father of microbiology, gave one of
the most important lectures in medical history to announce his discovery of the causative
agent of TB.20 In his lecture that evening, Koch illustrated to his audience how he
successfully isolated, stained and cultured the tubercle’s bacilli.21 Koch was awarded the
Nobel Prize for “his investigations and discoveries in relation to tuberculosis" in 1905.22
But long before Koch made his discovery, Mycobacteria species and their associated
diseases have existed throughout human history. Molecular evidence of tuberculosis was
found in Egyptian mummies.23,24 Chinese, Indian and Egyptian scriptures dated as far
back as to 4000B.C contained description of both tuberculosis and leprosy.20 It is
estimated that TB alone, also known as consumption or white plague, has consumed at
least one billion human lives between 1700 and 1900.20 Other mycobacterial diseases
have surfaced more recently. The third most common mycobacterial disease, Buruli
ulcer, was not defined and its causative agent M. ulcerans has not been described until
1948 despite some initial reporting of an ulcerative skin disease in Uganda by Sir Robert
Cook in 1897.25,26 With the progress of scientific research tools and the ever-rapid
accumulation of human knowledge, the genus mycobacterium now includes nearly 80
species, the majority of them were discovered during the last five decades although most
have existed since prehistoric times.
1.2 Current Burden of Mycobacteria
The single most important species of the genus mycobacterium is M. tuberculosis, a
single species that infects one third of the world population and is responsible for nearly
two million deaths every year due to tuberculosis (TB).12 The World Health Organization
(WHO) estimates that M. tuberculosis infects more than one person every second
worldwide with the latent form of the disease. Among those infected, 10% will develop
an active infectious form of the disease in their lifetime and can infect 10-15 persons a
year if left untreated.27
2

Despite the long history of human encounter with TB, the fight against this pathogen
has not been won yet especially with constant emergence of new challenges. Of the nine
million new cases reported every year, more than 70% of these cases are reported in Asia
and sub-Saharan Africa where the failure to control TB infection is attributed to the
HIV/AIDS epidemic in this region.28,29 It is estimated that one third of HIV patients are
co-infected with TB which is considered the number one killer of HIV patients.30 This
co-infection also makes it 800 times more likely for an individual to develop an active
form of the disease and thus spread the TB infection.30 With the devastating human
health cost comes also a great economic burden as 80% of TB patients are between 15
and 49 years of age amidst their productive life and are in most cases the only supporters
of their large families.31
In the last two decades, we were confronted with another challenge with the spread of
multi drug resistant TB (MDR-TB) and more recently extensively drug resistance TB
(XDR-TB)32 which has in turn complicated the HIV/TB problem.33,34 MDR-TB is a form
of the disease caused by strains that resist treatment with more than one of the frontline
anti-tuberculosis drugs. For example, an MDR-TB strain resistant to both rifampin and
isoniazid (INH) was associated with an outbreak in New York City in the early 1990s
that grabbed scientists’ attention and caused public panic.35 XDR-TB is a term introduced
in 2006 to describe another form of the disease caused by strains that are resistant to both
rifampin and INH in addition to key second line anti-TB treatment including a
fluroquinolone and one injectable drug from the aminoglycosides and capreomycin
group.34,36 Although anti-TB drugs have been in use since the 1940s, the current
repertoire of anti-TB drugs has now limited capabilities and low potential to provide a
tool for eradicating TB. Many global health initiatives have been launched in the recent
years to counteract the spread of this disease and help treat the millions affected by it.
Yet, there has been no significant down turn in the global rates of incidence or mortality
due to tuberculosis.
On the other hand, the prevalence of two other mycobacterial human diseases (leprosy
and Buruli ulcer) stands at about 250,000 cases worldwide with their associated cost of
treatment and lost productivity.37,38 Being limited in their geographic distribution to the
tropical regions, these diseases receive limited attention from both research and health
organizations despite the fact that a lot of questions remain regarding disease
transmission and the availability of limited treatment options.
It is also worth mentioning that at least thirty Mycobacteria species are known to
cause diseases to domestic and wild animals and have significant economic implications.
This group includes M. bovis, Mycobacterium marinum, M. fortuitum, M. chelonae and
M. avium subsp paratuberculosis among others. M. bovis is the cause of tuberculosis in
cows while M. avium subsp. paratuberculosis is believed to be the causative agents of
Johne’s disease in cattle and some evidence points to a role of this organism in human
Crohn’s disease, a painful chronic disease that affect 500,000 in the US alone.39,40
Systemic mycobacteriosis is considered a major problem for aquatic animals. A number
of Mycobacteria that are natural habitat of water are known to cause systemic infections
in fish.41 Recently, a new species, M. pseudoshotsii, was identified as the cause of an
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endemic mycobacteriosis in the sea striped bass in Chesapeake Bay.42,43 So, in addition to
the negative human health impact of Mycobacteria, there are both economic and
environmental burdens that threaten our aquatic and agricultural reserves.
1.3 The Pathogenesis of Mycobacterium tuberculosis
Beside the fact that Mycobacterium tuberculosis is the main cause of pulmonary
tuberculosis, it is also responsible for another serious form of tuberculosis, disseminated
or extra pulmonary tuberculosis, in neonates and severely immune-compromised
patients.44,45 In the disseminated form of TB, the bacilli can escape the lungs and
disseminate to other organs through the lymph system most commonly bones and
joints.46 Both the pulmonary and the extra-pulmonary diseases spread through inhalation
of the bacterium. A host can inhale contaminated droplets produced through the
coughing and sneezing of an infected individual who spreads a load of Mycobacteria into
the atmosphere where the bacilli can survive for several hours.47 It is estimated that the
infectious dose to the new host can be as low as a single bacterium.
Once inhaled, the bacilli travel deep into the airways where they are engulfed by
alveolar macrophages in an attempt to destroy the invading pathogen.48,49 However, the
TB bacilli have the ability to survive and replicate inside these macrophages by inhibiting
maturation and acidification the phagosome.50 At this stage, multiple cytokines are
released by the infected macrophages (TNF-α is the most important). This cytokine
cascade recruits successive waves of CD4+, CD8+ and natural killers T-cells to contain
the infection. As these cells start to surround the infected macrophages, they initiate the
formation of a well organized pulmonary lesion (known as tubercle or granuloma) the
pathological signature of tuberculosis.49 Once the infected macrophages are surrounded
with T-cells, the immune response to the infection is suppressed through the secretion of
INF-γ from these cells. With time progression, the peripheries of these tubercles become
surrounded by fibrous cuff and the blood supply to the lesion diminishes.51 The bacilli at
the core of these lesions can remain viable for extended period of time (dormant bacilli)
but in a contained phase where the host cannot transmit the infection to others (latent
infection).51,52 Reports indicate that one third of the world population are infected with
this latent form of the disease and that between 5-10% of these individuals will develop
an active form of the disease later on their life time.52,53
The activation of a latent infection is usually a result of a deteriorating host immune
system that can be related to malnutrition, co-infection with HIV, immunosuppressive
therapy or other factors. For example, when the CD4+ cell count diminishes as a result of
HIV infection, the granuloma can no longer be contained and its walls rupture allowing
the migration of the free bacilli to the airways. At this point, the acid fast bacilli start to
appear in the patient sputum and the host becomes infective to those who are in close
contact.49 Usually six to eight weeks of anti-tuberculosis therapy (rifampin, INH,
pyrazinamide and ethambutol or RIPE) are necessary to clear the sputum but four more
months of therapy (rifampin and INH) are still required to eliminate all loci of infectious
bacteria with all different populations to deter the development of resistance.54-56
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1.4 Mycobacteria Cell Envelope
The persistence of TB as a major health problem is attributed to the ability of
Mycobacteria to adapt to different environmental conditions inside and outside the
human body.57 Not only can M. tuberculosis survive and resist the killing mechanism
inside human macrophages, but it also has the capacity to slow down its metabolism and
replication to stay hidden from the host immune system for extended periods of time.
Still at this latent phase, Mycobacteria retain the ability to monitor the host immune
system and remain in a state of preparedness to be activated once host defense
mechanisms are compromised.53
For a better understanding of Mycobacteria pathogenicity, it is crucial to examine its
cell wall as it accounts for 60% of the bacterial cell weight and is commonly believed to
be partially responsible for Mycobacteria drug resistance and virulence. Like all
eubacteria, the Mycobacteria cell is surrounded by a peptidoglycan–based cell wall, but a
unique and very complex cell wall assures its survival and resistance to different killing
mechanisms by the host immune system (Figure 1.1). The cell wall of Mycobacteria (and
in fact all actinomycetales) is classified on a chemical basis as chemotype IV cell wall.58
In addition to the plasma membrane and the peptidoglycan, chemotype IV is
characterized by the presence of a special polysaccharide structure known as
arabinogalactan (AG). This arabinogalactan is terminally substituted with long chain fatty
acids that vary in length based on the bacterial species and tend to form an outer lipid
layer that function as a permeability barrier.59,60 The total composition of the cell wall
will be discussed in more details below.
1.4.1 The Plasma Membrane
1.4.1.1 Membrane general features
The plasma membrane of Mycobacteria has all the general features recognized in the
membranes of other prokaryotes. It has the general arrangement of a phospholipids
bilayer. The phospholipids of the plasma membrane are mainly derivatives of
phosphatidic acids59 (Figure 1.2). The most abundant of which is bis-phosphatidyl
glycerol, also known as cardiolipin.61 Other phospholipids include phosphatidyl
ethanolamine, phosphatidyl inositol and its corresponding mannosides PIMs, which are
located mainly in the membrane outer leaflets. The fatty acid substitutions in all
membrane phospholipids are mainly palmitic (C-16), hexadecenoic (unsaturated C-16),
oleic (C-20) and tuberculostearic acids (methylated C-20).62
The plasma membrane also contains a number of associated components that perform
different cell membrane functions, menaquinone for electron transport, carotenoids for
photolysis protection, and glcosyl phosphopolyprenols which serve as carriers and
intermediates in the process of cell wall biosynthesis.63 Porin-like proteins are also
essential in the membrane and usually span the entire cell wall to allow the selective
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Figure 1.1 Schematic Presentation of the Cell Wall of Mycobacteria
Reprinted with permission. Riley, L.W. Of mice, men, and elephants: Mycobacterium
tuberculosis cell envelope lipids and pathogenesis. J. Clinical Invest 11, 1575-8 (2006).64

Figure 1.2 Phospholipids of the Mycobacterial Plasma Membrane
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passage of hydrophilic nutrients through the permeability barrier of mycolic acids and the
hydrophobic lipids enclosed within.59,60
1.4.1.2 Phosphatidyl myo inositol mannosides (PIMs)
These are highly abundant phospholipids that are located in the plasma membrane
(mainly the outer leaflet) of actinomycetes. Their chemical structure has been well
established and was shown to consist of phosphatidyl inositol which is glycosidically
linked at positions 2 and 6 to two mannose residues to form phosphatidyl inositol
dimannoside (PIM2)65 (Figure 1.3). The Mannose residue at 6- position can be further
glycosylated with 1-4 mannose residues to form tri, tetra, penta and hexa derivatives
(PIM3, PIM4, PIM5 and PIM6 respectively).66,67 Variability in the acylation patterns of
PIMs has been recognized lately and has received considerable research effort. Beside the
two lipids chains of the phosphatidic acid, the existence of multi acylated PIMs was
reported by several researchers.68,69 In fact, among PIMs isolated from M. bovis BCG, tri
and tetra acylated PIM2 and PIM6 were found to be the most abundant.66
PIMs are known to react with toll like receptors-2 (TLR-2) thus activating the host
innate immune response.66 Other studies have suggested the involvement of PIMs in the
recruitment of natural killer T-cells.70 Some of the molecular basis of these activities can
be explained through the high affinity interaction between the lipid chain of PIMs and the
human CDb1 receptors.71 The hydrophobic nature of this interaction unequivocally
explains the loss of biological activity of PIMs if they are subjected to alkaline
hydrolysis.72
1.4.2 The Peptidoglycan Mycolyl Arabinogalactan Complex (PG-mAG)
The covalently bound PG-mAG complex can be isolated from the cells in a pure form
and it is described as the cell wall skeleton. A summary of the main structural features of
individual parts of the cell wall skeleton is discussed below.
1.4.2.1 Peptidoglycan (PG)
Peptidoglycans provide the bacterial cells with the rigidity necessary to maintain a
defined shape. They are universal in their distribution among bacteria with few
exceptions such as mycoplasma.73 The peptidoglycan of Mycobacteria is classified as AIγ
type, in which the glycan strands of alternating N-acetyl muramic acid and N-acetyl
glucosamine are connected via cross linkage between two peptide chains of L-alanyl-Disoglutaminyl-meso-diaminopimelyl-D-alanine. The two peptide chains are connected
between one diaminopimelyl of one strand and D- alanine of the other strand.58 This type
of PG is common among bacteria but that of Mycobacteria has several characteristics to
it.74 First, about 30% of the muramic acid residues are N-glycolylated instead of Nacylated.75 Second, the peptide chain link can be between two molecules of Daminopimelic acid (DAP) instead of the more common DAP/D-alanine link. Peptide
chain cross linkage in general occurs with a higher than normal frequency in
7

Figure 1.3 Structure of Tetracylated PIM6
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mycobacterial PG (75% cross- linkage compared to 25% in case of E. coli).73,76 Third, the
amino acids of the peptide chain display different chemical modifications, some DAP
residues can be amidated while the L-alanine as well as the D-glutamate residues can be
substituted with glycine.77 The likely purpose of these modifications of the peptidoglycan
is to provide the cell wall with more rigidity and chemical stability.73
1.4.2.2 Arabinogalactan (AG)
Outside the PG and covalently attached to it, is the complex polysaccharide of
arabinogalactan (AG).78 The link between PG and AG is thought to be through a
disaccharide phosphate linker of rhamnose and N-acylated glucosamine where a
furanogalactan residue is linked to the 4-position of the rhammonose residue in the linker
region to form a polysaccharide chain of β-D-Galf-(1→5)-β-D-Galf-(1→4)-α-l-Rhap(1→3)-α-d-GlcNAc-1-P which then attaches to the PG through about 10%-12% of
muramic acid residues of PG.79
The building units of the AG complex, i.e. arabinose and galactose, are both in the
unusual furanose ring structure.80 The galactan chain of AG consists of 25 residues of
alternating 1→5 and 1→6 linked β-D-Galf78,81 (Figure 1.4). Hepta-arabinan chains are
frequently attached to some of the 6- linked galactose units through a 1→6 glycosidic
linkage.82,83 These arabinan chains are further branched through an α-3,5 Araf residue to
two tetra arabinan chains. The short tetra arabinan chains terminate with a branched
arabinan moiety of six arabinose units known as Ara6.84 In addition to the two basic
saccharide units, a succinyl residue or a galactose amine residue can be attached to the C2 oxygen of the inner 3,5-α-D-Araf residue at the arabinan branching points.84 At the
terminal end of the Ara6 structure mycolic acids are esterified to position-6 of the
terminal β-D-Araf.
1.4.2.3 Mycolic acids
The mycolic acids attached to the mAG-PG complex are very long fatty acids that are
limited in their distribution to the actinomycetals. They are chemically described as αalkyl-β-hydroxy fatty acids with two alkyl branches; a shorter unsubstituted α-branch and
the longer β-branch or meromycolate chain.85 This structural feature remains valid among
Corynebacteria, Mycobacteria and Nocardia but mycobacterial mycolic acids are
characterized by having the longest carbon chain with an average length between 70-90
carbons.86,87
Variations in the substitution of the meromycolate chain are responsible for the
presence of several types of mycolic acids.88-90 Unsaturation is the most common
substitution among fast growing Mycobacteria as well as non-Mycobacteria
actinomycetals. The name α-mycolates is used to describe molecules where the chain
substitution is either unsaturation or cyclopropation.91 In α-mycolates the double bonds or
cyclopropyl rings can be either in cis or trans configuration with the trans substitution
adjacent to a methyl group (Figure 1.5). Other types of mycolic acids usually contain one
cycloprpopyl ring together with an oxygenated functional groups like hydroxyl, epoxy,
9

Figure 1.4 Schematic Presentation of the Structure of Mycobacteria AG
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Figure 1.5 Major Types of Cell Wall Mycolic Acids

11

keto or methoxy groups and are commonly known as oxygenated mycolic acids. These
oxygenated mycolic acids always contain a methyl branch next to the oxygenated
function as well.90,91
Mycolic acids that terminate the arabinogalactan are tightly packed to form an outer
pseudomembrane layer that appears as an electron transparent zone in the electron
micrograph.92 Variation in both the chain length and the distribution of different types of
mycolic acids in a certain species have had implication on the taxonomical classification
of actinomycetals.93,94
1.4.3 Extractable Cell Wall Lipids
Apart from the cell wall skeleton, the cell envelope of Mycobacteria contains some
lipids of unusual structures that are believed to play an important role in virulence and
pathogenicity. The general agreement is that these lipids are loosely attached to the
mycobacterial cells by hydrophobic forces that keep these lipids within the lipid pseudomembrane of mycolic acids.92 It was the common belief that these lipids do not exhibit a
particular arrangement but recent evidence by improved microscopy techniques has
argued for an organized lipid bilayer structure in the outer membrane.95
The different chemical nature and structural diversity exhibited by these lipids suggests
a different biological role for each chemical class of lipids. In favor of this argument is
the fact that certain classes of lipids can be remarkably abundant in one species yet
completely absent from others. Even within a single class of lipids, inter-species and
inter-strain variations do exist.96,97 Over the past few decades, researchers have gathered
information that displays the unique structural diversity of the cell wall lipids. The
relatively polar glycolipids of the cell wall include trehalose esters, lipooligosaccharides,
phenolic glycolipids and glycopeptidolipids. More hydrophobic lipids are also found
associated with the cell wall and these include triacyl glycerols, wax esters, mycocerosic
and phthiocerol derivatives and acylated glycerophospholipids.
With the wealth of research on the role of different cell wall lipids and the conflicting
results it produces, it is crucial to develop a consensus on their biological activities. For
example, one of the most ubiquitous glycolipids, known as trehalose dimycolate (TDM),
has been associated with serious pathological and immunological effects that contradict
its universal distribution among both pathogenic and non pathogenic Mycobacteria.98 On
the other hand, it can be argued that subtle differences in the mycolic acids substitution
within the TDM molecules among different species can account for some variation in
their biological activity.64,99 The cell wall fractions also include some proteins and
lipoproteins that can be involved in membrane transport functions. A brief description of
the major extractable cell wall lipids is outlaid in the following sections.
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1.4.3.1 Lipomannans LM and lipoarabinomannans (LAM)
These are immunogenic lipoglycans that are interspersed within the cell wall and are t
thought to be partially surface-exposed.100 Degradative analysis of cell wall LAM
indicated the presence of glycerol, inositol, arabinose, mannose and phosphate in addition
to a variety of fatty acids.80 Detailed structural analysis of these glycolipids concluded
that they are multiglycosylated derivatives of PIMs which strongly suggests that they
may have the same cellular location as PIMs, i.e. they are anchored to the outer leaflet of
the cell membrane via their phosphatidyl inositol portion.
Unlike PIMs the mannan part of both LAM and LM is further extended to a backbone
of repetitive units of α-(1→6) D-Manp (Figure 1.6) which are frequently substituted at
the C2- position (C3-position in few cases) with another Manp residue.101,102 In the case
of LAM, this mannose-based backbone is further substituted with a number of arabinan
side chains of α-(1→5)D-Araf units.103 These side chains are further substituted at
different points with shorter arabinan chains. The arabibnan chains are terminated with
one of two arabinan moieties the first is a linear chain of α-(1→5) Araf (Ara4) and the
second is a branched moiety similar to the Ara6 of AG.104
Based on the substitution of the terminal arabinose residue, LAM can be classified
into three classes. The first is manLAM where the arabinose reducing terminal is capped
with one to three mannose residues as it is the case in both M. tuberculosis and M.
bovis.104-106 The second type is most common among fast growing Mycobacteria such as
M. smegmatis where the arabinose termini are partially capped with phosphoinositol
forming PiLAM.107 The third type is devoid of both mannose and phosphoinositol caps
such as in M. chelonae and is called araLAM.108 On the other hand, Lipomannan (LM) as
the name indicates is devoid of any arabinose residues and can be considered as a
biosynthetic intermediate of LAM.100 Despite that, the two lipoglycans display different
immune-modulatory properties. While manLAM is thought to down regulate the
inflammatory response to subvert the host immune response and inhibit lysosome
phagosome fusion,100,109-111 evidence points to a role of LM in triggering a potent
proinflammatory response (induction of TNF-α, IL-8 andIL-12) and stimulating innate
immune response through TLR-2.111,112
1.4.3.2 Acylated trehalose (ATs)
Trehalose is a non reducing disaccharide formed through α,α-1,1glycosidic linkage of
two α-glucose units. The most studied acylated trehaloses are 6,6’-trehalose dimycolates
(TDM), also known as cord factor (Figure 1.7). TDM was first reported in M.
tuberculosis when many researchers have attributed the virulence of the tubercle bacilli to
this molecule as they associated it with the ability of virulent Mycobacteria to form
serpentine cords (hence the name cord factor). Further research has proved that TDMs
have a more ubiquitous distribution as they exist in other non pathogenic Mycobacteria as
well as Corynebacteria and Nocardia.60,97 Yet, there is no shortage of reports about the
biological activities attributed to TDM that range from inducing Th1 response and
initiating granuloma formation to desiccation resistance.98,113,114 Results from in vivo
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Figure 1.6 Schematic Representation of the Cell Wall manLAM
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Figure 1.7 Representative Examples of Acylated Trehalose
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experiments to investigate the exact role of TDM in Mycobacteria pathogensis point in
many different directions which leaves a lot of doubt about the pathological function of
these molecules. It is clearly established, however, that the monomer unit of TDM,
glucose monomycolate (GMM), is one of the ligand to human CD1b receptors.71,115
Beside cord factor, other forms of ATs exist in some mycobacterial species (some are
shown in Figure 1.7). These include trehalose monomycolate (TMM), 2,3-diacyl
trehalose, triacyl trehalose and pentaacylated trehaloses.116-119 Most of these acylated
trehaolse derivatives are esterified with methyl-branched fatty acids such as
tuberculostearic, phthieonic, mycocerosic and phthioceranic acids.
Other trehalose esters can be restricted in distribution to certain species. For example
Mycobacterium phlei is characterized by the presence of special trehalose phleates, a
family of lipids that consists of a trehalose sugar esterified by multiple molecules of
polyunsaturated fatty acid (phleic acid).96,120 The most abundant of which is the fully
acylated trehalose octaphleate which contains 40 double bonds. So far, trehalose phleates
have been shown to be restricted in their distribution to M. phlei.63
1.4.3.3 Sulfated glycolipids (SL)
Sulfolipids or sulfatides are ATs that were discovered during the search for the acidic
substance responsible for the reactivity of virulent M. tuberculosis towards staining with
the cationic phenazine dye neutral red.121-123 They consist of a family of acylated
trehalose sulfate the most abundant of which is SL-1 (2,3,6.6’-tetraacyl
trehalose-2’-sulfate)121 as shown in Figure 1.8. The esterification of trehalose sulfolipids
includes always a palmitic or stearic acid at C2 position while other substitutions are long
methyl-branched fatty acids of phthioceranate or hydroxyphthioceranate. Four other
sulfolipids were isolated namely SL-I’, SL-II, SL-II’ and SL-III.63
Until now, sulfolipids are thought to be limited in their distribution among
Mycobacteria to a limited number of pathogenic species. Interestingly, the avirulent

Figure 1.8 Structure of SL-1
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strain M. tuberculosis H37Ra was found to be devoid of all major sulfolipids.124 Although
initial reports indicated a major role of sulfolpids in the virulence of M. tuberculosis,125
this claim has been recently refuted by mutation studies that used sulfolipid deficient
strains.126,127
1.4.3.4 Lipooligosaccharides (LOS)
The term is used to describe a variety of glycolipids that have been identified among
several species of Mycobacteria and share a common core structure. The core of these
LOS is based on a polyacylated trehalose to which other sugar residues are glycosidically
linked.128,129 Like most glycolipids, LOS are considered as major antigenic components
of the mycobacterial cell wall and their antigenic properties are mainly associated with
the terminal sugar. Some of these sugars are very rare and are specific to distinct species
like the N-acyl kansosamine sugar isolated from of M. kansasii LOS.130 The variability
among LOS in the types of sugars substituents and their acylation patterns make these
compounds valuable tools in serotypying.
LOS are often substituted with methyl branched fatty acids but substitution with other
groups have also been reported such as substitution with pyruvic acid in the case of M.
smegmatis.129,131 LOS seem to have a ubiquitous distribution as they have been reported
in several pathogenic as well as non pathogenic Mycobacteria including M. kansasii, M.
malmoense, M. szulgai, M. gordonae, M. butyricum, M. marinum and M. tuberculosis
Canetti strain.120,132-136
1.4.3.5 Phthienoic and mycocerosic acids
Phthienoic, also known as mycolipenic acids, are odd numbered dextrarotatory methyl
branched acids of average carbon chain length between 25 and 31 carbons.63 Cason and
Sumrell were able to isolate a dozen of these acids and concluded that they have an α,β
unsaturated acid moiety together with three or four methyl branches in the carbon
chain.137,138 These fatty acids were originally isolated from the phosphatide fractions of
M. tuberculosis but were also found in small number of slow growing
Mycobacteria.139,140
Some variabilities in the structure of these acids were reported (Figure 1.9). These
variations include the presence of hydroxyl group (hydroxyphthienoic acid) and presence
of unsaturation (mycolipdienoic acid). It is important to point out that cellular phthienoic
acids and their analogs are rarely found in a free state instead they are usually esterified
to sugars mainly trehalose or long chain fatty alcohols.116,141
Another class of methyl branched fatty acids, mycocerosic or mycoceranic acids, are
distinguished from phthienoic acids by being levorotatory. They exist in the cell wall
esterified by long chain fatty alcohols, phthiocerols. They are usually 30-32 carbons in
length with tetra methyl substitution at positions 2, 4, 6 and 8. Being structurally similar
to phthienoic acids, both lipids have been implicated in some of the inflammatory
characteristic of tuberculosis lesions.142
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Figure 1.9 Examples of Phthienoic and Mycocerosic Acids
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1.4.3.6 Phthiocerol diesters
The phthiocerol family consists of a mixture of long chain β diols that exist in the
mycobacterial envelope in diester form. Closely related to this family are phenol
phthiocerols which are basically aromatic derivatives of phthiocerol143,144 (Figure 1.10).
Phthiocerol and their aromatic derivatives are found only in the cell wall of few
Mycobacteria usually esterified to the multimethylated fatty acids mentioned above
(namely mycocerosic and phthienoic acids). This group of lipids is produced mainly by
slow growing pathogenic Mycobacteria which include M. tuberculosis, M. bovis, M.
kansasii, M. marinum and M. ulcerans.145 Also, they were reported in the uncultivable M.
leprae and the non pathogenic M. gastri.145
In order to validate the role of phthiocerol derivatives in Mycobacteria virulence,
Goren and colleagues have compared the virulence and pathogenicity of M. tuberculosis
H37Rv and a mutant deficient in the synthesis of phthiocerol esters in aerogenic infection
model using Guinea pigs.146 The mutant strain was less virulent and was drastically
unable to maintain the surface tubercles which were almost cleared within 50 days.146
1.4.3.7 Phenolphthiocerol glycolipids (PGL)
This group of lipids carries a great structural similarity to the phthiocerol diesters but
they are synthesized by only a limited number of Mycobacteria species and some specific
strains of certain species.59,147 The chemical structure of these lipids consists of the same
core as phthiocerol diesters where the phthiocerol chain is terminated by a phenolic ring
but in PGLs this ring is further substituted through glycosidical linkage with one or more
sugar residues (Figure 1.11).
When first reported, PGL were named mycosides. Mycosides A, B and G were
isolated from M. tuberculosis strain Canetti, M. bovis and M. marinum respectively and
were shown to have very similar aglycon part.145,148,149 However, mycoside A is
terminated with a trisaccharide of methylated sugars,150 151,152 while mycoside B and G
are terminated with a single sugar residue, 2-O-methylrhamnose and 3-O-methyl
rhamnose respectively.145,148 The use of the term mycosides has faded and now these
molecules are more likely to be called phenolic glycolipids (PGL). Recently, evidence
has suggested the association of PGL with increased virulence of some strains of M.
tuberculosis due to some immune-modulatory properties linked to this molecule.153
1.4.3.8 Glycopeptidolipids (GPL) or “mycoside C”
Glycopeptidolipids were isolated initially from M. avium, M. intracellulare and M.
scrofulacceum (MAIS subgroup) and later more lipids with similar structure were
isolated from other Mycobacteria from different clades.154,155 C-mycosides are generally
characterized by a peptide core of D-aminoacids mainly D-phe-D-alloThe-D-Ala and this
small peptide sequence is usually terminated at the carboxy end with an L-alaninol or
ethanolamine substituent156 (Figure 1.12). The “tetrapeptide core” is further substituted
through its N-terminus, the D-phenylalanine residue, to a long chain fatty acid.157
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Figure 1.10 Structure of Phthiocerol Derivatives
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Figure 1.11 Structures of Some PGL from Different Mycobacteria
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Figure 1.12 The Tetrapeptide Core of GPL
There are two main sites for glycosylation in the PGL core. The first one is at the
hydroxyl group of L-alaninol which is usually monoglycosylated with O-methylated -Lrhamnose and the other is at the D-allotheronine site where one or more sugar residue can
be attached starting with a 6-deoxy L-talose.155,157 The presence of an oligosaccharide
attached to the L-talose residue is associated with eliciting a strong strain specific
immune response to M. avium and M. avium complex.96 Thus these oligosaccharides are
the main tool used for serotyping M. avium complex clinical isolates.16
1.4.3.9 Triacyl glycerols (TAG)
Triacyl glycerols constitute about 5-10% of the cellular mass of M. tuberculosis when
it is grown in the presence of glycerol.158 However, this percentage is greatly reduced
when the glycerol in the media is totally replaced by glucose.159,160 TAGs are ubiquitous
among all Mycobacteria and can be extracted from both the cell wall fraction of the
bacilli as well as the cytoplasmic fraction.7 The accumulation of TAG in fat bodies or
lipid vacuoles has been observed in M. tuberculosis, M. marinum, M. bovis, M. kansasii
as well as Corynebacterium sp. when their growth was stimulated by the addition of a
lipid substance in the growth media such as Tween 80.7
The acyl substitution of mycobacterial TAG exhibits little variation among different
species. Position-1 is often substituted with stearic, tuberculostearic or oleic acid.
Position-2 is usually esterified with C16 fatty acids while longer chain fatty acids C20C32 are located in position-3.161 The metabolic turnover for TAG was found to be very
rapid for actively grown bacteria which suggest that they may serve as biosynthetic
precursors or temporary energy storage for the bacterial cell.63
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1.4.3.10 Mycobactins and carboxymycobactins
Mycobactins (Figure 1.13) were discovered in the 1950s as the growth factors
necessary to cultivate M. avium subsp paratuberculosis.162,163 They are hybrid peptidepolyketide iron chelating compounds secreted by Mycobacteria to sequester iron during
iron limiting conditions such as in the case of competing with its host for a limited iron
supply.
The basic iron chelating nucleus of these molecules is 2-hydroxyphenyloxazoline ring
which is biosynthesized from salicylic acid condensation with serine or threonine
residue.164 The serine residue is further linked to a small chain of two lysine residues and
one hydroxyl acid. To attain lipid solubility, the side chain nitrogen of one of the lysine
residues is substituted with long alkyl chain (C20 or longer). Mycobactins can bind one
iron atom per molecule through the coordination of the iron atom by the two hydroxamic
acid groups and the hydroxyl group of the salicylic acid residue.164,165
Several mycobactins have been isolated from different Mycobacteria and were
designated by letters e.g. mycobactins P, T, S, M and H.163,166,167 Each species produces
its own collection from these mycobactins. Carboxymycobactins are chemical analogues
of mycobactin molecules that are excreted outside the cells (exomycobactins). To
improve their water solubility, the long alkyl chain is replaced in carboxymycobactins by
a shorter chain that terminates with a carboxylic group.168,169
1.4.3.11 Carotenoids
These colorful polyene compounds (Figure 1.14) are usually associated with plants
and fungi that are capable of photosynthesis.170 However, some species of Mycobacteria
demonstrate the ability to produce these caratenoid pigments either in a constitutive
(scotochromogens such as M. phlei and M. gordonae) or inducible way
(photochromogens such as M. kansasii and M. marinum.7,63 The biosynthesis of the βcarotene pigments from isoprenene units includes several intermediates such as the
colorless phytoene and the pink colored lycopene.
The distribution of these carotenoids among Mycobacteria depends on both the
species and its growth conditions. For example, M. kansasii which produces extracellular
β-carotene crystals is thought to produce mainly oxygenated carotenoids (Xanthins) only
when they are exposed to lights.7 These pigments are believed to protect cells against
oxidation that can be induced by UV exposure or chemical dyes such as toluidine blue.171
1.4.3.12 Menaquinones
Menaquinones, 2-methyl-3polyprenyl-1,4 naphthaquinone, are key components of the
respiratory chain of all Gram positive bacteria including Mycobacteria. Menaquinones
nomenclature (Figure 1.15) follows the general formula of menaquinine-X (Hy), where
(X) is the number of isoprene units attached at position 3 of the ring and (y) is the number
of hydrogen atoms that saturate that chain.172 Variation in the number of isoprene units
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Figure 1.13 General Structure of Mycobactins

Figure 1.14 Structure of Some Examples of Carotenoids

Figure 1.15 General Structure of Menaquinone

24

and the degree of unsaturation led researchers to use menaquinones as taxonomical
markers in the classification and identification of actionmycetes.172
Among Mycobacteria, menaquinone-9 (H2) is the most abundant and has the widest
distribution with limited amounts of menaquinone-8(H2) and menaquinone-7(H2)
reported in some species. This also distinguish Mycobacteria from Corynbacterium
dephteriae which contains mainly menaquinone-8(H2).173
1.5 Role of the Mycobacterial Cell Wall in Virulance
The unusual complexity of the Mycobacteria cell wall necessitates that a significant
part of its genome is dedicated to genes that participate in the biosynthesis of all of its
unique components. This in turn imposes a metabolic burden on the bacterial cell and
requires the devotion of large amount of energy for its assembly. Despite such
evolutionary pressure, the structure of the cell wall is well conserved among most
Mycobacteria. All of this suggests the importance of each single component of the cell
wall to the survival of these organisms.
As previously discussed, there are several unique characteristics to the mycobacterial
cell wall. For example, in the mycobacterial PG, both the glycan and the peptide branches
have been modified to confer superior rigidity and chemical stability to the cell wall.73
The AG complex adds more strength to the cell wall and serves another important
function by anchoring the mycolic acids to the cell skeleton.60 These Mycolic acids are
the main permeability barrier for the penetration of most chemotherapeutic agents thus
rendering Mycobacteria resistant to most commonly used antibiotics and antiseptics.59,60
Loosely bound mycobacterial lipids that are located at the surface of the bacterial
envelope can easily diffuse and interact freely with the host's immune system. Some of
the glycolipids associated with the cell wall have already been shown through in vitro and
less frequently in vivo experiments to interfere with the host defense mechanisms and
many are thought to represent potential virulence factors. For example, TDM was shown
to produce toxicity in mice but not in other animal species. GPL are well recognized as
antigens that are used for serotyping of M. avium complex and are thought to enhance the
survival of M. avium inside the macrophages.120,155 Phenolic glycolipids (PGL) are
known as the main antigenic component of M. leprae and are now thought to play an
important role in the hypervirulence of M. tuberculosis W-Beijing strain.143,144,153 They
have also been proved to posses the capability of modulating the early host immune
response.174 In most of these cases however, clear undisputable evidence is lacking,
which underscores the importance of more thorough studying of these exotic molecules
preferably through the use of a more global approach.
Overall, there is no shortage of evidence to indicate a significant role of the cell wall
in the virulence and pathogenesis of Mycobacteria. Many in vivo experiments have
demonstrated a powerful host immune response upon the injection of different cell wall
components.50,98,100,111,113,120,155,175-177 In fact, cell free preparations of M. bovis BCG cell
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wall skeleton have demonstrated some anti neoplastic properties and have recently found
a place in immunotherapeutics.178-180 The immunostimulatory activity of M. bovis BCG
cell wall preparations has been previously attributed to TDM181,182 and in a more recent
study to a newly discovered monomycolated glycerol lipid.183
1.6 Mycobacterial Cell Wall as Diagnostic and Taxonomic Tool
Long before the rise of rapid genomic sequencing and other genetics tools, the
characterization of Mycobacteria was based mainly on the biochemical analysis of its cell
wall components.184 The most abundant lipids of the cell wall, mycolic acids, exhibit
enough structural diversity among different Mycobacteria which led to the use of mycolic
acid patterns obtained through different chromatographical techniques as biochemical
criteria for the taxonomical classification of Mycobacteria.86,93,185
Few decades ago, simple chemical hydrolysis of the mAG complex followed by
separation with thin layer chromatography (TLC) was used to resolve the pool of mycolic
acid in two directions. The 2D-TLC patterns produced through these procedures can be
diagnostic for every species.185 This technique has found some application in the
mycobacteriology research for a certain period of time.186 Later with the spread of non
tubercular mycobacrterial infections, the need for a powerful diagnostic tool pushed for
further improvement of such concept through the use of GC and HPLC. Both methods
afforded a much better resolution of the mycolic acid pool and were thus used as a
reliable tool in both the taxonomy of Mycobacteria and the characterization of clinical
isolates from tuberculosis patients.94,184,187
1.7 Analysis of the Mycobacterial Cell Wall
1.7.1 Analysis of Peptidoglycan Structure
The general structure of PG shows relatively little variability among bacterial species.
Routine procedures have been used to detect the amino acid sequence of the peptide
chain and the saccharide units of the glycan chain. Due to its location beneath complex
layers of lipids and polysaccharide, several procedures including delipidization,
deproteinzation, and lysozyme digestion are necessary before PG analysis.188
Both enzymatic and chemical hydrolysis are used to break down the cell wall skeleton
to yield smaller analyzable fragments of the PG polymer. Subsequent chromatographic
procedures are then used to separate the oligosaccharide and the peptide fragments and
these fragments are then sequenced through HPLC.58 Earlier attempts have used Dcycloserine to inhibit peptidoglycan crosslinking allowing the accumulation of
peptidoglycan precursors to facilitate their analysis. However, such treatment resulted in
some artifacts that led to few misinterpretation of the PG structure of Mycobacteria.73
Later, milder hydrolytic procedures and coupling of the HPLC to advanced MS
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techniques have provided a more quantitative analysis of the peptide and saccharide
residues of the PG macromolecules which is responsible for our current understanding of
the special feature of mycobacterial peptidoglycan.74,75
1.7.2 Analysis of Arabinogalactan Complex
1.7.2.1 Degradative analysis
The original strategy for AG analysis included harsh chemical hydrolysis to release
the arabinogalactan complex from the cell wall through delipidation and hydrolysis with
1N sodium hydroxide.80 The hydrolytic step is followed by neutralization, dialysis
against pure water and AG precipitation by 80% ethanol. Successive column
chromatography on Dowex and DEAE cellulose removes proteins and yields pure
fraction of AG and arabinomannan. Further steps of hydrolysis and derivatization are
then necessary to break down the polymers into small sugar fragments that can be
analyzed using GC/MS or HPLC/MS.80 These long analytical procedures require a large
cell mass of about 800 grams. Yet, a lot of information regarding the sugar linkage and
the branching pattern of the cell wall polysaccharides can be lost during the harsh
chemical treatment.
A milder protocol was introduced by Daffe et al in 1990 that included the production
of high quality cell wall preparation through sonication and treatment with surfactant
such as triton-x.81-83 Extraction with SDS was then necessary to remove associated
proteins. The cell wall preparation produced was per-O-methylated using dimethyl
sulfinyl carbanions then partially hydrolyzed with trifloroacetic acid. The partial
hydrolysis resulted in random glycosidic cleavage at different positions of the AG chain
to produce different fragments. Upon reduction of these fragments with Na BD4, 43
different alditol fragments were produced which can be differentiated through analysis
via GC/MS.81 Through this methodology, linkages and branching within the AG complex
were elucidated.79 Later, the same method with few modifications was used to establish
the type of linkage between the PG and the mAG complex.
1.7.2.2 Solid state NMR HR-MAS for elucidation of AG
The previously discussed procedures have established the structure of AG, its sugar
composition, linkage type and branching pattern. This well documented research paved
the way for a faster method for screening the structure of AG without long hydrolytic
procedures through the use of solid state NMR spectroscopy. While solution NMR was
used to establish the configuration and linkage type of the predigested fragments, high
resolution magic angle spinning (HR-MAS) can be used with live bacterial cell to
analyze intact AG molecule through the production of 1H-13C HSQC maps.189,190 Due to
the dynamics of HR-MAS acquisition, the HSQC spectrum of live bacteria preferentially
contains signals of arabinogalactan and lipoarabinomannan rather than lipids and mycolic
acids. This is due to several factors concerning the short T2-relaxation time of lipids and
their slow molecular tumbling in the absence of organic solvents.
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Different residues of arabinose and galactose at specific branching points and with
variable substitution were represented by distinct signals in the HR-MAS spectrum.189
These signals can be used as indicators for the presence or absence of specific branching
points or substituents. The method requires supplementing the culture with 13C-carbon
source like glucose and glycerol to obtain good quality spectra in a reasonably short time.
After enrichment, 30-40 mgs of culture is sufficient for simultaneous structural analysis
of both AG and LAM.189,190
1.7.3 Free Lipid Extraction
Any biochemical approach for studying lipid composition and function has to start
with an extraction process to remove the lipids from the cell wall. Two main
methodologies have been used for this purpose. First is the Folch’s protocol developed by
Jordi Folch in 1956 which uses a mixture of chloroform: methanol 2:1 v/v for lipid
extraction.191 As he described it, an excessive amount of solvents is usually used for
extraction (twenty times the volume of the cell pellet). Then the extraction step is
followed by washing steps using a solvent mixture of chloroform: methanol: water
3:48:47. This ratio is critical to reduce loss of the lipids to the aqueous layer that
separates from the lipid organic layer upon centrifugation.191
The second protocol is the method developed by Bligh and Dyer in 1959 which was
proposed as a modification of the Folch’s to avoid excessive solvent use.192 This protocol
is better suited for extraction of tissues with more moisture and low lipid content and was
proved to be more efficient in extracting polar lipids. It was also simplified from the
Folch’s protocol to avoid the multiple washing steps through using an extraction solvent
with higher methonal ratio then adding more chloroform and water to achieve biphasic
solution. Lipid extraction is first achieved using a mixture of chloroform:methanol 1:2 .
Subsequently, chloroform and water are added to the final lipid extract to bring the total
solvent ratio to chloroform:methanol:water 2:2:1.8 which renders the extract biphasic.
The two layers are then separated by centrifugation. The upper aqueous upper layer
(devoid of lipid content) is then discarded.
It is to be noted though that both protocols were originally designed for the extraction
of membrane lipids from animal tissues which are not covalently bound to the cells.191,192
In the case of Mycobacteria both methods can serve the purpose of extracting only
loosely attached free lipids. In order to perform mycolic acid analysis, the extraction
procedures has to be preceded by a step of alkali or acid hydrolysis to release the
covalently bound mycolic acids from the arabinogalactan complex.
1.7.4 Mycolic Acid Extraction
Mycolic acids in Mycobacteria are present in two forms; A minor fraction is esterfied
to sugars mainly in the form of trehalose mono and dimycolates, while most of the cell
wall mycolic acids are covalently bound to the PG-mAG complex.59 In order to analyze
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the total mycolic acids pool, the covalently bound fraction has to be released in a free
extractable form. This is achieved through either acid or alkaline hydrolysis. Alkaline
hydrolysis (saponification) produces the highest yield and is the most frequently
used.90,94,187 It includes three consecutive steps of hydrolysis, neutralization and
extraction. Methanolic or ethanolic potassium hydroxide can be used for saponification
followed by acidification of the saponified wax with HCl to release mycolic acids.193 At
this point, the free mycolic acids are readily extractable with an organic solvent such as
diethyl ether or chloroform.193 For analytical characterization by GC or HPLC, the
mycolic acids have to be derivatized to their methyl esters.194 Esterification is performed
by a methylating agent such as iodomethane or diazomethane.
Alternatively, mycolic acids can be extracted through methanolic acid hydrolysis.195
In this case, a mixture of methanol, sulfuric acid and toluene or methanol/6N HCl can be
used to release mycolic acid esters which can then be extracted with n-hexane. Both
alkaline and acid hydrolysis have been proven effective in preparation of high quality
mycolic acid extracts. They also proved to be amenable to scaling down. Few milligrams
of cells were satisfactory in obtaining a reproducible HPLC or GC mycolic acid pattern in
both cases.196
1.7.5 Lipid Analysis
After the initial extraction, different bioanalytical methodologies can be applied to
create a “lipid profile”. The ideal bioanalytical technique to be used for such purpose
should result in a lipid profile that would represent the lipid pool of the original sample in
both qualitative and quantitative manner. In most cases however, a combination of
techniques is required to fully analyze a complex and diverse mixture of lipids such as
that of the mycobacterial cell wall. The fact that these lipids represent a wide spectrum of
physical properties (different degrees of polarity, ionization potential and extraction
accessibility) make it especially challenging for a single technique to overcome this
complexity.
The range of techniques that have been used for this purpose included traditional
chromatographic techniques (TLC, GC and HPLC), lipid radiolabeling strategies and
most recently spectrometric techniques such as MS and NMR. Both spectroscopic
techniques have been traditionally reserved for structural elucidation of individual lipid
molecules. But with the advancement in both MS and NMR fields and the development
of robust statistical methodologies, these two methods are increasingly being applied for
comprehensive lipid analysis studies.
Because of their abundance and diversity among different species, mycolic acids
received the most attention towards their identification and analysis. Almost the full
range of chromatographic techniques has been applied for this purpose. Due to its
simplicity and low cost, TLC was the first chromatographic technique to be used in
producing mycolic acid patterns. After considerable success and wide application,
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problems of low resolution had to be addressed through the introduction of more
sophisticated and powerful chromatographic techniques such as HPLC and capillary GC.
1.7.5.1 Simple thin layer chromatography (TLC)
TLC was the earliest technique used to detect and classify bacteria based on their
mycolic acid patterns. When mycolic acids are extracted as mentioned in section 1.7.4.
The methyl mycolate esters (usually derivatized by the use of iodomethane) can be
separated on thin layer chromatography plates both in one dimension but preferably in
two dimensions.185,197 The sensitivity of detection can be enhanced by incorporating
strategies such as radiolabelling and silver impregnation.198,199 Further modification of
the solvent system through the addition of small amount of acid has eliminated the need
for esterification steps. The most commonly used TLC protocol for mycolic acid analysis
now includes two successive developments first in heptane:diethylether:acetic acid 94:5:1
for half length then for the full length in petroleum ether: acetic acid 98:2.198
1.7.5.2 2D-TLC systems
Dobson et al introduced the first small scale procedures for comparative analysis of
mycobacterial lipids. The methodology was meant to address the full polarity range of
mycobacterial lipids by using a sequential solvent extraction to fractionate the loosely
bound lipids to polar and non-polar pools. These two lipid pools were then analyzed
using five different chromatographical developing systems with increasing solvent
polarity.200 In the non-polar lipid fraction, two developing systems of low polarity were
used to detect triacyl glycerols, menaquinones and phthicerol waxes. By increasing the
polarity of the two developing systems, a diverse group of glycolipids were resolved
using three other solvent systems with increasing solvent polarity. This group includes
acylated trehalose, phenolic glycolipids and sulfolipids. In the polar lipid fraction,
glycopeptidelipids, phosphatidylinositol mannosides and other polar glycolipids were
resolved using two relatively polar developing systems.
The fact that this method does not rely on specific analytical equipment allowed its
wide use by microbiologists. As a result, this method has found application in
comparative analysis of different strains, investigating the effect of growth condition in
lipid biosynthesis and probing gene functions by providing evidence for inhibition of the
biosynthesis of a certain molecule as a result of gene knockout. However it was obvious
that the low detection sensitivity allowed the method to be capable only of detecting
abundant lipid species and thus it was only useful when gross changes in the lipid pools
were expected. An additional step of acidic or alkaline methanolysis is necessary if the
method is to be used to analyze the lipid pool of covalently bound fatty acids.
1.7.5.3 Gas chromatography (GC)
Gas chromatography has been a major research tool in identification and structural
characterization of Mycobacteria cell wall components. The use of capillary GC/MS is
indispensible for the proper identification of the cell wall glycolipids as it is the method
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of choice for identification of the type of the glycol part and the nature of the glycosidic
linkage that exist in a molecule.81 However, the initial introduction of GC in the
mycobacterial research field was only to be used as a tool for identification of
Mycobacteria among other microorganisms through pyrolsis.201-203 The concept of using
GC in the identification of mycobacterial clinical isolates remains popular among
researchers although nowadays it is done through fatty acids pattern rather than pyrolsis
products.204,205 The diverse repertoire of fatty acids and alcohols that make up the
complex cell wall lipids produces a distinct lipid profile that can be used as a finger print
to differentiate between species of Mycobacteria.193
For this type of analysis, the cellular fatty acid pool is released from the cells through
organic solvent extraction and then esterfied through the process of alkaline
methanolysis.193,205 These methyl esters are then analyzed by capillary GC/MS to produce
a specific fatty acid profile that can be used to distinguish between Mycobacteria and
other closely related actinomycetes.193,205 Due to its accuracy and reproducibility, this
protocol has been further developed to include full automation and standardization of the
extraction and analytical procedure along with a database that includes fatty acid profiles
for most Gram positive and Gram negative bacteria. This fully automated computer
assisted identification system is now commercialized under the name Sherlock Microbial
Identification System® (SMIS) which is commonly used for simple identification of
microorganisms.206 Comparison between the automated system and the use of
conventional GC analysis of fatty acids methyl esters found that they both produced
similar results when used to identify 68 Mycobacteria clinical isolates.205
1.7.5.4 High performance liquid chromatography (HPLC)
The center for disease control and prevention (CDC) has incorporated the use of
HPLC as a standard procedure for Mycobacteria classification and diagnosis in 1990.187
This procedure employs HPLC to produce a well-resolved chromatogram of the cellular
mycolic acid pool that is species specific and thus can be used as a diagnostic tool in
dealing with mycobacterial infections. After initial steps of saponification followed by
acidification and extraction into chloroform, the saponified wax (mycolic acids) are
derivatized using p-bromphenacylbromide, 4-bromomethyl-6,7-dimethoxycoumarin, 9anthryldiazomethane or other fluorescent reagent to maximize sensitivity to UV
detection.94,207-209 These derivatives are then separated by C18-reverse phase column with
a methanol/dichloromethane gradient to produce a chromatogram that is unique for a
particular species. Two internal standards of different molecular weights are added to aid
in the pattern comparisons and recognition, a process that can be achieved visually or
through computer-assisted pattern recognitions.187,209
The utilization of HPLC for mycolic acid analysis has been modified over a
considerable period of time to develop into a protocol that can be highly reproducible and
easily automated. Initial problems of long extraction procedures, low sensitivity and
subjective process of manual pattern recognition have been successfully overcome.210
The result of these refinements is a standard protocol that can decisively identify any of
the mycolic acid producing actionmycetes within 40 minutes analysis time and with 98%
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accuracy.187,211 More recently it has been used in some academic setting as a tool to
assess the drug susceptibility of certain clinical isolates.212
1.7.5.5 Mass spectrometry (MS)
Coupled with GC or HPLC, mass spectrometryhas found great use in the structural
determination of many Mycobacteria lipid classes. Since the development of soft
ionization techniques such as electrspray ionization (ESI-MS), fast atom bombardment
(FAB-MS) and matrix assisted laser desorption ionization (MALDI), MS has been used
in sequencing both the peptide and oligosaccharides component of the lipid cell
wall.81,102,133,157,213,214 With the great advancement in MS, analysis of complex biological
mixture without prior separation is now attainable. Soft ionization techniques that
produce minimal fragmentation can produce a relatively simple spectrum for a biological
mixture. In addition, advancement in resolving techniques and the availability of different
analyzers with ultrahigh resolution capability that can reach a value of 100,000 in some
cases have offered better accuracy in mass determination that can reach 1ppm.
In a recent example of the utilization of MS in the analysis of mycobacterial lipids,
Cox et al has coupled the soft ionization of ESI ion source to the super resolving power
of ion cyclotron analyzer to directly analyze a crude mixture of mycobacterial lipids
using Fourier transform ion cyclotron resonance (FT-ICR)-MS.215 The technique was
applicable both to cells grown in vitro and in vivo using ten milliliters of bacterial culture
or bacilli isolated from infected mouse lung. The entire free lipid pool was
simultaneously monitored and a number of metabolic changes in this pool were identified
as a result of gene mutation or limitation in the availability of biosynthetic precursors.
With the privilege of having a comprehensive look at the entire lipid pool, the researchers
were able for the first time to identify compensatory mechanism and metabolic coupling
of two Mycobacteria virulence factors PDIM and SL-1. These metabolic processes were
also detected in an in vivo model of mycobacterial infection in mice. Changes in lipid
metabolism related to both the relative abundance of the lipid produced and its specific
structural modification such as variation in lipid chain length were also detected.215
However, some problems were reported by the researchers concerning the inability to
recover low abundant lipids after in vivo infection as they were below the limits of
detection by this technique. But the relative simplicity of the technique and the wealth of
structural information it can offer promises a wide range of future application. A wider
application of such method in the mycobacteriology research can be hampered by the
limited access to such mass analyzer for most laboratory microbiologists.
Another elegant application of MS in Mycobacteria lipid analysis was proposed by
Wenk and colleagues.216 In his research, the mass spectrometry analysis of Mycobacteria
lipids was preceded by a separation step using HPLC. The HPLC was integrated in that
system to allow the analysis of low abundant lipids which may not be detected by MS if
analyzed within a mixture of other highly abundant lipids. The ion source chosen was
ESI which beside its soft ionization advantages, is better suited to coupling with
HPLC.216 A potential problem of peak broadening and ion suppression during mass
analysis was partially overcome by the use of piperidine in the HPLC mobile phase. The
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addition of piperidine in the mobile phase enhanced ionization and conferred an increase
in sensitivity by 2-10 folds. But the choice of relatively high pH mobile phase
necessitated the use of special reverse phase column that can withstand these conditions.
An isocratic elution scheme of 15mM piperidine in a mixture of chloroform: methanol
1:1 was used to effectively separate the mycobacterial lipids over a period of 85 minutes.
The mass analysis of the effluent from the capillary column was achieved using Q-tof
mass analyzer operating in the negative mode where most of the membrane and the cell
wall phospholipids can effectively ionize. Another advantage of this method is that
mycolic acids can be directly analyzed after hydrolysis without the need of a
derivatization steps as it is normally required for GC or HPLC-based mycolic acid
profiling. The technique was presented as a “non targeted readout” methodology which
can be used for the analysis of paired samples (i.e. control versus treated) and was
applied by the authors to study the changes in the mycolic acid pool between replicating
and dormant M. bovis BCG in a qualitative and semi quantitative manner.216 The
limitation of the method however remains in the low ion response for some groups of
non-polar lipids which includes for example acyl glycerols and PDIM.
1.7.5.6 Nuclear magnetic resonance (NMR)
Nuclear magnetic resonance has provided researchers with plethora of structural
information about Mycobacteria cell wall components that is unmatched by any other
technique. NMR has been an indispensible tool for structural elucidation of all the cell
wall components that we came to know. Gross structural features such as the nature of
functional groups and the degrees of unsaturation are readily detected by NMR as well as
more fine structural features such as the configuration of double bonds and the anomeric
carbon of sugar residues. Such information can be obtained with relative ease through
analysis of NMR coupling constants. However, NMR use has always been restricted by
its relative low sensitivity. This hurdle is likely to be of less significance in the near
future with the frequent use of very sensitive sample probe (e.g. cryogenic probe) and the
development of smarter pulse sequence. Nevertheless, in the past two decades NMR has
found great application in the biological field. For Mycobacteria, an HR-MAS based
methodology was developed that uses live bacterial cells to monitor metabolic changes in
polysaccharide components of the cell wall (mainly AG and LAM).189 This type of
application is likely to remain of limited use in lipid analysis due to irregularities in
molecular tumbling and relaxation that can be expected from relatively high molecular
weight lipids when dealing with the condition of solid state NMR.
1.8 Current Challenges in Mycobacteria Research
Tuberculosis remains the leading cause of death from a bacterial infection. Large
efforts have been directed to combat this devastating disease and limit its progression
worldwide. Despite these efforts, TB has claimed 1.7 million lives and spread to nine
million individuals during the year 2006.12 Until the dynamics of the battle between
humans and the tubercle bacilli change significantly, it is likely that TB world causalities
33

will remain at the same level that we experience today. The first step in eliminating this
disease is through new treatment regimens that include an arsenal of drugs with new
molecular targets and novel mechanisms of actions. For development of such drugs,
researchers in the mycobacteriology field need innovative approaches to achieve a better
understanding of this successful pathogen and its challenging capabilities. Some of these
challenges are summarized below.
1.8.1 Mycobacteria Latency and Persistence
We are aware that during infection Mycobacteria adapt a complex life cycle in which
the bacterial population responds to changes in its surrounding environment by shifting
between different metabolic states.49,52,53,217,218 In establishing a new infection, the
bacteria are dividing rapidly inside the human alveolar macrophages in aerobic but acidic
condition and remain essentially accessible for chemotherapeutic agents.49 However in
case of inactive infection, the bacilli remain isolated inside the tubercle structure and so
they enter a state of latency (limited cell division) and shift most of the metabolic
processes to more of an anerobic nutrient-deprived life style.52,219 Due to their isolated
location inside the TB granuloma with limited blood supply, halted replication and
adaptation to slow metabolic rates, latent bacilli show tolerability to chemotherapy.73,220
Upon reactivation and liquefaction of the organized tubercle structure, the bacilli start to
rapidly grow and spread to new infection loci as well as to new hosts.49,51
Reports have shown that latent bacilli isolated from an intact tubercle are viable but
uncultivable in the laboratory under normal growth conditions.52 Innovative ways to
study the metabolic shifting during the process of latency and subsequent re-activation is
necessary to define all elements involved in these processes. A potential success in
identifying new molecular targets essential for this process can lead to the emergence of a
new class of anti TB drug candidates. Such drugs that abolish Mycobacteria ability to
persist in latent state or to be activated to an infectious state will effectively reduce the
length of treatment regimens, limit the spread of the infection and significantly reduce the
world repertoire of the infectious bacilli.
1.8.2 Mycobacteria Virulence
Despite decades devoted to studying virulence determinants of the tubercle bacilli,
there has not been a major breakthrough in that field. Our inability to this day to list with
clarity the Mycobacteria virulence factors remains frustrating at best despite the
availability of complete genome sequences for several virulent and avirulant strains of M.
tuberculosis.221-224
This underscores the need to complete the gene annotation of M. tuberculosis genome
which possesses many unique genes some of which may have direct involvement in
virulence. It is also important to carry out comparative genomics studies aimed at
explaining variability in strain virulence among different clinical isolates and different
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lineages. Another aspect concerning Mycobacteria virulence is to identify cellular
components that participate in host-pathogen interactions and to define signaling
pathways that mediate cell entry and promote bacteria survival inside macrophages.
Research done so far in this area has implicated several cell wall lipids such as PIM and
manLAM in triggering the host immune response and halting the process of phagosomal
maturation respectively.66,110,111
1.8.3 Mycobacteria Drug Resistance
Tuberculosis is no longer the incurable epidemic (white plague) it once was which
claimed millions of life in Europe in the 19th century.20 We owe this to the development
of several anti-TB drugs starting with streptomycin in 1944.21 However, the current
regimen for TB treatment remains exceptionally long (the short treatment course last for
six months and involves four drugs), which results in poor adherence of TB patients to
that long and seemingly unnecessary course.54,55 When a patient stops his treatment
improperly due to relief of symptoms, the bacterial growth is only partially suppressed
allowing the enrichment of the bacterial population with naturally occurring resistant
mutants. Once the resistant strains are activated again, the infection is exceptionally hard
to treat and typically requires two years of therapy with the possibility of spreading the
infection to others during this period.34 MDR-TB now has a global distribution while the
more serious XDR-TB is being reported in several countries including the United
States.15,34,36 Several questions remain on the best way to curb the spread of such
dangerous strains as well as to the molecular basis to this sort of multiple drug resistance.
1.8.4 NTM Infections and Emerging Mycobacterial Diseases
The incidence of non tuberculous Mycobacteria (NTM) lung disease is alarmingly on
the rise.15 The term NTM is generally used to describe Mycobacteria species other than
that of the M. tuberculosis complex and M. leprae. 4 These NTM are ubiquitous
environmental organisms that we are exposed to everyday as they exist in the soil and
water.2,225 M. avium has been known to have the ability to colonize parts of the human
body such as the urinary and respiratory tract without causing diseases.16 However,
individuals infected with HIV are especially vulnerable to infection with these organisms
due to their severely compromised immune system. The most prevalent NTM infections
among HIV patients are the disseminated infection with members of M. avium complex
or MAC.226 Most recently, cases of NTM lung disease are being reported in several
western countries in individuals with no history of immune-suppression or HIV
infections.16,227 We have limited understanding of the pathogencity of these bacteria and
the disposing factors (other than HIV) that can make an individual vulnerable to these
infections. All members of MAC complex produce highly antigenic glycopeptidolipids
GPL but until now these fascinating molecules have not been shown to play a specific
role in virulence and pathogenicity.155 Other less common NTM do not make these
haptens but are still capable of producing serious infections in some individuals.228-230
More research is necessary to define the molecular basis underlying the infectivity of
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NTM and the host pathogen interaction associated with them. Such effort are likely to
reveal interesting new pathways in which Mycobacteria surface components can interact
with the host cells and how these events affect the clinical outcome.
In certain areas of the globe, there is a growing number of cases of infections with
another mycobacterium species. Buruli ulcer (BU), caused by M. ulcerans, is now
reported in more than thirty countries with the highest incidence rate in West Africa.14,38
Once not recognized by physicians and scientists, BU infections have been emerging
rapidly as a serious health concern during the 1980s. In response to the emergence of this
disease, WHO has launched the Global Buruli Ulcer Initiative in 1998 to raise awareness
of the disease and encourage scientific research to further define the disease and its
causative agent and help find new treatment options for the thousands affected by it.
Due to the prevalence of BU in relatively poor and remote communities, the exact
incidence rate of BU is not completely known. Also, prevention strategies are hard to
implement since the mode of transmission of M. ulcerans has not been established yet.
Beside our need to understand disease transmission and pathology, there is an urgent
demand to develop new treatments and vaccines to counteract the emergence of such
devastating illness. One of the remarkable breakthroughs in our understanding of BU was
the establishment of M. ulcerans virulence factors. In 1999, George, KM et al reported
the identification and chemical characterization of mycolactone A/B, a macrolide toxin
secreted by M. ulcerans that produced the same pathological features as BU in animal
models.231
1.9 Purpose of This Study
Our understanding of the mycobacterial cell wall, its biosynthesis, structural features
and the role each cell component plays in the pathogenicity is largely based on data
obtained through multivariate experiments that evaluate a single molecule at a time. A
better way to study the mycobacterial cells should include a global approach to provide a
panoramic view of as many metabolites as possible simultaneously and avoid the
drawbacks of dissecting cell metabolites on multiple experiments. The key focus of the
research project discussed in this dissertation is to utilize the analytical power of NMR
spectroscopy to develop a new methodology for global analysis of Mycobacteria lipid
pool as a complementary technique to the previously developed HR-MAS that focuses
mainly on the cell wall polysaccharides. The two techniques share a similar strategy of
13
C-isotope enrichment and reliance on 1H-13C 2D-HSQC experiments. When combined
together the two techniques will provide a comprehensive analysis of major cell wall
components in reasonably short time period and with minimal sample manipulation.
The goals of this research were outlined to insure the simplicity of the new
methodology which will make it available to a wide spectrum of investigators. The
results obtained from such techniques have to be easily analyzed and standardized to
allow valid comparison of results obtained by different research groups. The following
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chapters offer a thorough discussion of the experimental design and the results obtained
towards achieving the main goals of this research which include
• Development of a lipid profiling technique with an optimized extraction,
acquisition and analysis protocols that insure the reproducibility of the results.
• Validation of the methodology in providing unbiased representation of the cellular
lipid pools of several Mycobacteria species.
• Combination of the method with HR-MAS technique for qualitative and
quantitative monitoring of adaptive changes in the cell wall metabolites when cells
are grown under stress conditions.
• Evaluation and application of MS and NMR-based techniques in targeted as well
as non-targeted lipid analysis.
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CHAPTER 2. DEVELOPMENT OF A NEW METHOD FOR ANALYSIS OF
MYCOBACTERIA LIPID POOL 1
2.1 Introduction
The cell wall of Mycobacteria has a very complex and unique structure with notably
high lipid content. Great research efforts have been directed to the characterization of the
individual components of the cell wall and investigating the role of these components in
Mycobacteria pathogenicity and virulence. Early attempts for global analysis of the
mycobacterial lipidome began in the 1960s during the search for a proper taxonomical
tool to assign newly discovered species in their right taxonomical order and to help
identify clinical isolates to the species level.86,233,234 A major breakthrough in this field
was achieved by Dobson and Minnikin who reported five 2D-TLC systems in the 1980s
to analyze the mycobacterial lipidome.200 Despite its wide application, this methodology
remained less than satisfactory. Problems associated with poor staining, low sensitivity
and limited resolution on one hand and the recent advancement of bioanalytical tools on
the other, have fueled a research effort for new methodologies to study the mycobacterial
lipidome.
Recently, two new methodologies based on mass spectrometry have been described.
The first uses Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR)MS.215 The second uses prior separation with HPLC followed by analysis with
electrospray ionization HPLC/ESI-MS.216 These analytical techniques are highly
sensitive, however, they require significant sample manipulation to overcome the
phenomena of ion suppression within the lipid mixtures thus are best used for the analysis
of readily ionizable molecules.215,216
All these methodologies offer great tools to investigate adaptive changes in
mycobacterial lipid pools. Such techniques can be used to study the mode of action of
anti-tuberculosis drugs, determine gene function, understand the stringent response of
Mycobacteria under stress conditions that resemble its in vivo environment, and to
investigate differences between species or strains of Mycobacteria. To maximize their
benefit, these lipidomics techniques are best used in complementary fashion and together
with other genomics and proteomic methods. As it is the case with other “omics”
techniques, the great utility of these methods is that they provide a wealth of information
regarding the total composition of the lipid pools, from which a small number of
candidate molecules can then be defined for more comprehensive follow up studies
through purification and isolation of such molecules of interests.
The method being developed in this dissertation focuses on the application of NMR
spectroscopy as a complementary tool that can be utilized to rapidly analyze the pool of
Parts of this chapter are adapted with permission. Mahrous, E.A., Lee, R.E. & Lee, R.E.
Lipid profiling using two dimensional heteronuclear single quantum coherence NMR. in
Lipidomics: Methods and Protocols (Humana Press, New York, 2009). In press.232
1
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membrane and surface free lipids directly. Considered as a universal technique, the use of
NMR can be successful in certain areas where other analytical methods have failed. As
NMR measures properties of nuclei rather than the physical property of the entire
molecule, NMR signals are less likely to be affected by the different physicochemical
properties exhibited by different classes of lipids (Molecular weight, polarity, ionization
potential, etc). This uniformity of response is advantageous because it limits artifacts and
confers quantitative representation of all lipids regardless of their structures. However,
several challenges exist for using NMR to study complex pools of metabolites. The first
of which is the low sensitivity associated with NMR analysis. This can be partially
overcome by enriching the cell lipidome with 13C-isotope through the replacement of the
carbon source in the growth media with 13C-labeled lipid precursors. The second
challenge is the complexity and the frequent overlapping of signals in the NMR
spectrum. This problem can be addressed through the use of two and three dimensional
NMR. Two dimensional 1H-13C heteronuclear single quantum coherence (2D-HSQC)
NMR can be used to rapidly generate lipid profiles with acceptable resolution, while
more sophisticated three dimensional experiments can be used to resolve the lipid profile
and help assign signals in the 2D-HSQC spectrum when necessary.
Beside the choice of the appropriate NMR pulse sequence, analysis of such complex
data requires extra consideration and efforts. To insure data quality, signals in the NMR
spectra need to be referenced in both their chemical shift and relative intensity to an
internal reference that produces a discrete signal in the 2D-HSQC NMR spectrum. To
enhance reproducibility, external references may be required to calibrate the NMR
spectrometer and account for any observed variation due to instability of the high
frequency magnet over time. The data must then be normalized based on these internal
and external standards using suitable software which confers robust analysis of large data
sets.
Other than NMR acquisition criteria, several parameters regarding cell growth
conditions and extraction procedures can also contribute to the quality of the lipid
profiling process. The extent of 13C-enrichment is controlled by several factors including
the type of growth media, size and strategy of inoculation, the concentration and the
nature of 13C-sources used. On the other hand, extraction procedures can be affected by
the type of extraction solvent, temperature and duration of extraction and the ratio
between cell weight and the volume of solvent used. Hence, several manipulations
within the growth and extraction strategy can be sought to target the analysis of specific
subpopulation.
2.2 Materials and Methods
2.2.1 Strains and Growth Conditions
M. smegmatis and M. bovis were grown in liquid growth media at 36.5°C with
continuous shaking at 250 rpm. Middlebrook 7H9 was used for growing the bacilli after
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addition of 10% ADG supplement and 0.05% Tween-80. For 13C-enrichment, the main
carbon source (dextrose and glycerol) were replaced with 13C6-dextrose and 13C3-glycerol
respectively. For method development, M. smegmatis mc2155 and M. bovis BCG were
used as surrogate for M. tuberculosis. M. smegmatis was inoculated at a starting O.Dλ600
of 0.005 while M. bovis BCG was inoculated at starting O.Dλ600 of 0.05.
2.2.2 Total Lipid Extraction and Fractionation
Cell cultures were harvested by centrifugation at 3700xg for 10 minutes at room
temperature. The cell pellet was washed twice with 5 milliliters of deuterium oxide (D2O)
and the supernatant was removed by repetitive centrifugation and decantation in between.
One milliliter of D2O was used to transfer the washed cell pellet to a pre-weighed microcentrifuge tube. The cell suspension was then centrifuged at 21,000xg for ten minutes and
all remaining D2O was carefully removed. For total lipid extraction, a 2:1 mixture of
CDCl3:CD3OD was added to the washed cell pellet (3µl per 1mg) of wet cell weight.
DMSO was added in certain experiment to be used as an internal standard to a final
concentration of 4, 8 and 16mM. The extraction was achieved at 37°C with continuous
shaking for 20, 40, 90 and 120 minutes.
For fractionation of the cellular lipid into polar and non polar fraction, two layers were
separated by direct centrifugation of the cell suspension at 21,000xg for 10 minutes. The
aqueous upper layer (polar lipids) and the organic lower layer (apolar lipid) were
separately transferred to 5mm NMR tube for analysis. For analysis of the total lipidome,
extra CD3OD was added to the extraction mixture (1µl per 1mg of cells) to bring it to a
single phase solution. Then the extract was separated from the cell debris by
centrifugation as above. In some instances, other extraction solvents were also used such
as acetone-d6 and benzene-d6.
2.2.3 Mycolic Acid Extraction
Delipidated cell pellets were re-suspended in two mls of 1M methanolic KOH. The
cell suspension was heated in a screw capped glass tubes at 70°C for 16 hours with
continuous stirring. After the alkaline hydrolysis, the extract was cooled down and
neutralized with concentrated HCl to release free mycolic acids. The extract was then
diluted with four volumes of deionzied water before being extracted twice with one
volume of diethyl ether. The combined ether extract was washed with deionized water
and brought to dryness under vacuum using a rota-evaporator at 40°C. For NMR
analysis, the mycolic acid residue was dissolved in a 1:1 mixture of CD3OD:CDCl3.
2.2.4 NMR Acquisition and Data Processing
All NMR experiments were done using Varian-Inova 500MHz spectrometer equipped
with a 5mm triple resonance trpfg probe. 2D-HSQC pulse sequences were done at 24°C
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for 256 increments and 2, 4, 12 or 60 transients after each sample was tuned, shimmed
and locked separately. Other acquisition parameters were optimized for each sample as
well. Felix-NMR 2007 were used to process and analyze the data after referencing to the
DMSO peak at δ1H=2.67, δ13C=39.4 ppm.
2.3 Results
2.3.1 Production of NMR Profiles and Assigning Signals of Some Cell Wall Lipids
The isotope enrichment strategy greatly enhanced the signal intensity and conferred a
good spectrum in a relatively short acquisition time. A good quality 2D spectrum was
attainable in 20 or 40 minutes. However, observation of some less abundant lipid species
necessitated a longer acquisition time of 90 minutes (Figure A.1). Signals in the HSQC
spectrum were well dispersed and can be categorized into three main regions; the most up
field region (δ1H, -0.5-3.0 ppm) representing the aliphatic chain of the lipid molecules,
the far down field region (δ1H, 5.2-8.5 ppm) representing unsaturated and aromatic
substructures and the middle region (δ1H, 3.0-5.4 ppm) which was crowded with signals
mainly from the sugar residues of different glycolipids (Figure 2.1). Although there is
significant crowding of some signal areas of the HSQC spectrum, since every molecule is
represented by multiple signals, we found that at least one or two signals from each lipid
molecules of interest did not overlap with other signals (examples are shown in Figure
2.1). Therefore, the presence or absence and the relative quantity of a certain molecule
can be readily determined by these diagnostic biomarker peaks (Table 2.1). When
possible, it is useful to identify and utilize multiple biomarker signals for a certain
molecule of interest to confer a greater degree of confidence in the data interpretation and
hence limit the possibility of artifacts from unidentified overlapping species.
2.3.2 Effect of Different Growth Conditions
It has been reported that the composition of the cellular lipid pool can change
depending on the growth conditions including the type of carbon sources used in the
growth media.158,159 Glycerol grown Mycobacteria usually accumulate large amounts of
acylated glycerols, while cells that depend in their growth on glucose as the main carbon
source tend to form less acylated glycerol and more of the acylated hexoses.159,235 We
observed similar changes in the growth of M. smegmatis in Middlebrook 7H9 media
when the growth media was supplemented with either 13C6-dextrose or 13C3-glycerol as
shown in Figure 2.2.
Some differences were also observed between the lipid profiles of cells growing in
liquid media, Middlebrook 7H9, and that growing in a parallel solid media, Middlebrook
7H11 agar. In the case of M. bovis BCG, we reported a general increase in the production
of triacyl glycerols, phenolic glycolipids (mycoside B) and methyl-branched fatty acids in
cells grown on solid media (Figure 2.3). On the other hand, the production of
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Figure 2.1 2D-HSQC Lipid Profile of M. bovis BCG
1

H-13C HSQC spectrum of the 2:1 v/v CDCl3:CD3OD extract of M. bovis BCG. The
extract was obtained as described in the text (section 2.2.2). For illustration, three
biomarker signals for menaquinones are shown (signals Ia-c), and two biomarker signals
are shown for trehalose dimycolate (signals IIa,b) including the diastereotopic CH2 of the
cis cyclopropyl ring. Signal III indicates the signal for DMSO, which was included as an
internal standard during the extraction. The total sample preparation time including
extraction was two hours. Total NMR acquisition time was 1 hour and 40 minutes
(ni=256, nt=10).
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Table 2.1 Chemical Shift Values of Major Lipid Biomarkers
δ1H
ppm

δ13C
ppm

Description

CH-glycerol

5.30

69.31

CH2-glycerol

4.38,
62.43
4.19
2.35 34.18

Description
TAGa

CH2CO fatty acids

trehalose- anomeric

trans double bond

aromatic CH

7.15

130.73

aromatic CH

6.81

115.86

PDIMc

CH2-CH-COOR

0.96,
1.23
4.87

71.55

Methylated fatty
acidsc
-CH3

1.05

17.37

-CH3

1.16

19.69

CH-glycerol

5.26

70.47

CH2-CH-COOR
4.21,
4.44
5.13

63.08
93.65

Fatty acidsa
cis double bond

δ13C
ppm

Mycobactinsb

a

acylated trehalose
trehalose-C6 CH2

δ1H
ppm

5.34
5.12

129.97

45.54

b

124.62

Phospholipids

GPLa
phenyl alanine

7.27

128.71

PIM2 anomeric

5.10

101.85

methoxy sugars

4.67

55.36

PIM6 anomeric

5.01

102.63
52.81

Menaquinone

b

TDM

b

aromatic ring

7.74

133.64

CHCO

2.47

double bond

5.05

118.94

Cyclopropyl CH2

-.33,
0.58

a,b,c

10.73

Chemical shifts were inferred from 2D-HSQC spectra of M. smegmatis, M. bovis or
M. ulcerans respectively. Subtle variations in these chemical shifts can be observed
between species due to minor structural details.
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Figure 2.2 Effect of the Composition of Growth Media on the Lipid Profile of M.
smegmatis
Insert (a) is an expanded window of the area where the signals of different triacyl
glycerols and glycerol phospholipids are usually detected. Signals of TAG and
phosphatidyl inositol, indicated by arrows, were recorded at lower intensity in the
absence of glycerol from the growth media (lower spectrum). Insert (b) is an expanded
window of the area where the anomeric signals of acylated hexoses are usually recorded.
These signals were recorded at lower intensity in the absence of dextrose in the media
(upper spectrum). The anomeric signal of acylated trehalose is indicated by an arrow.
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Figure 2.3 Effect of the Use of Different Growth Media on the Lipid Profile of M. bovis
BCG
M. bovis BCG cells were harvested and extracted from either 13C-labeled 20mls culture,
(a), or the lawn of one 13C-labeled 7H11 agar plate, (b). Signals of mycoside B were
detected at higher intensity in the lipid profile of cells grown on solid media (biomarkers
of mycoside B are enclosed in dashed-line circles). However, mycobactins were detected
at higher intensity in the lipid profile of cells grown in liquid media (biomarkers of
mycobactins are enclosed in solid-line circles). Effect of using different growth media in
the lipid profile of M. avium is shown in Figure A.2.
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mycobactins seemed to be of less abundance in cells grown on solid media. These
differences can be either due to a real metabolic shift as a result of a change in the growth
environment of the bacteria or due to shedding off some surface lipids in the liquid
growth media with the continuous shaking and the addition of a surfactant such as
Tween-80.
Cells have also been extracted at different growth stages including early exponential
phase, mid exponential phase and stationary growth phase. The rapid cell division and
turnover of metabolites in the exponential phase was translated to relatively low signal
intensities in the lipid profiles of cells growing at optical density of 0.3- 0.4 (Figures
2.4a, A3). Cells harvested at later stages of growth at optical density of ≥ 0.7
demonstrated more diversity and intensity of lipid signals especially in the areas where
glycolipids signals are usually detected (Figures 2.4b, A4). However, throughout the
different stages of growth, stability in the relative abundance of glycerolphospholipids
can be observed. This class of lipids is indispensable for the integrity of the cell
membrane of living cell and so they may be used as an indicator of the overall spectral
quality or as an additional internal standard when two sets of spectra are being compared.
In principle, supplementing the growth media with specific13C-labeled lipid
precursors can achieve some selective labeling of certain group of lipids. For example,
adding 13C2-sodium acetate in the growth media of the cells resulted in selective labeling
of straight chain fatty acids and significant reduction in the intensity of glycolipids
signals and signals pertaining to polyketide lipids such as PDIM. The result was a
2D-HSQC spectrum that was representative mainly of straight chain fatty acid
substituents of major cell wall lipids (Figures 2.5, A.5).
2.3.3 Effect of Initial Culture Volume, Solvent and Duration of Extraction
The choice of the extraction solvent to be used depends mainly on the pre-determined
target of the lipid profiling. In certain cases, it may be desired to profile a specific sub
population like apolar lipids, acetone soluble lipids thus the extraction solvent will be
chosen accordingly. For total lipid analysis, a 2:1 mixture of chloroform-d1 and methanold4 is regarded as a first choice due to the existence of validated well-respected lipid
extraction protocols by both Folch191 and Bligh and Dyer192 that depend on the use of
chloroform:methanol mixtures.
Cells harvested from 20 and 50 milliliters cultures and extracted with 2:1 mixture of
CDCl3:CD3OD to a final volume of 500-600µl produced good quality 2D-HSQC spectra
using 5mm trpfg probe (Figure A.6). On the other hand, cells harvested from smaller 10
milliliters culture (50mg) required the use of 3mm NMR probe to accommodate smaller
sample volumes of about 150µl to produce a 2D-HSQC spectrum of comparable quality
and in reasonable acquisition time (Figure A.7).
Extraction with CDCl3:CD3OD for 20 minutes was sufficient to produce a good
quality lipid profile of the major cellular lipids. Longer extraction time of 40, 90 and 120
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Figure 2.4 Lipid Profile of M. bovis BCG Harvested at Different Growth Stages
M. bovis BCG cells were harvested and extracted at different stages of growth; at
O.Dλ600=0.4, (a), and O.Dλ600=0.72, (b). Lipid signals were generally reported at higher
intensity in cells harvested at later stages of growth. The two spectra were normalized in
their intensities to the intensity of menaquinones signals, indicated by the small arrows.
Lipid profiles of M. bovis BCG cells harvested at other optical densities are shown in
Figures A.3, A.4.
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Figure 2.5 Effect of Acetate Labeling on the Lipid Profile of M. marinum
Cells were grown in Middlebrook 7H9 where 0.2% 13C2-sodium acetate have been added
as a 13C-source, (a), or 13C6-dextrose and 13C3-glycerol were used as 13C-source, (b).
Acetate labeling resulted in selective labeling of straight chain fatty acids as indicated by
the presence of fatty acids signals at comparable intensity in the two spectra
(representative signals for straight chain fatty acids are indicated by arrows). Another
example for the effect of acetate labeling is shown in Figure A.5.

48

minutes offered better representation of lipids of lower abundance with no substantial
improvement observed for extraction longer than 90 minutes (Figure A.8). In all four
cases, the lipid profile produced after re-extraction of the pellet was of poor quality and
only displayed signals of some fatty acids and some membrane phospholipids (Figure
2.6).
Extraction with acetone-d6, produced good quality spectra but with a slight bias
towards non polar lipids and against glycolipids, especially phospholipids (Figures 2.7,
A.9). Other solvents with lower polarity such as benzene and petroleum ether failed to
produce a reasonable quality spectrum when used to extract the D2O washed cell pellets.
In fact, re-extraction of the cell pellet remaining after extraction with benzene-d6
produced a lipid profile where signal intensities were comparable to other profiles
obtained with a single step chloroform: methanol extraction (Figure A.10). Due to its
low dielectric constant, benzene-d6 as a solvent failed to solubilize the relatively polar
cell wall glycolipids that are included within an organized mycolic acids layer in the
outer membrane.
2.3.4 The Use of DMSO as an Internal Standard
Dimethyl sulfoxide DMSO was chosen here as an internal standard for a number of
reasons. i) It is miscible with most organic solvent. ii) It is easy to measure due to its
physical stability as a non volatile liquid. iii) It produces a single discrete signal in the
2D-HSQC spectrum which does not overlap with other signals in the lipid profile. iv) It is
chemically stable which means that it does not interact with cellular lipids under the mild
conditions of extraction and NMR acquisition. In a series of calibrating 1H-13C 2D-HSQC
spectral evaluation, NMR spectrometer was able to produce a linear response to different
concentrations of DMSO between one and 25mM that were detected in 1:1 solution of
CD3OD and CDCl3 (Figure 2.8). Similar linearity in response was obtained when three
concentration of DMSO at 4mM, 8mM and 16mM were used to reference the lipid pool
of M. smegmatis. From these concentrations, 8mM concentration (0.025µl of DMSO per
10mgs of cell pellet) was chosen to provide a reference signal of reasonable integration
value and without overlapping with other signals in the spectrum.
2.3.5 Reproducibility of the Lipid Profiles
Four cell cultures of M. smegmatis grown under the same growth conditions were
used to investigate the reproducibility of the procedures. The integral values of three
biomarker signals for PIMs, TAGs and unsaturated fatty acids (unFA) were collected as
indicators for the reproducibility of the results. With the use of a standard extraction and
NMR acquisition protocols and prior to any adjustment, the standard deviations for the
three sets of data collected for PIMs, TAGs and unFAs were reported at 17.1%, 17.2%
and 15.2% respectively (Figure 2.9). When these values were adjusted by normalization
to the peak intensity of the internal standard DMSO, the values for standard deviation
were improved to 11.3%, 14.7% and 11.4% respectively. Further improvement to10.6%,
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Figure 2.6 2D-HSQC Spectrum Produced by Repeated Extraction of the Cell Pellet
The cell pellet remaining after extraction of M. smegmatis cells by 2:1 mixture of
CDCl3:CD3OD was re-extracted with the same solvent mixture in 3:1 ratio as used
before. Only signals of straight chain fatty acids were observed in the lipid profile of this
extract. The 2D-HSQC spectrum shown above was obtained after 10 transients and 256
increments.
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Figure 2.7 Effect of Using Acetone-d6 as the Extracting Solvent
M. smegmatis cells were extracted with either acetone-d6, (a), or a 2:1 mixture of
CDCl3:CD3OD, (b). Signals of GPL were reported at higher intensity in the acetone
extract (biomarker signals of GPL are enclosed in solid squares). Also highlighted, is the
loss of signals indicatives of cellular PIMs from the acetone extract (biomarker signals of
PIMs are enclosed in solid ovals).
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Figure 2.8 Calibrating Curve of Different Concentrations of DMSO
The integral volumes of the DMSO signals in a series of dilutions in 1:1 mixture of
CDCl3:CD3OD are plotted as diamond (R2 value=0.996). Also plotted on the curve are
integral volumes of DMSO peak obtained through the addition of 8mM DMSO to the
lipid extract of M. bovis BCG, (solid triangles) or M. smegmatis, (squares).
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Figure 2.9 Assessment of the Reproducibility of Data Obtained from 2D-HSQC Lipid
Profiles
Data are presented as integral volumes of lipid biomarker peaks, (a), or integral volumes
normalized to the DMSO peak, (b), or normalized integral volumes divided by total cell
number, (c). Biomarker signals used were δ1H=5.26, δ13C=70.47 ppm for PIMs,
δ1H=5.30, δ13C=69.31 ppm for TAG and δ1H=5.12, δ13C=124.62 ppm for unFA.
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12.9% and 8.77% was achieved when the DMSO-normalized intensities were referenced
to the total number of cells used for extraction (Figure 2.9c).
2.3.6 Lipid Fractionation through Solvent Partition
Separation of the polar and apolar lipids can be easily achieved through a simple
modification in the extraction method. When water is released from cells during
extraction with 2:1 CDCl3:CD3OD, the relative ratios of chloroform to methanol to water
in the solvent mixture result in partitioning of the sample into two phases. When the two
phases are separated the most lipophilic lipids are concentrated in the lower chloroformic
phase while polar lipids migrate to the upper methanolic/aqueous phase. The result of this
separation was the elimination of the most abundant lipids (namely TAG and acylated
PIMs) in one pool leaving most glycolipids in a separate more polar pool. This resulted in
the appearance of multiple signals of less abundant lipids in the HSQC spectrum of the
methanolic phase, while a better resolution of some overlapping signals was also
achieved.
As an example, Figure 2.10 shows the effect of solvent partition on the representation
of M. bovis BCG lipid pool. Signals of mycoside B were detected exclusively in the
apolar lipid spectrum while mycobactin signals were observed in the polar lipid spectrum
only. Signals for the glycerol containing phospholipids that were overlapping in the total
lipid pool became more abundant and better presented in the polar lipid pool when the
abundant TAG and PIMs were removed into the more lipophilic phase. In other species
that have different lipid compositions, cellular lipids were effectively fractioned as well.
Glycopeptidolipids GPL of M. avium were only detected in the non polar solvent while
other lipooligosaccharides remained in the polar methanolic phase (Figure 2.11). Other
examples of the effect of solvent portioning are demonstrated in Figures A.11 and
Figure A.12.
2.3.7 Mycolic Acid Analysis
Upon extraction of mycolic acids, we were able to detect all classes of mycolic acids
in the 2D-HSQC mycolic acid profiles (Figure 2.12). Non overlapping biomarker signals
were identified for each unique class of mycolic acids including different signals for cis
and trans configuration of the cycloprapane rings and double bonds substitution. These
discrete biomarker signals are summarized in Table 2.2. Among these signals, two
signals can be used to represent the total mycolic acid pool. These are the α-CH at
δ1H=2.38, δ13C=51.61 ppm and the β-hydroxy CH at δ1H=3.65, δ13C=72.15 ppm. The
two signals are present in all types of mycolic acids thus they can be used as a way to
estimate the total mycolic acid pool. The relative contribution of a specific type of
mycolic acid can be measured by referencing the intensity of each biomarker signal to
any of these two common signals. Also, an insight to the average chain length of the
mycolates can be gained through measuring the intensity of the alkyl chain CH2 peak and
referencing it to either the α-CHCO or the β-CHOH signals.
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Figure 2.10 Fractionation of the Lipid Extract of M. bovis BCG
1

H-13C HSQC spectra generated from M. bovis BCG grown in 13C-labeled 7H9, (a), total
lipid, (b), apolar lipids and (c), polar lipids. Expanded views showing detail of the
biomarkers for mycobactins and mycoside B (bottom inserts, δH 6.68-7.28, δC 113-132.3
ppm) and glycerol containing phospholipids (upper inserts, δH 5.0-5.44, δC 67-78.8 ppm)
have been shown in these spectra as examples of how lipids can be separated through
simple fractionation. Only mycoside B is present in the apolar lipid spectrum while
mycobactin signals are observed in the polar spectrum. The glycerol containing
phospholipids signals are overlapping in the total lipid pool, (a). However, when the
abundant TAG and PIMs are removed into the apolar solvent, less abundant species were
better presented in the polar lipid spectrum.
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Figure 2.11 Fractionation of the Lipid Extract of M. avium
2D-HSQC profiles of the lipid extract from M. avium, total lipids, (a), nonpolar lipids, (b)
and polar lipids, (c). For demonstrating lipid migration between solvent phases, areas
that represent certain lipids are enclosed within dashed boxes. From the upper most part
and going downward, first TDM is shown to migrate completely to the non polar solvent
phase as indicated by its cyclopropyl ring signals. Second, signals for the peptide core of
GPL disappeared from the polar extract due to migration to the chloroformic phase. The
third area shows the partitioning of glycolipids between the non polar and polar phase as
indicated from the sugar anomeric signals. Finally, signals of the phenylalanine residues
of GPL are detected exclusively in the non polar solvent phase upon fractionation.
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Figure 2.12 2D-HSQC Profile of Mycolic Acids Isolated from M. bovis BCG
1

H-13C HSQC spectrum of mycolic acids extracted from M. bovis BCG as described in
text (section 2.2.3). Examples for signals common to all mycolic acid are shown by
arrows (a, βCH-OH and b, α CH-COOH). Signals indicative to specific classes of
mycolic acids are circled in dashed lines.
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Table 2.2 Chemical Shift Values of Major Mycolic Acid Biomarkers
Description

δ1H
ppm

δ13C
ppm

Total mycolates

δ13C
ppm

-0.33

10.89

0.58

10.89

Cis CH

0.65

15.80

Trans CH2

0.13

10.43

Cyclopropyl ring

CH2CO

2.38

51.61

CH-OH

3.65

72.15

Keto Mycolate
CH2CO

δ1H
ppm

Description

2.56

46.49

Methoxy mycolate

Cis CH2 ring

Double bond

OCH3

3.36

57.23

Cis CH=CH

5.35

129.87

CHOH

3.56

62.36

Trans CH=CH

5.12

124.45
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2.4 Discussion
The chemical diversity displayed by the lipid content of the mycobacterial cells
represents a great challenge for its comprehensive analysis.216,236 Previous methods
developed for this process used different techniques and each has its own merits and
weaknesses. The classical 2D-TLC method is favored by many researchers when the
purpose is to track a specific cell wall lipid due to the simplicity of the procedures and the
lack of requirement for special analytical instruments.136,200,237 When a specific molecule
is being tracked, a single solvent system can be used and an optimized detection strategy
(most often radiolabeling) can be employed to improve the sensitivity towards this
specific molecule.10 The recent MS and LC/MS methods represent great opportunities to
researchers but they ideally require significant sample manipulation to reduce ion
suppression or improve HPLC resolution for reasonable data interpretation.215,216 These
methods confer high sensitivity that allows the detection of minor metabolites that are
hard to detect by other techniques. On the other hand, MS-based methods are inherently
biased to polar lipids that can easily ionize under MS acquisition conditions.
It is crucial in the development of any global analytical technique to guarantee the
representation of all components of the cellular lipid pool in their respective cellular
abundance while maintaining enough flexibility to enrich any specific subpopulation if
desired. In order to achieve this goal it is important to i) optimize extraction and
acquisition condition for comprehensive analysis of the total lipid pool, ii) develop a
standard protocol with several measures that insure the reproducibility of lipid profiling
techniques, iii) investigate the possibility of enriching and targeting specific lipid
subgroups and iv) provide a clear plan for maximum validation and utilization of the
acquired data with an easy to apply analytical and statistical models.
2.4.1 A Summary of a Standard Protocol for Comprehensive Analysis
A standard protocol was developed for lipid analysis as discussed in section 2.3.1.
This basic protocol uses a 2:1 mixture of CDCl3:CD3OD to extract pre-washed cell pellet
in 3:1 volume per weight ratio. The lipid profiling protocol was found to be reproducible
when growth conditions, the type of solvent, initial culture volumes, duration and
temperature of extraction and NMR acquisitions parameters are held constant. A
universal enrichment of the 13C-content of the cellular lipids was obtained after
inoculating unlabeled cells in a growth media containing 13C6-dextrose and 13C3-glycerol
as the main carbon source. About 20mls of 13C-enriched culture in the middle of its
exponential growth was required for developing a high quality spectrum using 5mm
NMR probe. We were also able to use 10mls of culture to obtain a high quality spectrum
using 3mm probe. It is feasible that by the use of more sensitive NMR-sample probes
such as the cryogenic probe, the initial culture volume required for a good profile can be
further reduced. Such advancement in NMR acquisition and future refining of the
extraction protocol can allow for the future use of NMR-based method in some in vivo
settings.
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2.4.2 Amenability of the Protocol for Both Comprehensive and Targeted Analysis
Although the procedure discussed here focuses mainly on the analysis of the overall
free cell wall lipids populations, the method can be easily modified to target a specific
lipid population. For such purpose, the global 13C-enrichement strategy using
13
C6-dextrose and 13C3-glycerol can be replaced by a biosynthetically-guided approach
that uses specific13C-labeled precursors in order to enrich signals from certain lipid
population. Moreover, subpopulation of apolar lipids, acetone soluble lipids,
lipooligosaccharides, covalently bound mycolic acids or others can be specifically
targeted by slight modification of the extraction procedures either by switching to a
different extraction solvent or by introducing additional steps prior to extraction (e.g.
alkaline hydrolysis followed by extraction in case of mycolic acids).
The fractionation of the total lipid pool into smaller better resolved sub population
pools can also be achieved through modification of the extraction methods. Some
example methods include successive extraction of cells with deuterated solvents of
increasing polarity, use of scavenger resins to pull down and fractionate anionic lipids
and cationic lipids,176,238 and the use of solvent partitions to remove very abundant signals
or to separate the polar and apolar lipid pools. The latter strategy was employed here with
considerable success.
2.4.3 Biomarker Assignment through Literature Source and Isolation of Standards
Due to the complexity of the spectra produced by this method and the incomplete
spectral assignments in the literature, it is important to have a set of standards and
analyze them under the same conditions as the lipid profile in order to use for effective
biomarker assignment. For assigning signals in M. tuberculosis lipid profiles, some
molecules may have low abundance in M. tuberculosis that is not sufficient to obtain
enough samples to be used as a lipid standard. In these cases, structurally similar
molecules (i.e. of the same lipid class) can be isolated from other species where their
cellular levels are significantly higher. If necessary, 3D HCCH-TOCSY and 3D HCCHCOSY can then be used to confirm assignment of biomarker signals in the total lipid
profile. This is especially useful for confirming the chemical shifts of any signals that
may vary slightly between similar molecules isolated from different species. Such
variations in the chemical shifts are direct results of subtle differences in structural
composition or substitution. After biomarkers have been assigned in the total lipid
profile, spectral sets can be compared and the relative amounts of cellular lipids can be
inferred by processing the data using software such as Felix or NMR Pipe.
2.5 Conclusion
In conclusion, a simple method to globally analyze mycobacterial cell wall lipids was
developed. While this method does not have the fine sensitivity of MS-based lipidomics
approaches, it has the advantage of being suitable to analyze lipid species regardless of
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their polarity or ability to ionize and allows the simultaneous analysis of a broader range
of lipids. NMR is particularly well suited for the analysis of mycobacterial lipid pool
since most of these lipids have relatively high abundance as structural components of the
cell wall. The lipid profiles produced by this method seem to offer a comprehensive
representation of all major classes of lipids that have been reported in the literature. The
rapid nature of this method, the simple procedures and the small sample size required
make it a new candidate strategy for the definition of target molecules involved in
virulence. The method requires only the availability of a standard high field NMR
spectrometer which can be found in most academic settings. This common access can
encourage a relatively wide use of this method by the mycobacteriology research
community.
Potential application of this method can include several areas of mycobacteriology
research that still represent serious challenges. Discovery of new genes that are involved
in the cell wall biosynthesis can be achieved through such simultaneous analysis of cell
wall lipids to pinpoint changes in the lipid profile as a result of gene mutation. Other
application areas include studying inter and intra species variation, investigating new
drugs mode of action and detecting cellular adaptation to drug treatment and other
environmental stress conditions.
The methodology also has the potential to be extended to include other bacterial
pathogens as long as they can be cultured in the laboratory in well defined growth
medium. Most members of the actinomycetal line have chemotype IV cell walls that are
rich in mycolic acids and other glycolipids. Actinomycetes include several pathogenic
species as well as other species that produce unique and clinically relevant cell
metabolites such as aminoglycosides produced by Streptomyces sp.239 Similar methods
can be developed for targeted analysis of such metabolites by employing the right
enrichment and extraction strategies.
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CHAPTER 3. USE OF 2D-HSQC NMR FOR ANALYSIS OF MYCOBACTERIA
CELL WALL 2
3.1 Introduction
3.1.1 Mycobacteria Human Pathogens
Mycobacteria species are mainly saprophytic but some are serious human pathogens
and are implicated with devastating diseases. One of the mycobacterial diseases, TB, is
caused by M. tuberculosis and claims 1.7 million lives every year while nine million new
cases are reported.12 The devastation of TB is most observed in areas of sub-Saharan
Africa and the densely populated parts of East Asia where the epidemic of HIV is most
prevalent and less successfully controlled.12,29 The second most common mycobacterial
diseas, leprosy, is caused by M. leprae with 250,000 reported cases.37 Both M.
tuberculosis and M. leprae are intracellular pathogens that can survive and replicate
inside human cells including macrophages, peripheral neurons and endothelial cells.
The third most common mycobacterial infection is that of Buruli ulcer which is
endemic to some tropical areas of the world.241,242 The causative agent for Buruli ulcer,
M. ulcerans, is an extracellular pathogen that mainly resides in the skin and connective
tissue of the limbs.243,244 Unlike M. tuberculosis and M. leprae, in the laboratory M.
ulcerans can only grow at temperature not higher than 32°C which makes it unable to
cause human systemic infections.26,245 M. ulcerans infects tens of thousands of people in
tropical regions with most prevalence in Ghana, Benin and Cote d’Ivoir in Africa,
Malaysia and Sri Lanka in Asia and Mexico and Peru in South America and few reported
cases in Japan, China and Australia.14 Another Mycobacteria pathogen M. marinum
causes granulomatous cutaneous human disease in the extremities (swimmer granuloma)
and systemic diseases in fish and frogs.43,246,247 This pathological spectrum is consistent
with the inability of M marinum to grow at temperatures over 33°C and its common
existence in environmental water.
Other human diseases can be caused by an increasing number of environmental non
tuberculosis Mycobacteria (NTM). The most common infections are those by M. avium
complex, or MAC, which includes M. avium subspecies avium, silvaticum and
paratuberculosis and M. intracellulare. MAC infections are responsible for more than
half the NTM infections and they are the most common opportunistic infections reported
in HIV/AIDS patients.15,226,227,248 Other NTM include the photochromogenic M. marinum
and M. kansasii, the scotochromogenic M. gordanae and M. scrofulacelum, and other fast
growing species such as M. fortutium, M. abscessus and M. Chelonae.15,16,249 These

2

Section 3.3.4 is adapted with permission. Mahrous, E.A., Lee, R.E. & Lee, R.E. A rapid
approach to lipid profiling of mycobacteria using 2D HSQC NMR maps. J Lipid Res 49,
455-63 (2008).240
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species can cause pulmonary TB-like disease and sometimes more severe disseminated
systemic diseases especially in immunocompromised individuals.16,248
3.1.2 Mycobacteria Animal Pathogens
Other Mycobactyeria are serious animal pathogens with direct economic impact.
Cattle can be infected with M. bovis which causes cow tuberculosis, a disease with
similar symptoms to the human TB. Another mycobacterial disease affecting cattle is
partuberculosis (also named John’s disease) which is caused by M. avium subsp
paratuberculosis and is characterized by severe diarrhea and granumlomateous enteritis.
Other live stocks can be infected by different Mycobacteria pathogens such as M
scrofulaceum and M. xenopi.250,39 M. lepraemurium is another animal pathogens that
infects mainly cats and rats and causes a disease with symptoms similar to human
leprosy.250 On the other hand, cold blooded animals have more susceptibility to certain
Mycobacteria that include M. marinum, M. liflandii, M. pseudoshittsii, M. xenopi and M.
avium subsp intercellularae.5
3.1.3 Old Classification of Mycobacteria
Mycobacteria species that we recognize today live in a wide range of environments
with different growth characteristics, infectivity and pathogencity. The early
classification of Mycobacteria which was based on microbiological features like colony
morophology and growth characteristics have resulted in long debates between
researchers. Another result from the use of such classification was some literature
confusion especially in the assignment of newly discovered organism as a distinct species
or a variant of an existing species. Generally, the most accepted classic classification is to
divide Mycobacteria into two main classes; slow growers and fast growers.1
This old classification gained credibility because most pathogenic Mycobacteria are
slow growers while few of the fast growing species are associated with disease
development. The same classification is still accepted now especially when the results
from 16S RNA sequencing came largely in agreement with this old classification.11
Mycobacteria slow growers can be further classified based on their evolutionary
relationship into multi-member clades. It is of special interest to lipidomic research that
species included within the same clade were found to share a common mycolic acid
pattern.1
3.1.4 Variability in Cellular Lipid among Mycobacteria
The variation of the cell wall composition of Mycobacteria (especially mycolic acids)
has played a significant role in its classification. Distribution of mycolic acids in terms of
chain length and the types of substitution have been will reported and it provided one of
the first biochemical bases for the chemotaxonomy of Mycobacteria.88,89,91 Other lipids
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that were suggested as a basis for biochemical classification of Mycobacteria due to their
wide variability among different species include menaquinones,172,251 caretenoids,7 fatty
acids,193 and mycobactins.163,164 The most clinically relevant example of the utilization of
such variabilties is the serotypying of MAC which depends solely on the nature of the
glycosidic part attached to a largely conserved lipopeptide core of its GPL. These GPL
are highly antigenic and they are often located on the bacterial surface in direct contact
with the host environment. Based on their oligosaccharide, these GPL can elicit different
immunological reactions that serve as the basis for MAC serotypying.96,155
3.1.5 Value of Lipid Profiling of Different Mycobacteria Species
With the routine use of 16S RNA sequencing as a rapid and accurate method for
taxonomical classification, Mycobacteria lipid profiling is no longer used for this
purpose. However, it can be used to provide valuable information about the participation
of certain lipids in several cellular processes that include virulence, niche adaptation and
stringent response. Some evolutionary relationships between species can also be inferred
from such profiles because cell lipids can be considered as ultimate gene products. Some
lipid profiling techniques such as HPLC are still used by CDC as a fast tool for diagnosis
of TB cases to characterize the causative agent for TB infections to the species level.187
This chapter discusses the variability in the cell wall metabolites among different
Mycobacteria and how it corresponds to variations in their growth characteristics,
pathogenicity and evolutionary relationship. It also further validates the use of NMR as a
rapid tool for monitoring the cell wall metabolites of Mycobacteria as well as other
microorganisms. The technique can also provide more comprehensive insights into the
cell wall composition when combined with the previously developed HR-MAS method
for monitoring cell wall polysaccharides189 (see section 1.7.2.2). This combination is very
reasonable as both methods require 13C-enrichement of the cellular metabolites and both
go through similar steps of sample preparation and data processing.
3.2 Materials and Methods
3.2.1 Strains and Growth Conditions
Mycobacterial cells were grown in Middlebrook 7H9 supplemented with 0.2% of
C6-dextrose, 0.2% 13C3-glycerol, 0.05% tween and 5% BSA at 36.5°C with continuous
shaking at 250 rpm. Fast growing species (M. smegmatis ATCC mc2155, M. fortuitum
ATCC 6841, M. phlei, M. abscessus ATCC 19977) were inoculated at initial optical
density O.Dλ600=0.005, while slow growing species (M. bovis BCG, M. tuberculosis, M.
avium ATCC25291) were inoculated at initial ODλ600=0.05. M. ulcerans 1615, M.
liflandii XL-5 and M. marinum 128 were grown at 31°C without shaking in tissue culture
flask (see Table 3.1 for a list of the species used). Corynebacterium glutamicum,
Bacillus subtilis and B. anthracis Sterne (a vaccine strain) were grown in Brain Heart
Infusion media (BHI) made from 1.75 %BHI, 0.2% 13C6-dextrose, 1% tryptone,
13
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Table 3.1 Summary of the Mycobacteria Species Investigated in This Study
Growth
Temperature°C

Pathogenicity

Main Host

M. avium

36.5

Opportunistic

Human

M. bovis BCG

36.5

Vaccine strain

Human

M. tuberculosis

36.5

Pulmonary, Systemic

Human

Species
Slow growers

M. liflandii

31

Systemic

Frog

M. marinum

31

Fish

M. ulcerans

31

Systemic
Skin, Connective
tissue

Human

Fast growers
M. abscessus

36.5

Opportunistic

Human

M. fortitum

36.5

Opportunistic

Human

M. phlei

36.5

None

None

M. smegmatis

36.5

None

None
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0.5%NaCl and 0.25% disodium phosphate. Cells were incubated with continuous shaking
at 250 rpm at 36.5°C.
3.2.2 Sample Preparation for HR-MAS
Cells from 40-50mls culture were harvested by centrifugation at 3700xg for 10
minutes then washed twice with 5mls of D2O with removal of the aqueous supernatant by
centrifugation in between. The washed cell pellet was then transferred to a pre-weighed
micro-centrifuge tube using 1ml of D2O. After centrifugation at 21,000xg for 10 minutes,
cells were re-suspended in minimal amount of D2O (~200µl). About 40µl of the cell
suspension was then transferred to an HR-MAS rotor for NMR acquisition.
3.2.3 Lipid Extraction
Total cell lipids were extracted from the previously washed cell pellets after the
removal of all remaining D2O. A 2:1 mixture of CDCl3: CD3OD was added to the cell
pellet on basis of the wet pellet weight (3μl per 1mg of cells) and cells were extracted for
90 minutes at 37°C with continuous shaking at 250 rpm. After extraction, more CD3OD
(1μl per 1mg of original cell weight) was added to the extraction mixture to obtain a
single phase solution which was then separated from the cell debris by centrifugation for
10 minutes at 21,000xg at room temperature. The lipid extract was then transferred to a
5mm NMR tube for NMR data acquisition.
3.2.4 Sterility Testing
For safety regulation, the organic extract of M. tuberculosis H37Rv was tested for
sterility. The lipid extract was air dried in a biosafety level-3 cabinet then re-suspended in
one milliliter of sterile Middlebrook 7H9. 100μl of the cell suspension was inoculated to
Middlebrook 7H11 agar plates. No growth was observed after incubation at 37°C for six
weeks.
3.2.5 Isolation of PGL from M. liflandii
M. liflandii cells were grown to stationary phase in Middlebrook 7H9, harvested by
centrifugation and subsequently extracted with ethanol. The ethanolic extract was dried in
vacuo. The dried residue (80mg) was re-suspended in CHCl3 and applied to a Biotage
SP1 flash chromatography system equipped with a Biotage Si 12+M silica gel column.
The column was eluted using a CHCl3-to-CHCl3/CH3OD 9:1(v/v) linear gradient. The
major PGL was detected through TLC analysis using CHCl3/CH3OH (95:5, v/v) as the
developing system (Rf of PGL=0.7). Lipid spots were visualized using cerric ammonium
sulfate in 2M sulfuric acid after charring. Fractions containing pure PGL were pooled and
dried in vacuo.
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3.2.6 NMR Acquisition
For solid state NMR, the MAS rotor containing 40 μl of cell suspension was inserted
at the magic angle in 5mm GHx nanoprobe. The 2D-HSQC sequences were recorded
using Varian Inova 500MHz spectrometer at 24°C degrees with continuous spinning at
2000Hz. The 2D-HSQC spectra were acquired for 8 transients and 256 increments. For
liquid profiling, the 2D-HSQC experiments were recorded using a triple resonance trpfg
probe for 10 transient and 256 increments. NMR data were processed using either VNMR
or Felix-NMR software.
3.3 Results and Discussion
3.3.1 Characteristic Features of Some Species
The use of NMR methods, both solid state and liquid NMR, can provide a rapid tool
to gain insights to the structural features of the cell wall polysaccharides and lipid
components respectively. Generally, No significant difference was observed in the AG
signals between the ten species tested (See Appendix B, Figures B.1-B.10). This
observation is consistent with the finding of Daffe at al who concluded through
degradative analysis and the use of GC/MS that AG structure is well conserved among
Mycobacteria.81 Some quantitative and qualitative differences were reported in LAM
signals. The relative abundance of LAM signals was significantly higher in some species
such as M. bovis and M. ulcerans as opposed to other species like M. smegmatis252
(Figure 3.1a-e). Other reported intra-species variabilities were related to the type of
capping of the terminal arabinan chains in LAM which follows one of three patterns;
mannose capping in manLAM, phospho inositol capping in PiLAM and no terminating
caps as in araLAM. Characteristic signals of manLAM can be detected at δ1H=3.59/ 3.69,
δ13C=68.13 ppm as in the case of M. bovis BCG.189 While those of PiLAM are detected
at δ1H=3.88/ 4.12, δ13C=66.20 ppm as in the case of M. smegmatis253 (Figure 3.1f-j).
In liquid NMR, signature lipids of different species can be readily detected in their
corresponding lipid profiles. Among the ten species investigated here, three can be easily
separated out (M. avium, M. smegmatis and M. abscessus) by the dominance of GPL
signals in their lipid profiles at δ1H=7.27, δ13C=128.71 and δ1H=4.31, δ13C=49.45 ppm
(Figure B.11, Figure B.12 and Figure B.13). M. avium is the only slow growing species
in this group and it produces a significant amount of cyclopropyl mycolates as indicated
by the two signals at δ1H=-0.33/0.58, δ13C=10.73 ppm (Figure B.11). M. smegmatis, on
the other hand, lacks those signals as well as signals of the methyl branched fatty acids
that can be easily detected in M. abscessus (Figure B.12 and B.13).
Among other Mycobacteria used in this study, three species grow at significantly
lower temperature namely M. marinum, M. liflandii and M. ulcerans. The presence of
phenol phthiocerol in very high abundance is a major characteristic of these three species
as indicated by its characteristic aromatic signals at δ1H=6.98, δ13C=129.47 and δ1H=6.7,
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Figure 3.1 Interspecies Variabilities in the Cell Wall LAM as Observed in the HR-MAS
Spectra of Different Mycobacteria
Partial windows of the HR-MAS 2D-HSQC spectra of different Mycobacteria.
Upper panel: LAM signals detected at (δ1H=4.81, δ13C=99.70), (δ1H=5.02, δ13C=98.08)
and (δ1H=5.05, δ13C=98.13 ppm) and circled in black dashed lines are almost absent
from the fast growing species M. abscessus, (a), and M. smegmatis, (b). The same signals
are detected with high intensity in M. bovis BCG, (c), M. tuberculosis H37Ra, (d), and M.
ulcerans, (e).
Lower panel: Variation in the type of substitution in LAM as detected by HR-MAS cell
profiles. Signals indicative of phosphoinositol capping were detected in both M.
abscessus, (f), and M. smegmatis, (g), at δ1H=3.88/4.12, δ13C=66.20 ppm as circled in
red. Signals indicative of mannose capping were detected at δ1H=3.59/ 3.69, δ13C= 68.13
ppm in M. bovis BCG, (h), M. tuberculosis H37Ra, (i), and M. ulcerans, (j), as circled in
red.
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δ13C=115.01 (Figure B.14). M. ulcerans can be further characterized by the low
abundance of most major glycolipids and triacyl glycerols (Figure B.15). In fact, signals
for TAG were not detected in the lipid profile of M. ulcerans using this method.
Meanwhile, the lipid profiles of M. liflandii and M. marinum displayed some degree of
similarity. However, M. marinum can be distinguished by a more complex profile which
is significantly rich in glycolipids and carotenoids (Figure B.16 and Figure B.17).
M. bovis BCG and M. tuberculosis H37Rv have very similar lipid profiles but M. bovis
BCG can be distinguished by the presence of the two aromatic signals of its phenolic
glycolipid (mycoside B) at δ1H=7.13, δ13C=129.39 and δ1H=7.00, δ13C=116.52 and the
relatively low abundance of methyl branched fatty acids and PDIM as inferred from the
low intensity of methyl groups signals at δ1H=1.16, δ13C=19.69, δ1H=1.05, δ13C=17.37
and δ1H=0.99, δ13C=18.11 (Figure B.18). On the contrary, M. tuberculosis produces
significantly higher amounts of PDIM and lower amounts of acylated glycerols (Figure
B.19).
The saprophytic M. phlei is easily characterized by the production of large amount of
trehalose phleiates,63 compounds that are easily detected through the presence of multiple
olefinic signals in the range between 5.00 and 5.60 ppm (Figure B.20). M. fortitum, a fast
grower, produces a lipid profiles that displays a lack of all signals of cyclopropyl
mycolates, GPLs and PGLs. It is characterized, however, by the presence of a form of
acylted trehalose previously designated mycoside F.118 This lipid molecule is represented
in the lipid profile by a cluster of methyl groups at δ1H=0.7-1.0 ppm and δ13 C=15-22
ppm (Figure B.21).
3.3.2 Comparison between Slow Growers and Fast Growers
Fast growing species included in this discussion, M. smegmatis, M. phlei, M. fortuitum
and M. abscessus, have an average doubling time of about 2-4 hours. The slow growing
Mycobacteria investigated here include M. bovis, M. tuberculosis and M. avium and have
doubling time of 12 hours or longer. We limited our comparison to these two groups
because both can grow in the same media and under the same growth conditions. As
expected, the HR-MAS profiles showed similar AG structural characteristics in both
groups but variations were observed in LAM and lipids signals. LAM signals at 1H=4.81,
δ13C=99.70, δ1H=5.02, δ13C=98.08 and δ1H=5.05, δ13C=98.13 ppm189 were detected at
higher intensity in M. tuberculosis H37Ra and M. bovis BCG and at lower intensity in M.
abscessus , M. fortitum , M. phlei and M. smegmatis (Figures 3.2a, B.1, B.4, B.7, B.8).
Also in all HR-MAS spectra of the fast growing species, signals for TAG at δ1H=5.13,
δ13C=69.00, δ1H=4.19/ 3.99, δ13C=62.01 ppm were easily detected which were absent
from the spectra of slow growing species (Figure 3.2b). This observation was further
confirmed in the corresponding lipid profiles as fast growing species clearly produced
larger amounts of TAG and fatty acids as indicated from the integral values of TAG
peaks in their lipid profiles (Figure 3.2c). On the contrary, polyketides-based lipids such
as PGL and PDIM were detected at higher intensity in the slow growers (Figure 3.2d).
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Figure 3.2 Comparison between the HR-MAS and Lipid Profiles of Some Fast Growing
and Slow Growing Mycobacteria
Panel (a), differences were observed in the intensity of LAM signals’ most notably in the
intensity of the terminal α-DManp signal at δ1H=4.81, δ13C=99.70, 2-α-D-Manp at
δ1H=5.02, δ13C=98.08 and 2,6-α-D-Manp at δ1H=5.05, δ13C=98.13 ppm in the HR-MAS
whole cell profile of M. abscessus, M. smegamatis, M. bovis BCG and M. tuberculosos.
Panels (b) and (c), variabilities in the amount of TAG produced by fast growers and slow
growers as indicated in both the HR-MAS profile, (b), and the total lipid profile, (c).
Signals of CH of glycerol at δ1H=5.13, δ13C=69.00 ppm, and CH2 at signals δ1H= 4.19/
3.99, δ13C=62.01 ppm are detected in HR-MAS profiles of only M. abscessus and M.
smegmatis. Similar results were observed in the lipid profiles where TAG signals were
observed with higher intensity in the fast growing species. The lipid profile of M. bovis
BCG show moderate levels of TAG that could not be detected in the HR-MAS probably
due to short T2 relaxation. Panel (d), signals of the methyl groups indicative of methyl
branched lipids such as phthienoic and mycocerosic acids were detected at high intensity
in the lipid profiles of slow growers at δ1H=1.05, δ13C=17.37 and δ1H=1.16, δ13C=19.69
ppm. Signals of such methyl groups can be seen at low levels in M. abscessus while they
were completely absent from the lipid profile of M. smegmatis. Panel (e), signals of
cyclopropyl mycolates were detected exclusively in the lipid profiles of slow growers at
δ1H=-0.33/ 0.58, δ13C=10.73 and δ1H=0.65, δ13C=15.80 ppm.
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Although both groups displayed signals indicative of trehalose dimycolates at1H=2.47,
δ13C=52.81 and δ1H=4.44/4.24, δ13C=98.08 ppm, signals of cyclopropyl mycolates were
absent from the lipid profiles of most fast growers (Figure 3.2e). However, these signals
were observed with low abundance in M. phlei.
It is worth mentioning that the line that divides Mycobacteria into slow and fast
growers overlaps to great extent with the line that divides them into pathogens and non
pathogens. Although some of these previous observations are best looked at in the light
of variable growth rates, others may be better understood in the context of virulence and
pathogenicity. For example, the disparity in the levels of the structurally simple TAG and
the complex polyketides between the two groups can be explained by differences in the
metabolic rates of the bacteria and the biosynthetic energy burden associated with these
lipids. Other observations such as the abundance of cyclopropyl mycolates and the
presence of mannose capped LAM seem to be in better agreement with the pathogenicity
and virulence argument. As a supporting evidence, the two totally non pathogenic species
investigated in this study (M. smegmatis and M. phlei ) both are fast growers and both are
devoid of most of immunogenic cell wall components previously identified in
Mycobacteria e.g. manLAM, PDIM and PGL. Other pathogenic Mycobacteria that were
not included in this comparison like M. ulcerans and M. marinum produce one or more of
these molecules and will be discussed in the following section.
3.3.3 Comparison between Intracellular and Extracellular Pathogens
M. ulcerans is one of the few Mycobacteria that can be detected in the extracellular
space in the infected host tissue (in this case human skin and connective tissues).243,244 In
order to limit the participation of multiple factors in this comparison, M. ulcerans was
compared only to M. marinum an intracellular human and fish pathogen25,26 that was
grown under the same laboratory conditions for the purpose of this study. Moreover, M.
marinum is closely related to M. ulcerans taxonomically and is thought to be the
evolutionary ancestor of M. ulcerans. Based on their HR-MAS spectra, M. ulcerans and
M. marinum share a similar AG structure but some differences were observed in LAM
signals. Most of the LAM signals were detected at higher intensity in M. ulcerans as
opposed to most Mycobacteria. These high levels can be observed in the signals of 6-αManp at1H=4.81, δ13C=99.70 and that of the terminal D-α-Manp at δ1H=4.93,
δ13C=102.19 ppm while AG signals in both species were recorded at comparable
intensity (Figure 3.3a,b). Also evidence from the HR-MAS suggests more frequent
mannose capping of LAM in the case of M. ulcerans as indicated by both the abundance
of the t-α-Manp as mentioned above and the high intensity of the mannose capped
arabinan CH2 signals recorded at δ1H=3.59/ 3.69, δ13C=68.13 ppm (Figure 3.3a,b).
More stark differences can be observed between the two species by examining their
lipid profiles. While M. marinum exhibits a lipid profile with some similarities to that of
other pathogenic species like M. bovis and M. tuberculosis that display a wide variety of
glycolipids and lipooligosaccharides, the lipid profile of M. ulcerans contains only
signals of PIMs and trehalose dimycolate in the carbohydrate region (Figure 3.3c,d).
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Figure 3.3 Comparison between the Extracellular M. ulcerans and the Intracellular M
marinum
HR-MAS profiles of M. ulcerans, (a), and M. marinum, (b). The two profiles indicate the
presence of manLAM in both species (signals at δ1H=3.59/ 3.69, δ13C=68.13 ppm are
circled in red in the upper insert). However, substantial difference can be observed
between the levels of manLAM detected in each case. Higher levels were detected in M.
ulcerans as shown by the intensity of the LAM signals in the lower inserts. Also in the
same insert the anomeric signal of trehalose base molecules can be detected at higher
levels in the HR-MAS spectrum M. marinum (the anomeric signal of trehalose is circled
in blue in both spectra).
The lipid profile of M. ulcerans, (c), is strikingly different from that of M. marinum, (d),
in the relative amounts of PDIM and glycolipids produced. M. ulcerans lipid pool shows
limited variety of glycolipids signals when compared to that of M. marinum (the
glycolipid region is circled in the two lipid profiles). The aromatic signals for phenol
phthiocerol and its glycosylated derivative (mycoside G) are highlighted in a rectangular
box in the lipid profile of M. ulcerans and M. marinum respectively. These signals are
shifted downfield in the lipid profile of M. marinum due to glycosylation. Also in the two
spectra, the location of TAG biomarker signals is indicated by a black arrow. This signal
was not detected in the lipid profile of M. ulcerans.
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Figure 3.3 (Continued)
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Under the growth conditions used, M. ulcerans produced unusually high amounts of
lipophilic waxes that include PDIM, phthiocerol, phthidiolone and their aromatic
derivatives. Meanwhile, signals for TAG were not detected in M. ulcerans based on the
detection limit of this method. In addition, signals characteristic of M. ulcerans secreted
toxin (mycolactone) were recorded only after long acquisition time at δ1H=5.04,
δ13C=131.21 and δ1H=4.90, δ13C=76.3 ppm.
3.3.4 Evidence of Evolutionary Relationship between M. liflandii and M. marinum
M. liflandii is a frog pathogen that was first isolated in 2004 from infected laboratory
frogs Xenopus tropicalis and X. laevis as reported by Trott et al. 254,255 At that time, it was
suggested that M. liflandii was closely related to either M. marinum or M. ulcerans.254
When the lipid profile of this species was compared with the profiles of other
Mycobacteria (M. tuberculosis, M. smegmatis, M. ulcerans, and M. marinum), indeed, the
similarity between the M. liflandii lipid profile and those of M. ulcerans and M. marinum
was evident by the production of abundant PDIM, mycolatone and phenolic glycolipids.
In fact, M. liflandii lipid profile represented an intermediate lipid expression between M.
marinum, which produces abundant glycolipids and carotenoids, and M. ulcerans, which
lacks most of these molecules (Figure 3.4a-c). This observation was validated recently
through in-depth genomic study of several mycolactone-producing strains.256 That study
suggested a recent reductive evolution of M. ulcerans from M. marinum, whereas other
mycolactone-producing strains like M. liflandii were identified as an earlier divergence
during this evolutionary process.257,258
From this study, it was also revealed that M. liflandii produces significant amounts of
PGL, a class of lipids closely related to phthiocerol dimycocerosates, which are produced
by few pathogenic mycobacterial strains.259-261 Signals attributed to PGL from M.
liflandii were found to superimpose with signals corresponding to PGL in the M.
marinum spectrum.262 This observation was confirmed by the subsequent isolation and
structural characterization of this molecule which was found to be phenolphthiodiolone
glycosylated with 3-O-methyl-rhamnose at the phenolic hydroxyl (Figure 3.4d). This
supports our previous observation about the evolutionary relationship between the three
species. On one hand, M. liflandii has a limited lipid metabolome like that of M. ulcerans
and on the other it still can produce PGL while M. ulcerans can not.
3.3.5 Different Lipid Profiles for Different Laboratory Strains and Clinical Isolates
Different laboratory strains of M. tuberculosis are traditionally used in TB research
either for drug susceptibility testing or other microbiological and biochemical research. In
this experiment, the avirulent M. tuberculosis H37Ra and some virulent laboratory strains
of H37Rv, Erdman’s, the highly virulent HN878 strain and the highly transmittable
CDC1551 strain were used. Comparison between these strains were limited only to their
lipid profiles as it is not possible to obtain an HR-MAS profile of such virulent strains
due to biosafety concerns. Some subtle differences, most of them are quantitative in
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Figure 3.4 Lipidomics Characterization of M. liflandii
a-C, 1H-13C HSQC spectra (δ1H,0.6-7.6 ppm, δ13C14-136 ppm) of total lipid extract from
M. liflandii, (a), M. marinum, (b), and M. ulcerans, (c). M. liflandii is thought to represent
an intermediate stage in the reductive evolution of M. ulcerans from M. marinum
progenitor which is reflected in these lipid profiles by comparing the diversity of the
glycolipid pools of the three species. (d), 1H-13C HSQC spectrum of the major PGL
purified from M. liflandii total lipid extract.
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nature, were observable between different strains (Figures B.22-B.26). For example,
when compared to M. tuberculosis H37Rv, Erdman’s strain seemed to produce higher
levels of methyl-branched fatty acids while H37Ra produced significantly lower amounts.
The validation of these observations is beyond the scope of this study and without prior
reports of similar results they could not be further verified.
However, our observations on strains from well characterized lineage such as HN878
strain which belongs to the W-Beijing lineage can be easily verified. In the lipid profile
of HN878, both qualitative and quantitative differences were observed. As an example of
the first, the production of PGL was detected in HN878 lipid profile by the presence of its
two aromatic signals at δ1H=7.02, 13C=17.6 and δ1H=7.18, 13C=129.7 ppm and its CH2
benzylic protons at δ1H=2.58, δ13C=46.8 ppm (Figure B.25). As an example of the
quantitative differences, we reported the production of unusually high levels of
triglycerides as indicated by the high intensity of the signal of C-2 glycerol at δ1H=5.30 ,
δ13C=69.32 which comes in agreement with recently published data that characterized the
general features of the W-Beijing lineage.263
3.3.6 Lipid Profiles of Other Bacteria: Corynebacterium and Bacillus
Corynebacteria are mycolic acid producing actinomycetes and they share a similar cell
wall structure with Mycobacteria that contains polysaccharides complexes like mAG and
LAM as well as free lipids such as acylated trehalose and acylated glucose.264 The HRMAS of C. glutamicum showed a similar AG and LAM structures to that observed in
most Mycobacteria species except for the apparent absence of the 3,5-α-Araf anomeric
signal which is usually reported at δ1H=5.07, δ13C=107.38 as it is the case of M. bovis
BCG (Figure 3.5a,b). Instead, two other anomeric signals were detected in C.
glutamicum spectrum at δ1H=5.08, δ13C=109.25 and at δ1H=5.01, δ13C=105.74 ppm.
This shift indicates a significant variation in the branching patterns of the AG
macromolecule between Mycobacteria and Corynebacteria. There was no literature report
of such observation to the best of our knowledge. Upon analysis of cell total lipids, the
lipid profile of C. glutamicum displayed similar general features to that of Mycobaceria.
Abundant glycolipids, phospholipids, mycobactins and limited amount of triacyl
glycerols were easily detected (Figure 3.6).
The second step was to utilize the method for the analysis of completely unrelated
species. Two Gram positive species were chosen; B. anthracis Sterne, a vaccine strain of
the pathogenic B. anthracis, and B. subtilis, a soil bacteria. Both species displayed a lipid
profiles that was different to a large degree from that of Mycobacteria and
Corynebacteria. The only reported similarities were in the fatty acid and some
phospholipids signals which are present in all bacterial plasma membranes. A distinct
feature observed in these two profiles was the presence of two anomeric proton signals at
δ1H=4.39, δ13C=102.9 and 1H=4.32, 13C=103.42 (Figure 3.7). These signals are likely to
be related to the mitogenic glycerolphosphoglycolipids isolated by Fischer et al in
1978265 and later confirmed in its structure and mitogenicity by Li, Y and colleagues.266
On comparison between the two species, B. anthracis lipid profile was rich with signals
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Figure 3.5 Comparison between the HR-MAS Profile of C. glutamicum and M. bovis
BCG
HR-MAS profiles of C. glutamicum, (a), and M. bovis BCG, (b). Differences can be
observed in the AG structure of C. glutamicum with the appearance of two distinct
signals at δ1H=5.08, δ13C=109.25 and δ1H=5.01, δ13C=105.74 ppm (signals are circled in
the blow-up inserts). The anomeric signal for 3,5-α-Araf detected at δ1H=5.06,
δ13C=107.04 ppm in the HR-MAS of M. bovis BCG was absent from the HR-MAS
spectrum of C. glutamicum as indicated in the inserts by the black arrow.
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Figure 3.6 2D-HSQC Lipid Profile of C. glutamicum

Figure 3.7 2D-HSQC Lipid Profile of Bacillus Species
2D-HSQC lipid profile of B. anthracis (Sterne), (a), and B. subtilis, (b). The arrows
indicate the position of the two anomeric signals of Bacillus mitogenic glycerol
phosphoglycolipid at δ1H=4.39,13C=102.9 and δ1H=4.32,13C=103.42 ppm.
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for long aliphatic chains, sugar residues and unsaturated substructures, while that of B. subtilis
displayed smaller number of signals especially in the sugar residue regions and very weak signals
in the oleifenic region (Figure 3.7).

3.4. Conclusion
3 4.1 NMR-Based Approach for Comprehensive Cell Wall Analysis
A combination approach of HR-MAS monitoring of cell wall polysaccharides (mainly
AG and LAM) and 2D-HSQC lipid profiling was developed. Such approach can provide
researchers with valuable insights to the structural features of the mycobacterial cell wall
in relatively short time and with reasonable degree of confidence in data interpretation.
Based on the examples discussed in this chapter and in the previous chapter, a cell culture
of 30-40 milliliters enriched with 13C-dextrose and/or glycerol can be used to produce
comprehensive reproducible profiles for both cell lipids and polysaccharides. Sample
preparation protocols for both techniques follow the same set of procedures for the most
part and human effort designated for this purpose can be greatly reduced as a result. The
two techniques combined require the use of a single high field NMR spectrometer with
interchangeable sample probes to accommodate both solid (HR-MAS) and liquid sample
(lipid profile).
This combination in itself can also serve the purpose of a self control. For example,
when certain gene mutation is being sought to affect cell wall lipid biosynthesis, lipid
extract from the mutant strains can be analyzed by 2D-HSQC NMR for that purpose.
Meanwhile, the same cells that were extracted can be used to generate an HR-MAS
profile to confirm the integrity of other cell wall components such as AG and LAM. Such
approach provides solidity of the interpreted data and can also help identify some
important cellular process like adaptation to gene mutation and possible metabolic
coupling.
3.4.2 Species Differentiation Using NMR Metabolic Profiling
Mycobacteria species and strains can be differentiated by a wide array of methods
with very high sensitivity. The purpose of this study was not to offer an alternative to
such techniques. However, several goals have been achieved from such study including;
i) demonstrating the utility of this combined approach across different number of
Mycobacteria that are representatives of different clades, ii) validating the utility of the
technique by its capability to detect both qualitative and quantitative differences between
multiple species, iii) starting a database of standardized referenced lipid profiles of
several Mycobacteria species and strains that can later be used as base line references, iv)
providing information that can help in the assignment of biomarkers signals for some
lipid molecules by choosing the most suitable lipid profiles where these signals can be
observed in high abundance and with optimal resolvability, v) exploring the possibility of
application of these method to characterize the main features of the cell wall
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compositions of newly isolated species and vi) pinpointing to differences that exist
between different laboratory strains and clinical isolates. Such differences must be taken
into consideration when comparing and using research data obtained through the use of
different laboratory strains.
3.4.3 Applicability to Other Bacterial Species
Like Mycobacteria, all actinomycetal line (Mycobacteria, Corynbacteria, Nocardia
and Rhodococci) have a chemotype IV cell wall and possess a complex cell wall structure
rich in lipids especially mycolic acids. The combined NMR approach discussed above
can be helpful in studying a large array of these species as long as they can be maintained
in the laboratory in a well-defined growth media that uses glycerol and/or dextrose as the
primary carbon source. As a demonstrative example, C. glutamicum was grown in BHI
media where 13C6-dextrose was added as the primary carbon source. This isotope
enrichment strategy was successful in providing high quality HR-MAS and lipid profiles
as outlined in section 3.3.7. Outside the actinomycetals line, all eubacteria share a similar
phospholipids bilayer plasma membrane and through lipid profiling, components of these
membranes can be investigated and compared with relative ease. This concept was used
here to compare between two Bacillus species. Such results also underscore the
applicability of such methodology to a wide spectrum of species and in diverse research
fields.
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CHAPTER 4. METABOLOMIC STUDIES OF MYCOBACTERIA ADAPTATION
TO STRESS CONDITIONS
4.1 Introduction
Since the introduction of streptomycin as the first treatment for TB in the 1940s, we
have made a significant progress that is undeniable. The great white plague that
devastated Europe is now a curable disease. However, this curable disease is reported in
nine million cases every year and is claiming close to two million lives annually.12 For a
certain period of time we were very optimistic of our capability to reduce TB to “a minor
aliment to man” as Waksman once announced in his 1960s book “The Conquest of
Tuberculosis.”267 This optimistic prediction seems so far from reality now like never
before. We now live in a world where one third of the population harbor the tubercle
bacilli in their bodies and where there is a serious concern in our ability to treat highly
drug resistant forms of the disease.
Our failure to eradicate TB is caused by the success of the tubercle bacilli to tolerate
anti-TB chemotherapy and develop resistance. Unlike most other bacterial infections that
can be treated with a single antibiotic, monotherapy has not been reliable as an anti-TB
treatment. Currently, any effective anti-TB regimen is based on the use of combination
therapy to deter the rise of resistance.34 However, one of our major health concerns now
is the global spread of MDR-TB. Although MDR-TB is currently treatable through a two
years regimen that includes several second line anti-TB drugs, it is hard for TB patients to
adhere to such lengthy and often not well tolerated course. As a result of our failure to
control MDR-TB, we were confronted with XDR-TB, a form of the disease that resists
treatment with rifampin and INH in addition to key second line drugs (a fluroquinolone
and at least one of the injectable aminoglycosides).36,268 XDR-TB is associated with very
high mortality rates and is currently untreatable by available anti-TB chemotherapy.36
The tolerance of M. tuberculosis to most antibacterial chemotherapy and the rapid rise
of resistance against the few useful anti-TB drugs can be partially explained by the
unique characteristics of the tubercle bacilli and the pathological features of TB itself. M.
tuberculosis cell wall displays unique complexity which includes an outer lipid
membrane of mycolic acids that works as an efficient permeability barrier against the
entry of most chemotherapeutic agents. Inside their host, the infecting bacilli exist in
different metabolic states including actively dividing and latent bacilli.217,218 While
actively growing bacteria are susceptible to commonly used anti-TB drugs, latent bacilli
are much harder to kill due to their slow metabolic rates and limited replication.52 In
addition, these latent bacilli are enclosed inside the TB-granuloma, a hypoxic locus that
receives limited blood supply. To constantly deliver anti-TB drugs at their inhibitory
concentration inside the TB-granuloma, anti-TB drug dosage and administration have to
be carefully monitored. Failure to maintain proper concentration of the drug inside the
granuloma enriches the latent population with naturally occurring resistant mutants.
When a patient prematurely terminates his TB treatment course due to a temporary relief
of symptoms, the latent bacteria can remerge causing a recurrence of the disease. The
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pursuit of novel chemotherapeutic agents that target the latent bacilli is now a top priority
in the TB research community.198,269,270 Such development when it happens will be a
major breakthrough as it should shorten the treatment course and limit the incidence of
resistance. In order to develop such drugs, we need to identify the intrinsic factors that
contribute to Mycobacteria latency and hence the persistence of the tubercle bacilli.
Several laboratory models have been developed to study the metabolic states of the
different bacterial population during latency. The most common animal models include
the murine, Guinea pigs, rabbits and non human primates.52 Although the murine model
is the most widely used in research, it carries the least similarities to the pathological
features of the human disease.52 On the other hand, non human primate models develop
lung tuberculosis that is very similar to human TB but their use in routine research is
limited by their high cost.271,272 In vitro latency models that try to mimic the growth
conditions of the latent bacilli have also been developed. The most common is that
developed by Wayne in 1996 which uses sealed culture with limited aeration to drive the
bacterial to a state of dormancy through gradual oxygen depletion.273,274 Bacilli grown
under these conditions pass through two phases of non replicating growth where cells
prepare for and then enter a microaerophilic metabolic phase.274 To adapt to these
hypoxic conditions, several genes are either down regulated or up-regulated to transfer
the cells to a state of low energy requirement. Lower expression of type-I NADH
dehydrogenase and most subunits of ATP synthase have been reported,275,276 while
isocitrate lyase,277 triglyceride synthases,278 and nitrate reductases275 are among genes
that have been found to be upregulated.
Other in vitro models are designed to test the persistence of Mycobacteria in case of
nutrient starvation. M. tuberculosis has the ability to survive and replicate inside human
macrophages and within the granuloma structure in an environment with a limited supply
of nutrients. In these models, a population of persistent drug tolerant bacilli can be
developed which can be used to validate the ability of drugs to kill persistent bacilli.220
The response of Mycobacteria under nutrient starvation includes down regulation in the
biosynthesis of most cell metabolites with up-regulation in the transcription of genes
involved in RNA synthesis and modification.279,280 Cells maintained under these nutrient
starvation conditions show significant stress resistance, higher stability in their mRNA
and low susceptibility to common anti-TB drugs such as rifampin and INH.279,281
Inside the macrophage, not only does M. tuberculosis have to survive in limited
nutrient supply but it also has to endure abundance of reactive oxygen species and
nitrogen intermediates in an environment of low pH.57,241,282 In the laboratory, the
response of Mycobacteria to stress condition (stringent response) can be induced by
starvation as well as by exposure to acids or UV lights.280 Evidence suggested that
significant number of genes that are up-regulated under laboratory stress conditions were
also identified in separate studies as essential for mycobacterial in vivo survival.52,217,277
These findings validate the use of in vitro models to identify genes and metabolic
products that are essential for Mycobacteria infectivity.
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This report investigates the changes of the mycobacterial metabolome under several
stress conditions mainly low oxygen, limited supply of nutrients and total starvation in
phosphate buffer saline (PBS). M. bovis BCG, a vaccine strain for TB, is used here as a
surrogate for M. tuberculosis. This use is common due to the availability of a complete
genome sequences and the reported similarity between the two species.
4.2 Materials and Methods
4.2.1 Strains and Growth Conditions
Mycobacteria bovis BCG was inoculated at an initial O.Dλ600 of 0.05 in Middlebrook
7H9 growth media supplemented with ADG and 0.05% Tween 80. For 13C-enrichement
the dextrose and glycerol in the ADG supplement were replaced by 13C6-dextrose and
13
C3-Glycerol respectively (Cambridge Isotope Lab. MA). For low nutrients conditions,
the concentration of glucose and glycerols were reduced to 0.02% instead of the normal
0.2% concentration obtained using the ADG supplement while all other growth
conditions were maintained unchanged. All bacterial cultures were incubated at 37°C
with continuous shaking at 250 rpm.
4.2.2 Starvation Model
Forty milliliters of M. bovis BCG grown in 13C-enriched Middlebrook 7H9 to the mid
exponential phase (O.Dλ600=0.6) were harvested by centrifugation then washed twice with
10mls of PBS. After washing, cells were left to starve in 40mls of PBS without shaking at
37°C for previously determined time periods. For reactivation of the starved cells, cells
were harvested by centrifugation at 3700xg. The cell pellet was then washed twice with
10mls of plain 7H9 then re-suspended in 13C-enriched 7H9. Viable count of the starved
and reactivated cells was determined by plating dilutions of the cell culture on
Middlebrook 7H11 agar plates and the number of colonies was counted after 4 weeks
incubation period at 37°C.
4.2.3 Low Oxygen Model
200mls of Middlebrook 7H9 supplemented with 13C3-glycerol and 13C6-dextrose were
inoculated with M. bovis BCG to an O.Dλ600 of 0.005 in round bottom glass flasks with
300ml total capacity. The culture flasks were sealed with silicon rubber caps and were
incubated at 37°C with slow stirring at 100 rpm. At different time points, the optical
density of the bacterial culture was measured and cells were subsequently harvested.
Methylene blue was used as a redox indicator to monitor oxygen level at 15µM
concentration. For reactivation, the bacterial cultures were transferred to new flask with
5X head space with continuous shaking at 250 rpm at 37°C.
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4.2.4 Sample Preparation for HR-MAS
Cells were harvested by centrifugation at 3700xg for 10 minutes. The cell pellet was
washed twice with 5mls of D2O. The supernatant washing liquid was removed in between
by centrifugation at 3700xg for 10 minutes. The washed pellet was then re-suspended in a
minimal volume of D2O and 40 µl of the cell suspension was transferred to an NMRMAS rotor.
4.2.5 Lipid Extraction
The bulk of the previously washed cell pellet was transferred to a pre-weighed microcentrifuge tube using one ml of D2O. After removal of D2O by centrifugation, cells were
re-suspended (3µl per 1µg wet cell weight) in 2:1 mixture of CDCl3:CD3OD to which
DMSO was added as an internal standard (0.0025 μl per every milligram of cells). Lipids
were extracted by continuous shaking for 90 minutes at 37°C degrees. After extraction,
additional volume of CD3OD was added (1µl per 1mg of original cell weight) to achieve
a single phase solution. The final lipid extract was removed by centrifugation for 10
minutes at 21,000xg then transferred to 5mm NMR tube.
For mycolic acid saponification, two milliliters of 1M methanolic KOH were added to
the delipidated cells in glass screw cap tubes. Saponification process was continued for
16 hours with continuous stirring. After saponification the solution was cooled down and
then neutralized with concentrated HCl to pH=4. Free mycolic acids were then extracted
twice with diethyl ether. The combined extract was washed with deionized water and
then dried with rota-evaporator under vacuum at 40°C. For NMR acquisition, dried
mycolic acids were dissolved in 1:1 CD3OD:CDCl3.
4.2.6 NMR Acquisition and Data Processing
2D-HSQC lipid profiles were obtained using a Varian Inova-500MHz NMR
spectrometer equipped with a 5mm trpfg probe using 2D-HSQC pulse sequence (nt=10
ni=256). Samples were individually shimmed, locked and tuned at 24°C and other
acquisition parameters were optimized for each sample. NMR data was processed using
Felix–NMR. Specific cross peaks in the 2D-NMR spectrum were integrated and
normalized to the integration value of the DMSO peak that was used as an internal
standard. For acquisition of HR-MAS spectra, MAS rotors were inserted at the magic
angle in a GHx-nanoprobe with continuous spinning at 2 KHz and temperature of 24°C
degrees. Acquisition parameters were adjusted for individual samples. 2D HSQC pulse
sequence was applied for 8 transients and 256 increments.
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4.3 Results
4.3.1 Effect of Low Nutrients
Cells grown in Middlebrook 7H9 with 0.02% only of dextrose and glycerol showed
normal growth curve compared to that of cells grown with 0.2% glucose and glycerol.
However, when the O.D. reached a value of 0.4-0.6, the growth of cells grown in low
nutrient supply halted. The lipid profile of these partially starved cells looked overall less
crowded than that of cells grown under normal growth conditions. The quality of the
spectra was first assessed by referring to the signals of cell membrane phospholipids
which fell in the normal range observed in control experiments. Upon comparison of
these lipid profiles, lower intensities of signals of major acylated trehalose and triacyl
glycerols were observed. There was also a significant reduction in the levels of
unsaturated fatty acids and PIM6 when compared to the levels recorded in normally
grown cells that have been harvested at different O.D. (Figure 4.1).
Upon examining the HR-MAS spectra for changes in the mAG complex, no such
changes were readily detectable (Figure 4.2). However, signals corresponding to the cell
wall glucan were detected at a relatively low intensity when compared to cells grown
under normal growth conditions and harvested at different stages of their growth. LAM
signals were recorded at significantly lower intensity in the partially starved cells as
opposed to AG signals which remained at stable levels. Meanwhile, all lipid signals that
could be detected in the HR-MAS spectrum were either absent (such as unsaturated fatty
acids signals) or recorded at much lower intensity (Figure 4.2).
4.3.2 Effect of Starvation
Cells starved in PBS were maintained over a period of four weeks. Over this period,
we observed a drop in the viable count of the starved cells by approximately one
logarithmic unit (Figure 4.3a). This loss in cell viability was directly detected in the
cellular lipid profile as one logarithmic unit decrease in the intensity of NMR cross peaks
previously assigned to cellular phosphoglycerolipids (PL) as shown in Figure 4.3b.
Other cellular lipids, most notably triacyl glycerols (TAG), were greatly affected by
prolonged starvation. TAGs are associated with the cell wall lipid pseudomembrane but
they are mainly located inside the cytoplasm in large lipid vacuoles. After starvation for
two days, the TAG pool was depleted from the cells (based on the detection limit of this
method), while other cellular components remained at their original levels. However,
after only six hours of transferring the cells to nutrients rich media, TAG levels were
measured at twice their value and continued to rise after 24 and 48 hours. During that
time, cells seemed to be preparing for a complete recovery and cell replication was
halted. After 2-4 days of this peak, the TAG levels were restored back to their normal
abundance in M. bovis BCG (Figure 4.3c).
Other cell wall lipids (PDIM, fatty acids, TDM, PIM and AT) of the cell wall
remained at their original levels for more than two weeks but a significant drop in their
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Figure 4.1 Effect of Limited Nutrients Supply on the Cellular Lipid Content of M. bovis
BCG
Cellular lipid contents are expressed as the integration volumes of specific biomarker
signals for each lipid class; δH=1.23, δC=45.54 ppm for PDIM, δH=5.30, δC=69.31 ppm
for TAG, δH=5.26, δC=70.74 ppm for PL, δH=5.10, δC=101.85 ppm for PIM2, δH=5.01
δC=102.63 ppm for PIM6, δH=5.34, δC=129.97 ppm for unFA, δH=0.67, δC=15.76 ppm
for TDM and δH=5.13, δC=93.65 ppm for ATs. All integral values were normalized to
that of DMSO which was used as an internal standard.
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Figure 4.2 Effect of Limited Nutrients Supply on the Cell Wall AG and LAM of M.
bovis BCG
HR-MAS 2D-HSQC spectra of M. bovis BCG cells which were grown at normal
conditions and harvested at O.Dλ600 of 0.3, (a), grown in limited nutrient supply and
harvested at O.Dλ600=0.45, (b), or grown under normal conditions and harvested at
O.Dλ600=0.6, (c). In general, HSQC signals for cellular lipids and glucans were recorded
at lower intensities in the HR-MAS spectrum of the partially starved cells as seen in (b).
Shown in the bottom inserts is the variation in the abundance of LAM between the three
spectra as indicated by arrows. At the same time, AG signals are recorded at comparable
intensities in the three spectra (the anomeric signal of 6-β-Galf is highlighted in the three
spectra inside small ovals).
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Figure 4.3 Effect of Prolonged Starvation in PBS on the Cell Wall Lipids of M. bovis
BCG
A drop in the viable count of the starved cells can be observed after one week, (a), a
parallel drop is also observed in cellular PL (solid diamond in b) and a less significant
drop is observed in PIM2 and PIM6 content (solid square and solid triangles in b). Levels
of other cell wall lipids were monitored during PBS starvation and subsequent
resuscitation, (c). All cell lipids are represented as normalized integral volumes of their
corresponding biomarker signals as described under Figure 4.1. Ratios of different
mycolic acid classes as compared to the total mycolate pool during starvation are plotted
in (d). The relative ratios of mycolic acids were obtained as the integral value for each
biomarker signal as described in Table 2.2 divided by the value of the β-CHOH signal at
δH=3.65, δC=72.15ppm.
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concentration was observed after four weeks of starvation (Figure 4.3c). At the same
point a further drop was observed in the viable count of the starved cells. Upon
transferring the starved cells to nutrient rich growth media, the cellular level of these
molecules remained relatively stable for the first 24-48 hours. During the same period,
the viable cell count remained constant while the concentration of TAG increased
drastically. Levels detected for most cellular lipids were not restored back to their normal
values till after four days of reactivation (Figure 4.3c). At which point it is expected that
the bacterial population has completely shifted to a logarithmic growth phase.
In the HR-MAS profile of the starved cells, minimal changes were observed in the AG
and LAM pool but there was a fast depletion of the outer cellular glucans as indicated by
the gradual loss of the intensity of the glucan signals in the 2D-HSQC spectrum. Glucan
signals were reported at significantly lower intensities after one week of starvation and
almost disappeared after four weeks. This observation was rapidly reversed upon
transferring the starved cells to a nutrient-rich media for less than 24 hours (Figure 4.4).
The integrity detected in the cell wall mAG complex upon starvation was further
confirmed by the stability observed in the covalently bound mycolic acid pool (Figure
4.3d). This suggests that even with prolonged starvation periods, Mycobacteria can
preserve the integrity of its structural cell wall components with no adjustments in the
substitution pattern of the covalently bound mycolic acids.
4.3.3 Effect of Gradual Oxygen Depletion
In our low oxygen model, M. bovis BCG cells exhibited a very slow growth when
compared to cells grown under normal growth conditions (Figure 4.5a). Aerobic
conditions were sustained in this model for the first seven days as indicated from the
color stability of the redox indicator methylene blue. At the end of this period, the optical
density of the cells reached 0.3 which was comparable to that reached by cells grown
under normal growth condition for the same period. However, when oxygen levels started
declining, the rate of cellular growth slowed down significantly. An increase in the
optical density to a plateau level of O.Dλ600=0.56 was achieved after 28 days of
inoculation and after fading of the redox indicator color. This slow growth is indicative of
an effective adaptation of the cells to low oxygen conditions. It has been previously
reported that the success of the transfer of Mycobacteria to anaerobosis depends on the
length of such transition periods.
During this slow process, some gross changes in cell density and texture were
observed in the actively adapting cells that may indicate cell wall reorganization. For
example, a gradual decrease in the cell density which reached its maximum at 28 days
was observed. In parallel to this gross morphological change, there was a significant rise
in the levels of TAG that also reached its peak at 28 days and started to decline
afterwards (Figure 4.5c). Upon exposure of the cells to normal oxygen levels, normal
cell density as well as TAG levels were partially restored after 6 hours. A complete
restoration of cell texture and TAG levels was detected after 4-7 days (Figure 4.5c).
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Figure 4.4 Effect of Prolonged Starvation in PBS on the Cell Wall Polysaccharides of M.
bovis BCG
HR-MAS 2D-HSQC spectra of M. bovis BCG grown under normal growth conditions
and harvested at O.Dλ600=0.6, (a), M. bovis BCG starved in PBS for four weeks starting
with the same optical density, (b), and M. bovis BCG that has been resuscitated for four
days after four weeks of starvation in PBS, (c). Circled in the three spectra are signals
indicative of the cell wall glucan which were greatly reduced in their intensity upon
starvation as seen in (b).
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Figure 4.5 Effect of Gradual Oxygen Depletion on the Cell Wall Lipids of M. bovis BCG
M. bovis BCG cells grown under low oxygen condition exhibited a very slow growth rate
as indicated by their O.D. measurement (solid square in a) when compared with cells
grown under normal growth conditions (solid circles in a). The arrow indicates the time
point at which the color of the redox indicator methylene blue started to fade. During the
oxygen depletion process, cellular levels of membrane phospholipids remained
essentially constant, (b). In panel (c), levels of other cellular lipids are reported during
oxygen depletion and after resuscitation. The relative abundance of TAG, PIM2, PDIM,
AT and fatty acids are plotted as the integral values of their corresponding biomarker
signals normalized to that of DMSO.
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As expected, there was a remarkable stability in the levels of cellular phospholipids
which levels remained unaffected during low oxygen conditions and also during
reactivation by exposure to oxygen (Figure 4.5b). This stability indicates successful
transformation to anaerbosis as any loss of cell viability will be detected by a loss of PL
signal intensity.
In the HR-MAS spectrum, signals of TAG (which are usually recorded at low
intensity in M. bovis BCG) were recorded at unusually high intensity indicating the
presence of an overwhelming amount of these lipids. Despite that, signals of glucan and
AG were easily detected at their normal levels (Figure 4.6). It is to be noted however,
that a significant shift in the LAM signals was observed. Cells grown under low oxygen
condition for four weeks showed very low intensity of signals indicative of 2-α-Manp and
higher intensities of those indicative of 2,6-α-Manp. As shown in Figure 4.6, the
anomeric signals corresponding to 2-α-Manp and 2,6-α-Manp are usually recorded with
comparable intensities (Figure 4.6a). However, under low oxygen conditions, it appears
that a larger number of 2,6-α-Manp residues are present in the mannan core indicating
extensive substitution of the linear mannan chain at the 2-position. Such observation can
be also supported by relative increase in the intensity of signals of the terminal Manp
residues as detected at δ1H=4.93, δ13C=102.19 ppm and a parallel decrease in the signals
for the unsubstituted 6-α-Manp residues (such effect can be seen in the C6 signal of 6-αManp as detected at δ1H=3.70/3.87, δ13C=65.26 ppm).
In addition, the apparent lower abundance of 2-α-Manp residues (2-α-Manp is located
in the mannose caps of manLAM) may indicate a lower frequency of mannose capping or
a shift in the LAM/LM ratios. The physiological outcome from any of these two
possibilities is likely to be similar. As previously discussed under section 1.4.3.1, both
uncapped LAM and LM are associated with the induction of a strong pro-inflammatory
response, while manLAM has some immune-suppressive actions. As a result, this shift in
balance towards the production of lower manLAM levels in dormant bacilli is likely to
induce a corresponding change in the host immune response to the infection. Further
studies are needed to confirm these findings considering the possibility that the gross
morphological changes that were observed in the cells may have affected the mobility of
some of the carbohydrate residues under HR-MAS acquisition conditions.
Unlike the stability observed in the mycolic acid pool under starvation conditions,
some significant changes were observed in the relative abundance of mycolic acid
classes. The most drastic of which was the gradual depletion of keto mycolates which
completely disappeared after four weeks (based on the detection limit of this
methodology). This reduction in keto mycolates levels was parallel to an increase in the
levels of hydroxyl and methoxy mycolates (Figure 4.7). Ketomycolates are one of the
major mycolic acid groups of M. bovis BCG while hydroxyl and methoxy mycolates are
normally present at lower levels. It is not clear how this may affect the cell wall
properties but such shift is a rational adaptation for cells that grow inside the TB
granuloma as it appears that the bacterial cells may not be able to retain molecules of
high oxiditative state under low oxygen conditions.
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Figure 4.6 Effect of Oxygen Depletion on the Cell Wall Polysaccharides of M. bovis
BCG
HR-MAS 2D-HSQC spectra of M. bovis BCG cells grown under normal conditions, (a),
grown under low oxygen conditions for four weeks, (b), and resuscitated for one day after
oxygen depletion, (c). Signals circled in the three spectra are that of TAG which are
usually detected at low intensity as seen in (a), but their levels reached a peak
concentration after four weeks of oxygen depletion as shown in (b). Bottom inserts show
the variability observed in the relative abundance of some of the LAM signals between
the three spectra. Signals for 2-α-Manp at δH=5.02, δC=98.08 ppm and that of 2,6-αManp at δH=5.05, δC=98.13 ppm are circled in these inserts. In the case of cells that
were grown under low oxygen for four weeks, the relative ratios of these two mannose
residues changed towards the dominance of 2,6-α-Manp signals (on the left). Such
change in the abundance of the 2,6 disubstituted Manp residues was paralleled by a
decrease in the intensity of the signals of monosubstituted 6-Manp (signal for C6 of
Manp are indicated by red arrows). To less extent, an increase in the number of terminal
α-Manp residues can be observed as indicated by black arrows in the bottom insert.
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Figure 4.7 Effect of Gradual Oxygen Depletion on the Cell Wall Mycolic Acid of M.
bovis BCG
Relative ratios of different classes of mycolic acids are plotted as the integral volumes for
their corresponding biomarker signals as described in Table 2.2 divided by the integral
volume of the β-CHOH signal at δH=3.65, δC=72.15ppm. Shown here are the relative
abundance of different chemical classes of mycolic acids as monitored during gradual
oxygen depletion and subsequent resuscitation. Mycolic acids represented here include
hydroxyl mycolate, ketomycolate, α-unsaturated mycolates, α-cyclopropyl mycolates and
methoxy mycolates.
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4.4 Discussion
4.4.1 Stability of the Structural Components of the Mycobacteria Cell Wall
It has been well recognized that Mycobacteria have the ability to survive under harsh
conditions. Such unique survival ability has led to its persistence as a human pathogen
since prehistoric times. In this aspect, Mycobacteria complex and unique cell wall can be
thought to act as the shield it uses to protect itself from the harsh environmental
conditions it usually encounter. Whether it is inside the human macrophage or enclosed
in a complex isolated granuloma, the cell wall seems to be one of the most essential
components of the Mycobacteria survivosome. Hence, the integrity of the cell wall is
crucial for Mycobacteria infectivity and virulence. This is most notable in the case of AG.
AG structure is conserved among all Mycobacteria as discussed in the previous chapter
and as we observed in this study, it also remains unaffected by different stress conditions.
While these observations pinpoints to the importance of an intact AG for mycobactrial
survival, it further underscore its value as an important target for the development of new
drug candidates. From this study, it became obvious also that cellular levels of many
other structural cell wall components were preserved despite the exposure to prolonged
stress conditions to maintain an optimal cell wall integrity. In fact, most of the major
changes identified in this study are related to TAG which are present for the most part
inside lipid vacuoles in the cytoplasm. In case of starvation, other changes in cell wall
lipid composition were found to be associated with a parallel loss of viability.
4.4.2 Phospholipids as Indicators of Cell Viability
From this study, we confirmed the use of phospholipids signals as indicator for cell
viability. During either starvation or hypoxic conditions, the levels of PL lipids that we
detected in our lipid profiles have always matched the cell viability determined by
traditional microbiological techniques. This is due to the fact that upon cell death and
membrane rupture, phospholipids are rapidly hydrolysed and utilized by other cells once
they are not stacked in an organized lipid membrane bilayer structure. Chemical analysis
of phospholipids has been used as indicator to the presence of viable bacteria in inorganic
and organic samples such as water and soil in other studies.283,284 For our purpose, not
only do these phospholipids serve as an indicator of cell viability, but they can be used
also to ensure the quality of the lipid profiles obtained through this methodology. In
comparative analysis that include different experiments, the integration value of these
molecules can be used as an internal standard to which integration values of other
biomarker signals can be normalized to.
4.4.3 Triacyl Glycerols as Favorite Energy Sources
One of the interesting results of this study was to elaborate on the role that TAG play
to enhance Mycobacteria stringent response and survivability. Our results indicate that
under hypoxic conditions and during exceptionally slow growth, cells have accumulated
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massive amount of TAG (up to 40 times their normal values). This result is consistent
with a similar study by Daniel et al who reported overexpression of triglyceride synthases
upon adaptation of the cells to hypoxic conditions.278 It can be argued that this process
can be a direct result of either accumulation of TAG due to halted β-oxidation or as a
measure taken by the cells in preparation for a long process of dormancy. There is more
evidence however in favor of the second argument. First of all, levels of TAG started
declining after reaching a peak level despite continued hypoxic conditions. Second, we
also detected a short term accumulation of TAG in the first hours of transferring the cells
to fully nutrient growth media in presence of normal oxygen levels. Third, we have
always observed that any decline of TAG levels from previous status was matched by an
increase in the levels of other organic molecules which points to the role of TAG as
biosynthetic precursors. Furthermore, if we look at multicellular organisms as an
assembly of unicellular ones, the behavior of hibernating animals which store their food
supply with the first signs of looming winter can be extrapolated to microbial cells
storing their favorite energy source after receiving signals of expected dormancy.
4.4.4 Process of Reactivation Has Optimum Goal
Regardless of the harsh conditions imposed on the mycobacterial cells, levels of
different cellular components are always restored to a preset limit upon returning to their
normal growth conditions. This observation was valid among cells that underwent partial,
complete nutrient starvation or oxygen depletion. In each case however, there were
certain temporary changes in the composition of cellular lipid pools especially during the
first few hours of reactivation. But such temporary changes were short lived and
restoration of a specific concentration to most organic molecules was achieved within
two to four days and most likely as a direct result of resumed cell replication.
4.5 Conclusion
In conclusion, we have demonstrated the adaptive response of Mycobacteria to
laboratory stress conditions that are generally accepted to mimic the in vivo environment
of latent bacilli. We were able to monitor gradual changes in the cell wall composition by
2D-HSQC NMR maps using less than 100mgs of cell. This NMR-based approach
allowed us to provide a comprehensive profile for different components of the cell wall
lipid pool, cell wall polysaccharides and the covalently bound mycolic acid pools. As a
result, we were able to detect changes in these pools and relate them to adaptive response
mounted by Mycobacteria during infection. For example, we have identified the
accumulation of large amount of TAG during oxygen depletion. Similar observation has
been reported from bacteria isolated from diseased tissues. Electron micrographs of these
bacilli indicated the presence of large lipid vacuoles that extend to cover more than 90%
of the cytoplasmic space.7,63 This apparent agreement in results supports our finding and
also validates the utility of in vitro oxygen depletion models. Furthermore, we observed
certain changes in the LAM/LM pool of the bacilli when they were grown in the same
oxygen depletion model. To the best of our knowledge, such observation has not been
101

reported previously and it is a candidate for further investigation due to the shift in
balance that it may impose in the Mycobacteria-host immune interaction.
This study has also validated previous reports of the unique ability of Mycobacteria to
adapt to a range of harsh environmental conditions. This adaptation process is better
served when the transition period to such new environment is prolonged. In our low
oxygen model, we reported a very successful transition to hypoxic conditions due to an
unusual slow growth rate. We also have noticed that cells that have been partially starved
in low nutrient media do not suffer any measurable loss of viability upon transfer to PBS
for an extended time period. Such transition periods are required for cells to adjust its
metabolome for the harsh environment it expect to encounter. However, regardless of the
stress conditions that the bacilli were subjected to, certain structural components (most
notably AG) remained well preserved during both the stress and the recovery period. This
underscores the importance of the integrity of AG for cell survivability and should
encourage scientists to further study AG biosynthesis to identify new targets for anti-TB
therapy beside the already established enzyme target (EMB-b) for etahmbutol.
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CHAPTER 5. TWO CASE STUDIES FOR THE USE OF BIOANALYTICAL
TOOLS IN SCREENING FOR VIRULENCE DETERMINANTS OF
PATHOGENIC MYCOBACTERIA 3
This chapter discusses two specific examples where different spectroscopic techniques
were used as a tool for targeted lipid analysis. In both cases the targeted lipid molecule is
an immune-modulator. However, due to differences in their physiochemical properties,
two different strategies where used for their analysis.
5.1 Case Study-I: Screening Various Mycobacteria Species for the Production of
Mycolactone Toxins
5.1.1 Introduction
Mycolactones are macrolides produced by a small number of Mycobacteria species
and are associated with potent immune-suppression and cytotoxic properties.286
Mycolactones were introduced to the scientific community in 1999 with the discovery of
the first mycolactone from a Malaysian isolate of M. ulcerans.231 Because it was isolated
as a mixture of two geometric isomers, it has been designated as mycolactone A/B.287
This was the first report of macrolide production by a mycobacterium although
macrolides in general have been isolated from many other organisms most notably
Streptomyces species.239 Other analogues of mycolactone A/B were later detected in
different M. ulcerans isolates and other closely related Mycobacteria.254,285,288-290 All
mycolactones share a totally conserved common macrolide core (a 12-membered lactone
ring conserved in its chemical substitution and stereochemistry). This core is esterfied at
C-5 position to a polyene acidic side chain. Mycolactone molecules identified that far
show only variability in the length and substitution of their side chains (Figure 5.1 and
Table 5.1).
All Mycobacteria producing mycolactone (MPM) contain a large plasmid that encodes
three large polyketide synthase (PKS) genes responsible for mycolactone biosynthesis
(mlsA1, mlsA2 and mlsB).291 All three genes belong to the bacterial PKS-type I class
where the PKS consist of several multi-enzyme modules that work together as a
molecular assembly line. Every module consists of at least three basic proteins;
ketosynthase (KS), Acyl transferase (AT) and acyl carrier protein (ACP) and is
responsible for addition of a specific unit to the growing molecule (Figure 5.2).291 More
diversity among these building units results from the activity of additional enzymes in
specific modules. Such enzymes include keto reductase (KR), dehydratase (DH) and
enoyl reductase (ER).292
3

Parts of this chapter are adapted with permission. Ranger, B.S. et al. Globally
distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic
macrolide, mycolactone F. Infect Immun 74, 6037-45 (2006).285
103

Figure 5.1 General Structure of Mycolactones

Table 5.1 Differences in the Structures of Mycolactones Isolated So Far

Side Chain (R)

Name

Parent Strain (Host)
Location of Isolation

Mwt

References

A/B

M. ulcerans (human)
Malaysia

742

231,287,293,294

C

M. ulcerans (human)
Australia

726

290,295

D

M. ulcerans (human)
China

756

296

E

M. liflandii (frog)
Laboratory colony USA

714

254,297,298
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Figure 5.2 Domain and Module Organization of Mycolactone A/B PKS Genes
Within each of the three genes (mlsA1,mlsA2 and mlsB), different domains are
represented by a colored block. The domain designation is described in the key. White
blocks represent interdomain regions of 100%identity. The structure of mycolactone has
also been color-coded to match the module responsible for a particular chain extension.
Reprinted with permission. Stinear, T.P. et al. Giant plasmid-encoded polyketide
synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci
USA 101, 1345-9 (2004).291
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Similarly, structural variations between mycolactones produced by different MPM are
attributed to genetic variability in specific modules which translates to addition or
elimination of a specific structural feature in the growing chain.286,291,292
The first mycolactone, isolated from M. ulcerans 1615 strain, was found to be a 2:3
mixture of two double bond isomers hence was the designation mycolactone A/B.287Most
other mycolactones exist in the form of an equilibrating mixture of two major geometric
isomers. This isomerization is a result from unrestricted rotation around 4’-5’ double
bond. For example, mycolactone A/B is a 2:3 mixture of Z-∆4’,5’ and E-∆4’,5’isomers and
mycloctone C is a 1:1 mixture of two similar Z-∆4’,5’ and E-∆4’,5’ isomers.295
Due to their structure, mycolactone are readily ionizable molecules that can be easily
detected by MS as sodium adducts at [Mwt+23] in the positive mode.290 On the other
hand, the chemical instability of the polyene structure and the possible isomerization due
to photo-oxidation can result in a mixture of a large number of geometric isomers
especially in aged samples. This large number of possible isomers can result in multiple
overlapping signals during NMR acquisition and mar the accurate interpretation of the
NMR data. Also the relatively low abundance of these molecules (1mg/liter in culture
grown in T-flask)299 makes MS better suited for their accurate and efficient analysis.
5.1.2 Materials and Methods
5.1.2.1 Bacterial culture and growth conditions
All isolates were grown either on plates of Middlebrook 7H11 agar media
supplemented with 10% oleic acid-ADG supplement, or in T-flasks in Middlebrook 7H9
supplemented with 10% ADG and 0.05% Tween 80. M. ulcerans strains were incubated
at 32° C. All other isolates were grown at room temperature.
5.1.2.2 Lipid extraction
Lipids were extracted from M. ulcerans using chloroform:methanol 2:1 (vol/vol) and
phospholipids were removed by precipitation with ice cold acetone to obtain acetonesoluble lipids (ASLs). Purified mycolactone was obtained using centripetal silica
chromatography with a chromatotron after elution with chloroform:methanol:water
90:10:1 (vol/vol/vol).
5.1.2.3 HPLC analysis
Methanolic extracts of ASLs were analyzed using Shimadzu LC-20AD analytical
HPLC with UV detection at 360 nm. Separation of various mycolactones was obtained
on a Phenomenex-Luna, C18 250X4.6 mm column at 2ml/min flow rate with
water/acetonitrile gradient: 55% acetonitrile 3 min; isocratic followed by a 37 min linear
gradient to100 % acetonitrile.
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5.1.2.4 MS analysis
UV active fractions were analyzed offline on an ion trap ESI Bruker-Esquire mass
spectrometer. MS analysis conditions: dry temperature of 300°C, gas flow of 5 L/min
and nebulizer pressure of 15 psi. For preliminary screening, the methanolic extracts of
ASLs were directly analyzed without chromatographic separation.
5.1.2.5 NMR analysis
Two milligrams of mycolactone F, purified from M. marinum DL240490 strain, was
dissolved in acetone-d6 (500µl). 1H NMR and 2D-COSY spectra were recorded on a
Varian Inova spectrometer at 500MHz. Chemical shifts were reported in ppm relative to
the residual acetone peak at 2.09 ppm.
5.1.3 Results
5.1.3.1 Screening by MS/MS and detection of mycolactones
Previously identified mycolactones and co-metabolites share a conserved core
structure with variation only in the substitution of the side chain. It is very advantageous
for MS analysis that the fragmentation of mycolactone often results in the formation of a
lactone core fragment through McLafferty rearrangement (Figure 5.3). This fragment,
detected at m/z=429, is indicative of the conserved mycolactone core sodium adduct.
This fact can be used to identify mycolactones directly from cellular lipid extract by
screening for ions that can produce such fragment. In the case of Mycolactone A/B, upon
capture and fragmentation of the precursor mycolactone adduct, it produces two main
ions; that of the core at m/z=429 and the other for the side chain at m/z=359 (Figure 5.3).
Therefore, MS analysis of ASLs can be a very useful tool in screening for new
mycolactones.289,290 MS analysis of several M. ulcerans isolates from Africa showed
precursor ion and fragment peaks consistent with that of mycolactone A/B. However,
different molecular ion peaks were observed in isolates from China where the dominant
ions where detected at m/z=779 and 777. Upon fragmentation, these precursor ions
produced the core fragment at m/z=429.4 and the side chain fragment at m/z=373 and
371 respectively. This pattern is in agreement with the presence of Mycolactone D.296
M. ulcerans 842 isolate from South America produced two major mycolactone ions at
m/z=763 and 737. The later, now identified as mycolactone E, produced a side chain
fragment ion at m/z=331 while the precursor ion at m/z=763 produces a product ion at
m/z=357. Similar patterns were observed upon the analysis of ASLs from different M.
liflandii isolates from two laboratory colonies of Xenopus tropicalis and Xenopus lavis.
However, no peaks at m/763 were observed. This indicates that while both the South
America M. ulcerans isolates and the frog pathogen M. liflandii produce similar molecule
(mycolactone E), there seems to be a limit to the length of the side chain of mycolactones
produced by the frog pathogen.
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Figure 5.3 Major Fragmentation Pathways of Mycolactone A/B
MS fragmentation of mycolactone A/B proceed through Mclafferty rearrangement to
produce two characteristic product ions; that of the core at m/z=429 and the side chain at
m/z=359. All mycolactone molecules produce the same core fragment while their side
chain fragments differ in their m/z based on the side chain substitution. Another
fragmentation pathway produces a product ion at m/z=565.7 is common among all
mycolactone that have the same side chain substitution between C1’-C-6’.288,296
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A newly identified organism (temporarily identified as M. shinshuense. and currently
as M. ulcerans subsp. shinshuense) was isolated in Japan from a small number of patients
with cases of skin lesions similar to that of Buruli ulcer.300,301 Direct MS analysis of the
ASL extract from this isolate identified at least three major mycolactones at m/z=793,
779 and 777. All three ions where associated with a product ion of the core lactone ring
upon fragmentation (Figure 5.4a,b). Their side chain product ions where detected as
expected at m/z=387, 373 and 371 respectively. A Peak indicative of mycolactone A/B
at m/z=765 was detected as well.
Finally, MS analysis for the ASL of M. pseudoshottsii L15 (a pathogen isolated from
sea striped bass found in the Chesapeake Bay)42 and nine isolates of M. marinum isolated
from infected fish in the Middle East region revealed a major ion at m/z=723 [M+Na]+.
Upon fragmentation, this precursor ion produced the conserved core fragment ion at
m/z=429 suggesting the presence of another mycolactone, later designated as
mycolactone F (Figure 5.4c,d). Moreover, the fragmentation patterns in all samples were
identical suggesting that the mycolactones produced by these strains have the same
chemical structure. In all ten cases, the side chain fragment was detected at m/z=317.
Other mycolactone characteristic product ions where detected at m/z=635, 565 and 273.
The complete results of MS screening of the various lipid extract are summarized in
Table 5.2.
5.1.3.2 HPLC profiles of different mycolactones
Because of the presence of six conjugated double bond in the side chain of
mycolactone A/B, it is relatively easy for mycolactone to undergo double bond
isomerization. It is well known that 1,3,5-hexatriene can undergo double bond
isomerization at C3-C4 through a biradical transition state as a result of photo-oxidation.
Similarly, due to the extended conjugation in the mycolactone side chain, unrestricted
rotation is possible around C4’-C5’ double bond. This free rotation is responsible for the
existence of mycolactones as equilibrating mixture of double bond isomers.
Traditional HPLC columns are capable of separating these geometric isomers. But
once outside the column, each isomer is converted to an equilibrating isomeric mixture of
specific ratio. For further structural analysis, it is necessary to understand the nature of
each mycolactone as a mixture of isomers rather than a single molecule. Under the
condition described in section 5.1.2.3, mycolactone A/B was separated by HPLC to two
major isomers with comparable concentration at 20.1 and 23.8 minutes (Figure 5.5a).
Other isomers of the same molecular weight were also detected. In the case of
mycolactone E and F, the side chain lacks one of the double bonds of mycolactone A/B.
This results in apparent stability of these two molecules. At room temperature, a
dominant isomer is detected by HPLC at 23.2 minutes in case of mycolactone E and at
20.5 min in case of mycolactone F (Figure 5.5d). The production of the same molecule
(mycolactone F) by multiple strains was also confirmed through the production of similar
HPLC chromatogram by ten of the strains tested in this study.
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Figure 5.4 MS Analysis of Different Mycolactone Molecules
MS analysis of the ASL of M. ulcerans subsp. shinshuense showing three major
mycolactones at m/z=793, 779 and 763, (a). Fragmentation of the m/z=793 precursor ion
result in the production of the mycolactone core ion at m/z=429.4, (b). MS analysis of the
ASL of M. pseudoshottsii L15 showing the dominance of a major mycolactone ion at
m/z=723, (c). Fragmentation of the precursor ion at m/z=723 produces a core ring
product ion at m/z=429 and a side chain product ion at m/z=317, (d). MS analysis
conditions were described under section 5.1.2.4.
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Table 5.2 Mycolactone Ions Identified in Different Mycobacteria Strains
[M+Na+] Ions

Strain

Origin

M. ulcerans 1615

Human Malaysia

765, 747, 749

M. ulcerans 98-912

Human, China

779, 777

M. ulcerans 842

Human, S. America

763, 761, 737

M. ulcerans subsp shinshuense

Human, Japan

793, 779, 777

M. liflandii 128

Frog, ,USA

737, 735

M. liflandii HW-1

Frog , USA

737, 751, 733

M. liflandii XL-5

Frog, USA

737, 753, 735

M. pseudoshottsii L15

Fish, Chesapeake Bay

723, 763, 755, 739

M. marinum DL240490

Fish, Red Sea

723, 763, 755, 739

M. marinum SA200695

Fish, Red Sea

723, 755, 739

M. marinum Hyb270995

Fish, Red Sea

723, 757, 739

M. marinum DL150991

Fish, Red Sea

723, 757, 755, 739

M. marinum DL180

Fish, Red sea

723, 755, 739

M. marinum CFO30494

Fish, Red Sea

723,.757,.755,.739

M. marinum DL045

Fish, Red sea

723, 739

M. marinum CC240299

Fish, Red Sea

723, 739, 721

M. marinum BB170200

Fish, Red Sea

723, 755,.739

Major mycolactone ions are highlighted in bold numbers.
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Figure 5.5 HPLC Profiles of the ASL Extract from Different Mycobacteria
HPLC chromatogram of the ASL obtained from M. ulcerans 1615, (a). Arrows indicate
the elution of mycolactone A/B isomers with m/z=765. HPLC profile of ASL from M.
liflandii XL-5, (b). Arrows indicate the elution of a mycolactone E isomer at m/z=737.
HPLC profile of ASL from M. ulcerans subsp. shinshuense, (c). Arrows indicate the
elution of different mycolactone molecules of variable m/z. HPLC chromatogram of the
ASL of M. marinum DL240490, (d). Arrows indicate the elution of mycolactone
molecules m/z=723. HPLC and MS analysis conditions were describes in sections 5.1.2.3
and 5.1.2.4 respectively.
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Finally, The HPLC chromatogram of the ASL extract from M. ulcerans subsp.
shinshuense showed more complexity than all previous cases (Figure 5.5c). In part, this
is due to the presence of at least three mycolactone analogs as detected by MS analysis
but double bond isomerization have significant contribution to this complexity as inferred
from offline MS analysis of the HPLC eluted peaks.
5.1.3.3 Structural determination of mycolactone F
Although mass spectrometry is an increasingly valuable tool for molecular analysis,
data from NMR analysis provides a more rigorous method for structural assignments.
The limited amount of mycolactone produced by mycobacterial species as well as the
very slow growth rate of MPM has made it extremely difficult to obtain sufficient
mycolactone for optimal structural analysis. However, the relatively robust growth yield
of lipids from some M. marinum isolates made it possible to undertake a more thorough
analysis of mycolactone F structure isolated from M. marinum DL240490 strain.
To determine the structure of mycolactone F, 1D and 2D NMR experiments were
performed on purified sample of mycolactone F. As expected, 1H NMR revealed a
structure very similar to that reported for mycolactones A/B with the characteristic core
proton signals at C9, C15, C11 and C5 easily identified at 5.16, 5.03, 4.93 and 4.75 ppm
respectively287 (Figure 5.6). In the region corresponding to the side chain, two
geometrical isomers were distinguished with an integration ratio of 10:1. Both isomers
showed five olefinic protons. For the major isomer, the most downfield proton was that
of C3’ which appeared as a doublet at 7.39 ppm and was coupled to C2’ proton (doublet
at 5.91 ppm). The presence of two singlet peaks at 6.4 and 6.1 ppm suggested the
presence of methyl substitutions at C4’, C6’ and C8’. This was confirmed by 2D-COSY
analysis which showed the long range coupling of these olefinic protons to methyl groups
at 2.06 and 2.03 ppm. The remaining side chain signals from C10’ to C15’ overlapped
signals from the mycolactone core in the 1D-1H NMR. Thus, 2D-COSY was used to
assign these protons (C9’ to C14’) using the off diagonal 1H-1H correlation peaks (Table
5.3). Mycolactone F is the smallest mycolactone identified so far and as with other
mycolactone variants, the core lactone structure is identical to that of other mycolactones,
whereas the side chain is unique.
5.1.4 Discussion
The use of MS for the structural analysis and screening for mycolactones is a very
efficient approach. Unlike most cellular lipids that posses long hydrophobic fatty acid
chain, mycolactones are polyketide in nature and their substitution pattern contain many
oxygenated function that make their ionization by soft techniques like ESI more efficient.
It is also useful that variations in the mycolactone structures are restricted to the side
chain and that the fragmentation pattern of mycolactone follows simple and often
predictable pathways. However, for a complete structural assignment, NMR provides the
necessary tool for structural determination provided that the analyzed sample is of
enough purity and shows significant chemical stability.
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Figure 5.6 Structure and 1H-NMR of Mycolactone F

Table 5.3 Proton Chemical Shifts of the Major Isomer of Mycolactone F
Side Chain
Atom δ1H (ppm)

Atom

Core Ring
δ1H (ppm)

Side Chain
Atom δ1H(ppm)

Core Ring
Atom δ1H(ppm)

2’

5.91 (d)

2

2.45, 2.04

16’

2.03

15

5.03

3’

7.39 (d)

3

1.60

17’

2.06

16

2.39

5’

6.46 (s)

4

1.7

17

3.5

7’

6.09 (s)

5

4.75

18

1.62, 1.13

9’

5.56 (t)

6

2.01

19

3.99

10’

2.31 (m)

7

1.92

20

1.13

11’

3.99

9

5.16

21

1.00

12’

1.12

10

2.51, 2.12

22

1.7

13’

3.56

11

4.93

23

1.03

14’

1.03

12

2.09

24

1.69

15’

1.06

13

2.14
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It was possible to determine that all ten fish pathogen tested here produced the same
molecule through analysis of both MS/MS and HPLC analysis. The production of the
same product ions upon fragmentation of the precursor ion at m/z=723 indicated that the
side chain of all these molecules are the same. On the other hand, consistency in the
HPLC profiles of the equilibrating double bond mixtures further confirmed this
observation. However in both cases, differences in the stereochemistry between these
mycolactone F molecules can not be ruled out. Recently, the structure of mycolactone F
was confirmed through chemical synthesis and its absolute stereochemistry has been
assigned.302
The structure of mycolactone D has been proposed by Hong et al through a detailed
examination of all the product ions it produced upon its fragmentation in MS/MS
mode.296 The presence of a C2’ methyl in mycolactone D (m/z=779) was suggested based
on the apparent mass increase in one of the mycolactone A/B fragment from m/z=565.4
to 579.6. This ion represents the fragmentation product due to aromatization of the side
chain at C1’-C6’. Due to the mass increase in this ion by 14 dalton in mycolactone D, the
presence of a methyl group was suggested and its only possible location was C2’.296
The utilization of the same approach with the mycolactones identified in the ASL of
M. ulcerans subsp shinshuense come to the conclusion that the three mycolactones in this
extract detected at m/z of 777, 779 and 793 are not structurally similar to mycolactone D
and are more likely to be related to mycolactone A/B. The presence of C2’ methyl can be
immediately ruled out on the basis of the production of the m/z=565.4 fragment. Also 1HNMR and 2D-1H-1H COSY analysis of a mixture of these three molecules indicated the
presence of three sets of coupled protons at δ1H=(2’CH at 5.96, 3’CH at 7.96 ppm),
(2’CH at 5.88, 3’CH at 7.48 ppm) and (2’CH at 5.98, 3’CH at 7.52 ppm). No other offdiagonal signals were detected between protons in the olefeinc region which may indicate
the presence of methyl substitution at C8’. Unfortunately, due to the existence of multiple
isomers in that mixture (as indicated from its HPLC chromatogram), further structural
characterization was not possible at the time.
From our screening of MPM isolates, we observed that all M. ulcerans isolates
(including subspecies shinshuense) produce mycolactones where the side chain reaches
16 carbons in length. This length is consistent with a PKS-I enzyme with seven modules
in addition to the loading domain. Differences in the side chain between M. ulcerans
mycolactones were restricted two areas. First, the substrate of one or more module can
change from malonate to methylmalonate resulting in an additional methyl branch (as in
mycolactone D). Second, the C12’ hydroxyl which is added by a p450 monoxygenase
may be absent (as in the case of mycolactone C). While M. ulcerans isolated from South
America produces a mycolactone with a shorter side chain, mycolactoneE, longer chain
analogues were also observed at m/z=763 and 761. This confirms the presence of a PKS-I
with seven modules. In mycolactones produced by both frog and fish pathogens, the side
chain length was C15 and C14 respectively. This suggests the presence of PKS-I of only
six active modules in addition to the loading domain. Differences between mycolactone
E, produced by the frog pathogen, and mycolactone F, produced by fish pathogens, were
limited to the loading residue which is either methylmalonyl residue in the first or
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malonyl in the latter. Some of these findings have been supported recently through an
elegant genomic study by Pidot, S et al.292
These structural variations between different mycolactones are translated to different
cytopathic activities of mycolactones in standard in vitro assays. Mycolactone A/B is
known to cause G0/G1 cycle arrest and produce cytopathic activity (CPA) at
concentration less than 1ng/ml.231 Mycolactone C which has the same chain length but
lacks the hydroxyl group at C12’ demonstrates comparable CPA but at much higher
concentration (800ng/ml).290 Shorter side chains (as in mycolactone E and F) are also
associated with reduction in CPA. For example, mycolactone E (C15 side chain)
produces CPA at concentration of 100ng/ml.254 With regards to their biosynthesis and the
range of biological activities attributed to them, mycolactones are fascinating bacterial
metabolites. Understanding their “structure activity relationship” as well as the genetic
bases behind it should encourage researchers to develop combinatorial biosynthetic
strategies targeted at the production of mycolactone analogs. Such effort will help further
elucidate the effect of substitution on mycolactone biological activity and might produce
novel drug candidates that can be used in the treatment of cancer or auto immune
diseases.
5.2 Case Study II: Screening Mycobacterium tuberculosis Clinical Isolates for the
Production of PGL
5.2.1 Introduction
Phenolic glycolipids (PGL) have been previously isolated from M. leprae, M.
kansasii, M. marinum, M. bovis and M. tuberculosis Canetti strain, a smooth colony
variant of M. tuberculosis.144,145,260,262,303,304 In a previous chapter, we have reported the
isolation of PGL from M. liflandii as well (section 3.3.4). The aglycon part of PGL is
usually phenolphthiocerol-A, phenolphthiotriol-A or phenolphthiodiolone esterified to
two molecules of mycocerosic acid. The glycon part which substitutes the oxygen of the
phenol ring can be either monosaccharide, disaccharide or trisaccharide.149,262,303
Examples of mycobacterial PGL were previously shown in Figure 1.11.
The aglycon part of PGL can be considered as an aromatic derivative of PDIM
(section 1.4.3.6). Different mutants of M. tuberculosis that are deficient in the
biosynthesis of PDIM have been shown to be attenuated in a murine model by different
research groups.146,305 However, the specific role of PDIM in virulence has not been fully
elucidated. It has also been suggested that the apparent attenuation of PDIM deficient
mutant is due mainly to gross structural modification of the cell wall.306
PGLs are associated with significant immune-modulatory effects that are well
supported by plethora of evidence. PGL-I of M. leprae is the main antigenic component
of this pathogen143,144 and the immune reaction to PGL-I is often used as a prognostic
marker for early infections with leprosy.307 Recent reports have suggested PGLs
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produced by M. tuberculosis as the cause of hypervirulence in isolates from the WBeijing lineage.153 Other recent studies, however, indicated that while PGL can modulate
the host immune response and suppress production of Th2 cytokines, they do not confer
hypervirulence in their own.174
Biosynthesis of PGL requires multiple enzymes in different pathways. These enzymes
include PKS and fatty acid synthases involved in phthiocerol and mycocerosic acid
biosynthesis, certain synthases like 4HB-synthase responsible for the production of 4hydroxybenzoic acid,308 glycosyl transferases which transfer of the sugar residues to the
aglyon,152 and PKS1-15 which links the aromatic residue to the fatty acid chain.150 Most
strains of M. tuberculosis are incapable of producing PGL due to a frame shift in the pks
1-15 gene.147,150 Meanwhile, all strains of M. tuberculosis have the capability of
producing PDIM and some forms of glycosylated benzoic acid esters like those detected
by Perez and colleagues in the culture filtrate of M. tuberculosis H37Rv.152
In this study we investigated the production of PGL by different MDR clinical isolates
collected from South Korea by the National Institute of Allergy and Infectious Diseases
(NIAID) collected by Dr. Clifton E. Barry III and his research group. We also included
some laboratory strains and other clinical isolates from the collection of the State of
Tennessee health department. We used NMR-based lipid profiling to determine the
production and the relative abundance of PGL in these strains and in the same time
ensure stability in the concentration of other cellular lipids.
5.2.2 Materials and Methods
5.2.2.1 Growth conditions and lipid extraction
M. tuberculosis isolates were grown in Middlebrook 7H9 supplemented with 0.2%
C6-dextrose, 0.2% 13C3-glycerol, 0.05% Tween 80 and 5% BSA at 37°C with
continuous shaking at 250 rpm. 94 isolates were used for this study including 85 from
South Korea, 5 from the state of Tennessee, in addition to H37Rv, CSU93, HN878 and
its ∆pks mutant stain. Cells were harvested by centrifugation at 3700xg for 10 minutes.
Cell pellets were washed and extracted as previously described under section 3.2.1.
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5.2.2.2 Isolation of PGL from M. liflandii
M. liflandii cells were grown to stationary phase in Middlebrook 7H9, harvested by
centrifugation, and subsequently extracted with ethanol. The ethanolic extract was dried
in vacuo and the dried residue (80 mg) was re-suspended in CHCl3 and applied to a
Biotage SP1 flash chromatography system equipped with a Biotage Si 12+M silica gel
column. The column was eluted using a CHCl3-to-CHCl3/CH3OD 9:1(v/v) linear
gradient. The major PGL was detected using silica TLC analysis with CHCl3/CH3OH
(95:5, v/v) as the developing system (Rf = 0.7). Lipids were visualized using cerric
ammonium sulfate in 2 M sulfuric acid after charring. Fractions containing pure PGL
were pooled and dried in vacuo.
117

5.2.2.3 NMR acquisition and data processing
The 2D-HSQC spectra were recorded using Varian Inova 500MHz spectrometer at
25°C degrees. The 2D-HSQC spectra were acquired for 256 increments and 60 transients
using a 5mm trpfg sample probe or 10 transients using 3mm internal flow cell probe. For
all NMR acquisitions, samples were shimmed, toned and other acquisition parameters
were optimized. NMR data were processed using either VNMR or Felix-NMR software.
Biomarker signals for different lipids were selected and their integral volumes were
measured (δ1H=7.74, δ13C=133.64 ppm for menaquinone, δ1H=5.26, δ13C=70.74 for PL,
δ1H=5.30, δ13C=69.31 for TAG, δ1H=0.67, δ13C=15.76 for TDM, δ1H=1.23, δ13C=45.54,
for PIM and δ1H=5.13, δ13C=93.65 for ATs. Integration values obtained for different
isolates were compared to the corresponding values in M. tuberculosis H37Rv after
normalization to the integration value of the menaquinone signal which was used as an
internal reference. The values of PL biomarker signals were used as a secondary
reference to insure the quality of the data.
5.2.3 Results and Discussion
5.2.3.1 Selection for biomarker signals for PGL
Before screening for PGL production, it was necessary to define the set of biomarker
signals to be used for this purpose. In choosing these biomarkers signals, it is important
that they will not overlap with other signals from other lipid molecules. It is also essential
to ensure that these signals are unique for the targeted molecule. Based on this latter
criterion and upon considering what is known about the lipidome of M. tuberculosis,
most signals in the phthiocerol part of PGL can not be considered as biomarker signals
because they are present in PDIM as well. For similar reasons, most of the signals of the
glycon part are not suitable because they are very similar to signals from the glycosylated
benzoic acid esters produced by some M. tuberculosis strains. However, signals of the
phenolic ring and the adjacent methylene (benzylic protons) can be of special utility in
detection of PGL for several reasons. First, few mycobacterial lipids have aromatic
nucleus thus the phenolic and benzylic signals are likely to fall in well-resolved area of
the spectrum. Second, these signals appear at the junction between the glycon and
aglycon part of PGL, therefore, the chemical shifts for these protons will uniquely reflect
the chemical environment created by that link which is specific to PGLs. Third, the gene
responsible for establishing this link, pks1-15, can be considered as the genetic marker
for PGL production within Mycobacteria and among different strains of M. tuberculosis.
Finally, a set of a parent and ∆pks1-15 mutant stains is available and can be used to
demonstrate the possibility of PGL detection and ensure the right assignment of the PGL
signals.
5.2.3.2 Use of isolated standard for the assignment of PGL biomarker signals
A major obstacle in studying M. tuberculosis PGL is their relative low abundance
when compared with other lipid molecules. Chemical structures of M. tuberculosis PGL
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were proposed based upon 1H-NMR experiment and glycosidic linkage analysis by
GC/MS. To assign PGL signals in the 2D-HSQC spectrum it is important to have the
chemical shifts for both the proton and carbon atoms in PGL obtained from a 2Dspectrum acquired under similar conditions to that used for our lipid profiling protocol.
However, it not practical to grow large amounts of cells to isolate enough PGL for 2DHSQC structural assignment. To solve this issue, we used the isolated PGL produced by
M. liflandii as our preliminary reference to assign most of the PGL signals in the lipid
profile of M. tuberculosis HN878. As expected, signals for the phenolic rings and the
benzylic carbon were well isolated. The two p-aromatic CH were detected at δ1H= 7.02,
δ13C=117.6 ppm and δ1H=7.18, δ13C=129.7ppm while the benzylic protons were
detected at δ1H=2.58, δ13C=46.8 ppm (Figure 5.7). To confirm the assignment, the lipid
profile of HN878 was compared to that HN878 ∆pks1-15, a mutant strain where the pks115 gene has been disrupted rendering the strain incapable of producing PGL. The two
profiles were quite similar except for the absence of PGL signal from HN878∆pks1-15
profile. These biomarker signals could not be detected also in the lipid profiles of M.
tuberculosis H37RV and the CDC-1551 strains.
5.2.3.3 Screening of other clinical isolates using 2D-NMR
In the previous experiments, lipid extract of CDC1551, HN878 wt and its ∆pks1-15
mutant were obtained from 30mls culture (150mgs) and the corresponding lipid profiles
were developed by prolonged NMR acquisition for 60 transients. For screening purposes,
both the initial cell pellet weight and the NMR acquisition time have to be reduced. Some
of the clinical isolate do not exhibit optimal growth behavior and the long NMR
acquisition time will be inefficient when dealing with a large number of samples. To
produce good quality spectra from smaller samples, we used 3mm NMR sample probe
which effectively reduced the sample volume required to 160µl. Such volumes can be
obtained from 10mls of cell culture grown to the mid exponential phase. Differences
observed in 2D-profiles between HN878 and its ∆pks1-15 mutant obtained using the
5mm probe were replicated using the 3mm sample probe in a shorter acquisition time of
about 1 hour 40 minutes.
Lipid extracts from 94 M. tuberculosis isolates were obtained from a 10mls of cell
culture as described previously and an HSQC lipid profile was obtained for each using
3mm NMR sample probe. Immediately, two isolates (OA033 and OB239) were
disregarded from further analysis after being identified as M. avium isolates by this
method. Overall, the quality of the spectra was satisfactory except in few cases (6 isolates
out of 94 tested).
Isolates from South Korea were easily confirmed to be from the W-Beijing strain by
the abundance of their TAG compared to H37Rv strain. PGL signals were detected in the
lipid profile of 48 cases of the 85 South Korean isolates and in none of the Tennessee
State isolates. It was also observed that when compared to the H37Rv, each of the two
different isolate collections displayed a specific pattern. While the Korean isolates
displayed high levels of TAG (three times or higher), they also showed significantly
lower levels of PIMs and ATs (at 40% their levels in H37Rv). On the contrary, all tested
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Figure 5.7 Selection of Biomarker Signals of M. tuberculosis PGL
A monosaccharide PGL isolated from M. liflandii was used to assign PGL signals in the
2D-HSQC lipid profile of M. tuberculosis HN878. Inserts, marked as (a), show partial
windows in both the PGL standard and the HN878 lipid profile where the benzylic
signals at δ1H=2.58, δ13C=46.8 ppm of PGL are highlighted by solid circles. Inserts
marked as (b), represent a partial windows where the aromatic signals of PGL at
1
H=7.02, δ13C=117.6 ppm and δ1H=7.18, δ13C=129.7ppm have been highlighted in
dashed circles in both spectra.
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Tennessee isolates showed significantly lower levels of TAG (2-15% of H37Rv levels)
and to less extent lower levels of TDM (30-50% of H37Rv levels), while ATs, PIMs and
PDIM were detected at comparable levels. Full results are outlined in Table 5.4.
Results from this screening are, to some extent, in agreement with the suggestion that
PGLs may be, at least partially, responsible for the hypervirulence of the W-Beijing
lineage as we were only able to detect PGL in strains that belong to this lineage.
However, our screening results suggest that other factors might participate in such
phenomenon since PGL were not detected at measurable levels in many of these isolates.
In addition, we have found some other differences between of the lipid composition of
the W-Beijing strains and strains that were obtained from other areas.
5.3 Conclusion
Different spectroscopic and chromatographic techniques can be used for the targeted
analysis of a specific lipid species. The selection of the analytical method to be used
depends largely on the properties of the molecule to be investigated. Molecules that are
readily ionizable are better analyzed via mass spectrometry while molecules that have
low ionization potential are bad candidate for such analysis. In the later case, the analysis
can be achieved through HPLC, GC or NMR. GC analysis requires that the target
molecules must show some degree of volatility or to be derivatized before analysis to
volatile derivatives. Depending on the type of HPLC detector used for analysis, HPLC
analysis may require certain characteristics to be built in the targeted lipid species. For
example, the most commonly used HPLC detector, UV-detector, requires a UV absorbing
functionality to be present or to be added to the molecule targeted for analysis. NMR on
the other hand has more universal detection but due to its low sensitivity it is better suited
for the analysis of relatively abundant cellular components. Certain measures are also to
be implemented during analysis of complex mixtures to insure good resolvability of the
data points as well. In all cases, some effort has to be directed towards the standardization
and optimization of the chosen strategy to enhance sensitivity towards the detection of
the targeted molecules.
In this chapter, two chemically different molecules were targeted for screening in the
lipid extract of different Mycobacteria and two different methods were chosen for this
purpose accordingly. The first example, mycolactone, represents a virulence factor of a
polyketide nature that is usually produced by MPM in relatively small amounts.
Mycolactones are easily ionizable as sodium adduct and hence are great candidate for MS
analysis. Moreover, MS analysis of complex lipid extract can easily identify analogues of
mycolactone due to the presence of a distinct fragment that represent the conserved
lactone ring at m/z 429. All mycolactones share also consistent fragmentation pathways
Knowledge of these pathways can help in determining certain structural features of
mycolactone as it is the case with our analysis of mycolactone D and other mycolactones
isolated from M. ulcerans subsp shinshuense.
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Table 5.4 Results from Screening M. tuberculosis Clinical Isolates for PGL Production
Strain
A29
B019
B076
B122
B148
B183
OA002
OA004
OA015
OA022
OA023
OA025
OA029
OA030
OA033
OA039
OA040
OA046
OA049
OA054
OA055
OA057
OA062
OA071
OA074
OA081
OA086
OA090
OA094
OA108
OA109
OA110
OA116
OA119
OA121
OA122
OB012
OB013

PGL
aromatic benzylic
+
+
+
+

TDM

TAG

PDIM

AT

PIM

=
+++
=
=
=
+
+++
+
=
+++
=
+
+
+++
=
=
+
+
+
=
+++
++
+++
=
+++
++
++
=
+++
+
+++
+++
++
+
+
+
+
=
+++
=
=
=
Signals at δ1H=7.2, δC=128.71 and δ1H=4.67,δC=55.36 ppm
++
++
=
+++
+
=
+
+++
+++
+++
+
+++
+++
=
++
++
=
+++
+
=
+++
++
++
=
+++
+
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+++
+++
=
+
=
+++
+
=
+
=
+++
=
+
=
+++
=
+
+
=
+++
++
+
=
+++
+
+
=
+
+++
=
+
+
+
+
+++
=
++
++
=
++
+
+
=
+++
+
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+
+++
+
=
+++
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Remarks
PGL +ve
PGL +ve
PGL +ve
Bad quality
PGL +ve
PGL +ve
Bad quality

PGL +ve
PGL +ve
PGL +ve
PGL +v e
M. avium
PGL +ve
Bad quality
PGL +ve
PGL +ve
PGL +ve
PGL +ve
PGL +ve

Bad quality
PGL +ve
PGL +ve
PGL +ve
PGL +ve
Bad quality
PGL +ve
PGL +ve
Bad quality
PGL +ve
PGL +ve

Table 5.4 (continued)
Strain
OB016
OB023
OB026
OB047
OB051
OB059
OB066
OB074
OB075
OB076
OB078
OB085
OB096
OB099
OB104
OB115
OB123
OB124
OB125
OB126
OB127
OB139
OB140
OB142
OB143
OB145
OB154
OB156
OB157
OB158
OB161
OB170
OB178
OB179
OB185
OB192
OB202
OB206
OB210

PGL
aromatic benzylic
+
++
++
++
++
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+
++
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+
+
++
+
+
+
+
++
+
++
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=
=
=
=
=
=
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=
=
=
=
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=
=
=
=
=
=
=

=
=
=
=
-
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PIM
=
=
=
=
-

Remarks

PGL +ve
PGL +ve

PGL +ve
PGL +ve

PGL +ve
PGL +ve
PGL +ve
PGL +ve
PGL+ve
PGL +ve
PGL +ve
PGL +ve
Bad quality
PGL +ve
PGL +ve
PGL +ve
PGL +ve
PGL +ve

PGL +ve

PGL +ve
PGL +ve
PGL +ve
PGL +ve

Table 5.4 (continued)
Strain

PGL
aromatic benzylic

TDM

TAG

PDIM

AT

PIM

OB218
OB227
OB228
OB229
OB231
OB235
OB239
CSU93
HN878
878∆pks
TN15
TN18
TN22
TN26
TN29

+++
+
+
=
+++
+
=
++
+
+
+
+
+
=
++
=
+
=
+++
=
1
Signals at δ H=7.2, δC=128.71 and δ1H=4.67,δC=55.36ppm
=
=
+
=
++
++
=
+++
+
=
=
++
=
=
=
+
=
=
=
=
=
+
=
=
=
=
=

Remarks
Bad quality
PGL +ve
PGL +ve
PGL +ve
M. avium
PGL +ve

Signal intensities for lipid molecules other than PGL are reported in comparison to
H37Rv. (=), comparable to H37Rv at 60%-140% value, (+) at 140%-200% value, (++), at
200%-300% value, (+++) at more than 300% value, and (-) at less than 60% of that signal
in H37Rv. Intensities of different biomarker signals were measured and normalized as
described in section 5.2.2.3. Samples were judged to be PGL positive if more than one of
the biomarker signals of PGL were detected in their corresponding spectra.
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Due to the presence of a polyene side chain in mycolactones, they are also good
candidates for HPLC-UV analysis. The absorption wavelength of these molecules at
360nm is relatively uncommon for other lipid molecules hence it is possible to use such a
technique for mycolactone detection in total lipid extract. In addition, HPLC can succeed
where MS analysis fail. While MS detect all geometric isomers as a single entity of the
same mass, a well-developed HPLC gradient can differentiate between geometric isomers
and provide information that are not attainable through MS analysis alone.
In the second case, screening for PGL represents a different challenge. The molecular
mass of PGL is not a fixed value due to the possibility of the variation in the aglycon
part. Both mycoserosic acid and phenolphthicerol exhibit variations in their structures in
both chain length and the number of substituent. This variability causes great variation in
the possible molecular weight of PGL. These molecules are also very hydrophobic in
nature and their ionization under most MS ionization techniques is considerably poor.
2D-HSQC-based screening for PGL that we used here was quite successful in several
aspects. We were able to determine biomarker signals that can be used for different
analogues of PGL irrespective of the variation in their corresponding mass. We were also
able to detect PGL in clinical isolates using only 10 milliliters of cell culture (and as low
as 0.75 mg of dried lipid extract) in a relatively short time period. While screening for
PGL in these samples, all other cell wall lipids can be measured simultaneously. This
adds a great value to the data obtained as it can point out in some case to certain
metabolic coupling processes. Unfortunately, some clinical isolates showed slow and
erratic growth behavior which affected the amount of lipids available for analysis. In
some cases, the lipid profiles were of such bad quality that deterred conclusive data
interpretation. Due to the relatively low abundance of PGL in some isolates, in certain
cases only one or two biomarker signals were detected for PGL instead of all three.
Hence, a threshold based on multiple referencing is needed as an important measure to
insure the quality of the spectrum and validate the conclusion drawn from it.
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CHAPTER 6. SUMMARY AND CONCLUSION 4
6.1 The Metabolomics Research Field
6.1.1 The “Omics” Era
The introduction of global analysis techniques came as a natural sequel of our ability
to decipher a whole genome sequence. With the availability of complete genomic
sequence of several organisms, the “omics” era began with the introduction of
microarrays in 1995309 as a tool to investigate the cellular transcriptome. Shortly after,
the concept of proteome as the protein complement of the genome was introduced310 and
followed by the introduction of the term proteomics in 1997.311 Several techniques have
been introduced since then for these purposes and several modifications and
improvements have followed. The result was unprecedented flood of information about
transcription and translation regulation during different stages of cell cycle and in
response to different environmental cues.
As researchers became accustomed to have a panoramic view of the cellular mRNA
and the protein pool, the need to develop a parallel view of the cell metabolites became
apparent. The term metabolome was introduced to describe the pool of small organic
molecules that include cell metabolites, metabolic intermediates and small molecules
involved in cellular signaling.312 The parallel terms metabolomics and metabonomics
were then coined to describe the measurement of all endogenous metabolites in a cell or a
body fluid. Changes in cellular metabolites can be regarded as the end product of the
regulatory response of the cell to environmental stimuli.313-315 In that sense,
metabolomics should provide a more direct representation of cellular events than those
offered by genomics and proteomics.316
In Mycobacteria research, the “omics” era started with the completion of the whole
genome sequencing of M. tuberculosis in 1998.221 Short after, whole genome sequences
of different Mycobacteria species and strains have also been completed.222,257,317
Microarrays and proteomics techniques have been successfully used in Mycobacteria
research. Some interesting examples include the use of RNA microarrays to identify the
mode of action of several anti-TB drugs.276,318,319 Through the use of such techniques,
researchers have also identified the role that isocitrate lyase and nitrate reductase play in
the metabolic shift of Mycobacteria to latency.275,277,320 Despite the availability of such
information, we are still represented with the great challenge of deciphering the genome
into the ultimate end products, the metabolome.
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Parts of this chapter are adapted with permission. Mahrous, E.A., Lee, R.E. & Lee, R.E.
A rapid approach to lipid profiling of Mycobacteria using 2D HSQC NMR maps. J Lipid
Res. 49, 455-63 (2008).240
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6.1.2 Challenges in Metabolomics
However, there has been limited development in the metabolomic field and it largely
seems to be lagging behind the great advances of genomics and proteomics. This can be
attributed in part to the relatively recent interest in the field and the many technical
challenges it faces. Metabolomic studies include two main stages; first, the extraction of
the cell metabolites then the detection of these small molecules in the extract which may
require a prior step of chromatographic separation.321 The great diversity of the cell
metabolites in terms of cellular abundance and chemical nature (carbohydrates, lipids,
peptides and polyketides) represents a major challenge since there is no reliable
extraction solvent or technique that can guarantee the extraction of all cell metabolites.
On the other hand, most analytical methods do not have enough capability to deal with
biological mixture with thousands of components of such diverse chemical structures and
with wide range of cellular concentration. In fact, until now a combination of analytical
methodologies has a limited power of analyzing few hundred metabolites which is a long
way to go compared to microarrays that can depict the whole transcriptome.322
6.1.3 The Field of Lipidomics
In order to partially overcome the problem associated with the chemical diversity of
the cell metabolome, it can be subdivided and analyzed as separate pools; lipid pool,
peptide pool, etc. One of the most significant metabolite pools is that of the cellular lipid,
the main focus of this dissertation. All lipidomics techniques follow a general scheme
that start with extraction of the cellular lipid with an organic solvent from a whole
organism, body fluid or tissue then the lipid pool is analyzed by either a chromatographic
or spectrometric method to produce a “lipid profile.”236 This lipid profile represents a
panoramic view of cellular lipids which include among others; membrane lipids, cellular
signaling molecules and biosynthetic intermediates.236
Genetic and metabolic differences in the starting materials, tissue or microorganism,
should be reflected in their lipid profiles. The changes observed in these profiles when
related to the initial variation of the analyzed samples are then used to formulate a
hypothesis about a certain metabolic pathway. A combination of data obtained from such
lipidomic approach together with data from genomics and proteomics can provide a
complete picture of the cellular response and the regulatory process involved within. In
that sense, it was encouraging that we were able to produce results that came in
agreement with other observation obtained through molecular biology techniques. For
example, our lipidomics characterization of M. liflandii was consistent with what is
known so far about its evolutionary relation to M. marinum and M. ulcerans256,258
(section 3.3.4). Also, our conclusion that Mycobacteria overproduces TAG during its
shift to dormancy came in agreement with previous results that showed an up-regulation
in M. tuberculosis’ TAG synthases when cells were subjected to low oxygen
conditions.278

127

6.1.4 Designing a New Lipidomics Approach
Before designing a new approach to address lipid profiling it is important to consider
several factors. In the extraction process, effort has to be made in the selection of the
solvent and the extraction methodology to insure that all cell lipids are included in the
lipid extract without bias toward certain class of lipids over the other. Multiple extraction
steps and the use of solvent mixtures instead of a single solvent can help to reduce such
bias. Choice of the analytical method in lipid profiling should require only minimum
manipulation and avoid partitioning of the total pool as much as possible to avoid loss of
some lipids or duplicating their presence (but with lower concentration) in multiple
profiles. Data analysis and management should include a statistical validation of the
acquired data, a scheme to relate data to results from other “omics” techniques, a clear
plan to develop a high throughput analysis and a depository mechanism to share the
massive amount of data generated.
6.2 New Techniques in Lipidomics
Recent interest in lipidomics resulted in a vigorous search for the best tool to be used
for such purpose. However, development of systems-level approaches for lipid analysis is
still in its infancy and we have not reached the breakthrough that the genomic research
arrived at with the development of microarray, or in proteomics through the 2Delectrophories/MALDI-MS approach. The old techniques of lipid analysis so often
included radiolabeling or fluorescent labeling of lipid precursors followed by
chromatographic separation of the components of the lipid extract. The relative ratio of
the lipid pool that can be analyzed through these experiments depends on the choice of
the lipid precursors and the extent of the label incorporation. The most common
technique involves the use of radiolabeled 32P- carbon precursors for the analysis of
membrane phospholipids.236 However, with the great advancement of multiple analytical
techniques, it became possible to develop more comprehensive and more accurate lipid
analysis techniques.
6.2.1 Mass Spectrometry (MS)
Several developments in mass spectrometry have eliminated most restrictions on the
use of MS in lipid analysis. First, the development of soft ionization techniques such as
electrospray ionization ESI and MALDI have greatly reduced the possibility of ion
fragmentation and thus provide more simplified spectra.199,323,324 MALDI offers an added
advantage of its tolerance to electrolytes and salt contamination which reduce sample
manipulation. Atmospheric pressure chemical ionization (APCI) can also be used for
analysis of some non polar lipids that show some difficulty in producing ions. In addition,
development of powerful analyzers such as time of flight (TOF) has greatly enhanced the
sensitivity of MS analysis.
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On the other hand, there are some problems that restrict the use of MS-based
lipidomics to certain areas. Most MS analysis techniques demonstrate their greatest utility
in analyzing polar lipids such as phospholipids (in the case of ESI) and complex
glycolipids and lipoproteins in the case of MALDI.323-326 Other problems can also be
encountered especially in the analysis of crude lipid extracts such as ion suppression
which hinder the analysis of low abundance lipid molecules. Quantitative MS analysis of
lipids hence requires careful sample preparation and the incorporation of lipid standards
to overcome ion suppression.236 Prior separation of the individual components of the lipid
mixture by HPLC is the most widely used approach for efficient and quantitative analysis
of lipid mixtures.327,328 An alternative approach, shotgun lipidomics, was introduced by
Gross, R.W.329-331 This approach avoids prior HPLC separation of the crude lipid extract,
rather it uses tandem mass scanning to develop two dimensional MS-fingerprints for the
cellular lipidome.332 Hundreds of individual lipid molecules were analyzed and quantified
through this technique which requires sub picomolar concentration of lipids for efficient
analysis.329,332,333 For example, shotgun lipidomics was successfully used to link
depletion of some cellular lipids to mitochondria dysfunction in diabetic myocardium.334
One of the most important applications of MS in lipidomoics is its use for targeted
lipid analysis. Anionic lipids like phospholipids, gangliosides, sulfatides and fatty acids
are great candidates for such studies. Through the development of triple quadropole
analyzer, it is now possible to use MS to quantitatively monitor a single molecule in a
complex lipid mixture using MS-MS sequences.325 Multiple reaction monitoring can
provide an accurate and highly sensitive method to detect and quantify a specific
molecule.327,335-337 This analysis, however, necessitates the incorporation of an internal
standard and a prior knowledge of the fragmentation pathway of the targeted molecular
ion. With the continuous introduction of new MS technology during the past two
decades, MS has established itself as a major tool for lipidomics studies.
In our hands, MS analysis was especially helpful in the analysis of Mycolactones.
These molecules are polyketide in nature and their structure is often decorated with
multiple ionizable groups (section 5.1). We successfully used MS for the rapid screening
and detection of mycolactones in the ASL of different Mycobacteria. However, our
attempts to use mass spectrometry in the analysis of other lipid species (like TDM) were
not as successful. The presence of lipid molecules as a series of analogues with variable
carbon chain length often complicates the MS spectrum. Moreover, any minor
contaminant with favorable ionizability can appear as a major component in an extract
when compared to the low ionizability of cellular lipids. Certain measures have to be
implemented to overcome this problem.215
6.2.2 Chromatographic Separation Methods HPLC and GC
Chromatography in general has preceded spectrometric methods and its development
has initially enjoyed faster pace than that of MS and NMR. For this reason,
chromatographic techniques, starting with TLC, have been used for metabolic analysis
for several decades before spectroscopy. The simplicity of TLC and its low cost
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guaranteed its wide spread and frequent use by researchers. However, it suffers from low
sensitivity and questionable resolution. Meanwhile, HPLC provides very quantitative
measurement but most HPLC detectors are either irresponsive to most lipids (UV
detector) or have low sensitivity (refractive index).236 The most commonly used HPLC
detector for lipid analysis is MS but it usually necessitates certain treatment at the LC/MS
interface to eliminate electrolytes and reduce the possibility of ion suppression. The
technical advancement in development of universal detectors like evaporative light
scattering and suppressed conductivity, was received with great enthusiasm from
researches and they have been successfully used for global lipid analysis.338-340
Gas chromatography is most commonly used for analysis of fatty acids. Although
analysis of lipids with GC requires a prior step of derivatization, the technique is very
well established that the entire process is fully automated and is frequently used in the
medical research field for diagnostic purposes.210 Other than fatty acid analysis, GC/MS
can be used to help in the structural determination of some lipids particularly lipoproteins
and glycopeptidolipids.
HPLC analysis was of a special use to us in our analysis of mycolactone (section
5.1.3.2). Due to the presence of mycolactones as equilibrating mixture of double bond
isomers, MS analysis does not reveal such heterogeneity in the analyzed sample as all
isomers have the same molecular weight. Moreover, the presence of such isomers can
complicate the NMR spectrum and deter data interpretation. We have successfully used
traditional UV-HPLC to understand the isomeric nature of different mycolactones. Others
have used chiral HPLC column as a part of a complete synthetic strategy to assign the
complete stereochemistry of different mycolactones as well.297
6.2.3 NMR spectroscopy
NMR represents a powerful analytical technique that offers a plethora of structural
information. Although it has been well established a long time ago as an indispensable
tool in organic chemistry, it keeps on offering researchers new opportunities in multiple
and diverse fields. In lipidomics, beside its traditional role as a structural analysis tool, 1H
and 32P-NMR have often been used for global analysis of phospholipids.341,342
Theoretically, NMR is a quantitative and universal technique by nature, thus it offers
great opportunities for application in the analysis of complex biological mixtures with
chemically diverse components. Recently, it has been successfully used for some
metabolomic studies.343,344
However for most biological research, the sensitivity of NMR is still considered to be
unsatisfactory for many applications and it shows bias to abundant metabolites. For lipid
analysis, structural membrane and energy storage lipids are good candidates for NMRbased lipid profiles due to their high natural abundance. While NMR analysis for less
abundant lipids like cell signaling molecules does not seem to be feasible at this stage.
With the vigorous effort deployed to advance NMR spectroscopy to its full potential, it is
expected that it will be a major contributing factor in lipidomics studies.
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Our NMR methodology was quite successful in the analysis of the mycobacterial lipid
pool considering that most of these lipids are structural components of the cell therefore
they are relatively abundant. Most lipid classes previously reported in Mycobacteria were
detected through this methodology regardless of their chemical class. However, when we
started to fractionate our lipid pool into polar and nonpolar fractions, it became clear that
more polar and less abundant lipids were underrepresented in the total lipid profile that
was dominated by signals of TAG and fatty acids (section 2.3.6). So, it can be concluded
that while all lipid classes were represented in our NMR lipid profile, the study of cellular
lipids of low abundance remains challenging. Also, in drawing conclusion from these
NMR profiles, the detection limit of the methodology has to be considered. For example
in our PGL screening (section 5.2.3), we can firmly conclude that certain strains do
produce PGL while we can not exclude its production by other strains considering its
overall low abundance and the detection limits of the method.
6.3 Summary of the Research
6.3.1 Method Development
In the previous chapters, the development of a new NMR-based method for the global
analysis of the Mycobacteria lipid pool was discussed. Several concepts were integrated
to develop a complete approach that would provide mycobacteriology research with a
new tool for investigating the role and the biochemical interaction of the cell wall
components. The method is summarized as a one step CD3OD:CDCl3 extraction of the
D2O washed cells followed by 2D-HSQC NMR acquisition. The purpose of the method
was to provide a global lipid analysis technique to complement the previously developed
HR-MAS based analysis of the cell wall polysaccharides.
For such a technique to provide maximum utility, several factors were considered for
method development. First, the simplicity of the procedure that includes only minimal
sample manipulation and hence requires limited personal skills and minimizes artifacts
during sample preparation. Second, the choice of the lipid profile format to be a simple
2D-HSQC NMR spectrum insures the possibility of wide application since it requires
only a high field NMR spectrometer and a simple pulse sequence. Third, the enrichment
of the cell metabolites with 13C-isoptope eliminates some of the problems associated with
NMR low sensitivity and greatly reduces the NMR acquisition time. Fourth, the fact that
every molecule is represented by multiple signals rather than one signal, greatly reduces
data ambiguity and positively increases confidence in data interpretation. Fifth, despite
some complexity in the spectrum each molecule can be identified by at least one signal
“biomarker signals”, which can be assigned to each molecule either through literature
search or through developing lipid profiles of isolated standard. Some highly congested
area in the spectrum still can be resolved by three dimensional NMR experiments such as
HCCH-TOCSY and HCCH-COSY in order to establish absolute clarity in data
interpretation. Sixth, a semi-quantitative analysis of the signal can be achieved by
normalization of biomarker signals intensity to that of a previously added standard.
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Finally, the method can provide a complementary approach to the HR-MAS profiling of
the cell wall AG and LAM.189 Hence, from the same starting material (13C-enriched cells)
a more complete metabolic picture can be developed by combining the two techniques;
lipid profiling which provides a representation of cellular lipid and HR-MAS which
provides a representation of cell wall AG and LAM.
6.3.2 Method Validation
The first validation of this NMR-based method came through developing a limited
library of lipid profiles of some Mycobacteria species that have been thoroughly studied.
As discussed in chapter.3, the lipid profiles of these species were reflective of the general
features of Mycobacteria and also of the unique characteristics of certain species. When
genes responsible for the production of a certain lipid were knocked out, signals
corresponding to this lipid disappeared from the corresponding lipid profile of the mutant
strains. For example, when pks1-15 gene was knocked out in M. tuberculosis HN878, we
observed the loss of the phenolic glycolipid signals in the lipid profile of the ∆pks 1-15
mutant strain (section 5.2.3.2). Also in our first attempt to use NMR for mycolactone
analysis, we observed the disappearance of mycolactone signals from the lipid profile of
avirulent M. ulcerans 1615A when it was compared to its parent strain, the virulent strain
1615. However, such results were obtained through MS analysis and HPLC profiling in
much shorter time.
Prior to the use of such method for more quantitative analysis, certain criteria have to
be established. These include the reproducibility of the data obtained from lipid profiles
under fixed growth, extraction and acquisition conditions and the inclusion of a reference
to facilitate the comparison between lipid profiles obtained by different personnel in
different laboratories. In this work, we used a specific signal produced through the
addition of a specific molecule (DMSO) to the lipid extract based on the weight of the
cell pellet as a referencing point. A demonstration of the use of 1H-13C 2D-HSQC for
quantitative measurement of metabolites in plant extract has been already published,344
which opens the opportunities for similar use in bacterial metabolites. For spectral
referencing, other small molecules can be used as long as they do not overlap with signals
in the spectrum. Trimethoxybenzene (TMB) can be used for this purpose, however it will
produce two discrete signals in two different area of the spectrum, which can then be
used for the alignment of multiple spectra for comprehensive comparative analysis.
6.3.3 Method Application
The purpose of this research was to develop a new tool that will help researchers
better understand the chemistry and biological function of the Mycobacteria cell
components for the ultimate goal of defining new drug targets and developing new
treatment option to control the spread of some devastating human and animal diseases.
There are several areas where the integration of such methodology with other genetics
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approach can greatly advance our understanding of Mycobacteria metabolism, virulence
and resistance. Some of the potential areas of method application are discussed below.
6.3.3.1 Gene annotation
The genome of Mycobacteria contains hundreds of genes that are involved in lipid
biosynthesis and lipid metabolism and hundreds other that have no known function and
need to be investigated for potential roles in survival and virulence for the purpose of
identification of new molecular drug targets.221 Now with the availability of new
molecular tools, a library of targeted mutant strains can be developed with relative ease
and manageable cost. Screening of these libraries for changes in the lipid profiles should
identify the lipid species affected by a specific mutation and offer the first steps to
identify a role of the mutated gene in lipid biosynthetic pathways. Complementation of
this lipid profiling technique with HR-MAS profiling of AG and LAM expand the area of
metabolites that can be covered and facilitates the identification of genes involved in cell
wall metabolism.
It is to be noted that changes observed in the HR-MAS and lipid profiles can be either
direct effects due to investigated gene mutation or an indirect result due to cell adaptation
to this mutation and accumulation of biosynthetic intermediates. Significant follow up
investigation at both the genetic and biochemical levels is necessary to identify the direct
gene function and distinguish it from other secondary effects. These secondary adaptive
responses are nonetheless valuable in identifying points of conversions and diversions in
the metabolic pathway and outlining compensatory mechanisms by which Mycobacteria
respond to physiological stress due to gene mutation.
A direct demonstration of such application includes mutation of Rv3792 gene in C.
glutamicum which resulted in disappearance of HR-MAS 2D-HSQC signals of all
arabinan residues in the AG structure (Figure 6.1). In the lipid profile, however, some
signals for acylated hexoses were observed in unusual abundance. Molecular biology and
chemical analysis concluded that Rv3792 encodes a new arabinosyl transferase,
designated aftA, that is responsible for transferring arabinose residue to the galactan core
of AG macromolecule82 which is in total agreement with the results from the HR-MAS
profile. From the lipid profile, it is apparent that the loss of a significant part of the
structural integrity of the cell wall may be compensated for by the accumulation of
hexose glycolipids.
6.3.3.2 Drug action and drug resistance
In vitro whole cell screening of chemical libraries is a useful strategy used by many
investigators to identify new drug candidates that are effective against the tubercle bacilli.
However, after identification of a viable drug candidate by this method comes the
daunting task of deciphering the new drug’s mode of action and its effects on cellular
functions and metabolism. In the case of many anti-TB agents, this has never been an
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Figure 6.1 Effect of Gene Mutation on the Cell Wall of C. glutamicum
HRMAS profile of C. glutamicum wt, (a), and C. glutamicum ∆ aftA, (b). Arabinan
signals (circled in red) were totally absent from the HR-MAS profile of the mutant strain.
Spectra (c) and (d) are partial windows of the 2D-HSQC lipid profile of C. glutamicum
wt, (c), and the ∆ aftA mutant, (d). Adaptive changes were observed upon mutation by
the appearance of multiple signals for what appears to be a trehalose based glycolpids in
the lipid profile of the ∆ aftA mutant signals (circled in blue).
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easy task. For example, after the discovery of isoniazid in 195221 by three different
research groups, its mechanisms of action have been investigated by several groups as
well.345-349 and several reasonable mechanisms of action have been reported. Although it
is clear by now that INH has multiple cellular targets, it is unclear which of them is
responsible for INH killing mechanisms. Ethambutol, another front line anti-TB drug,
was discovered in 1961 through screening.350 Its mechanism of action has been widely
speculated as well.345,346,351 Currently and after more than three decades of investigation,
most researchers agree that the mechanism of action of ethambutol involves inhibition of
arabinan biosynthesis, an event that leads to the inhibition of mycolic acids attachment to
the cell wall and the subsequent accumulation of trehalose mycolates.67,352,353
We were able to reproduce these results following ethambutol treatment in M.
smegmatis using both HR-MAS and lipid profiling methods in an unequivocal manner
and in a very short period of time. Treatment of the cells with increasing concentration of
ethambutol resulted in gradual disappearance of the branched structure of AG as
indicated from the HR-MAS spectrum (Figure 6.2a-c). Meanwhile in the HSQC lipid
profiles, there was a parallel gradual accumulation of trehalose dimycolate in the cellular
lipid pool (Figure 6.2d-f). These results are in accordance with the reported
literature and further underscore the argument for the mode of action of ethambutol
through inhibition of arabinan synthesis.345,346,351
6.3.3.3 Identification of virulence determinants
Due to the worldwide spread of tuberculosis, there has been meticulous collection and
documentation of many clinical strains. These clinical strains often demonstrate different
transmitability, drug resistance and virulence. For example among the frequent outbreaks
in different communities such as prisons, hospitals, schools and homeless shelters,
different rates of transmission have been reported.354 An outbreak in clothing factories in
Tennessee was associated with unusual high rates of transmission from the primary
source as well as secondary sources.355 Investigation of the causative strains designated
as CDC-1551 or CSU93 found out that although the strain displayed usual rates of initial
implantation in a murine model, it was able to grow faster and to a lager extent than most
laboratory strains which translates to a higher rate of transmission.355,356 Another strain
responsible for an outbreak in a Texas prison, HN878, was found to be hypervirulant in
mice when mice failed to induce appropriate immune response to the infection.357 In both
cases, the variability in transmission and virulence was traced to specific changes in cell
wall lipids.153,358
It is also well known that variable degrees of pathogenicity and virulence among
different clades of M. tuberculosis can stem from certain structural polymorphism in its
genome.357,359,360 Even of more interest to mycobacteriology scientists, is the notion that
M. tuberculosis has evolved to develop strain compatibility to different human
demography in different geographical regions.360,361 All of this genetic variability is
ultimately represented as variability in cellular proteins and cellular metabolites and some
of them can be detected by global analysis techniques, which include proteomics,
metabolomics and lipidomics as well.
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Figure 6.2 Effect of Ethambutol Treatment in the Cell Wall of M. smegmatis
Panels a-c, 1H-13C HSQC HR-MAS spectra (δ1H, 3.4-5.3 ppm, δ13C, 64-110 ppm) of
live M. smegmatis cells in absence of ethambutol, (a), treated with ethambutol at
0.1μg/ml, (b), and 0.2μg/ml, (c). All spectra were referenced to the anomeric signal of 6β-Galf (δ1H 5.28 ppm, δ 13C106.98 ppm). Gradual decrease in the intensity of signals
corresponding to the branching of the Ara6 motif of AG; 3,5-α-Araf (I) and 2-α-Araf
→3(II) can be observed.
Panels d-f, 1H-13C HSQC spectra (δ1H, 0.6-2.6 ppm, δ13C,13-60 ppm) of total lipid
extract from M. smegmatis cells in absence of ethambutol, (d), treated with ethambutol at
0.1μg/ml, (e), and 0.2 μg/ml, (f). All spectra were referenced to the fatty acid terminal
methyl signal (δ 1H=0.82 ppm, δ13C=17.82 ppm). Gradual increase in intensity of signals
corresponding to trehalose mycolates can be observed at (δ 1H=2.38 ppm, δ13C=56.73
ppm) and (δ 1H=1.32 and1.54 ppm, δ13C=38.17 ppm).
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In our effort to use our NMR-based methodology to screen for certain virulence
determinants, we screened more than 90 Mycobacteria tuberculosis isolates for PGL
production. In the process of doing so, we were able to detect the production of PGL by a
high percentage of clinical isolates from the W-Beijing lineage. Moreover, we were able
to detect certain characteristics that distinguish these isolates from our laboratory M.
tuberculosis strains and other isolates obtained from the State of Tennessee strain
depository which did not produce PGL (section 5.2.3.3). Such results demonstrate the
value of using such global technique which allows the simultaneous monitoring of
multiple metabolites in studying variabilities in strain virulence.
6.4 Future Development
The research discussed in this dissertation represents the first steps towards the
development of a novel “omics” approach designed specifically for the analysis of the
mycobacterial cell wall metabolites. Also, it can be used for the investigation of other
bacterial metabolites as long as these bacteria can grow in the laboratory in well defined
growth media. Like other metabolomics methods, the extent to which our proposed
methodology can be applied will depend on result-validation and reproducibility as well
as user convenience. Convenience does not only include simplicity of the procedures but
extends also to data analysis and data sharing. Based on our knowledge of previous
experiences in the development of other “omic” approaches, future research efforts for
this approach are likely to be directed to each of three main areas.
6.4.1 Assignment of the 2D-HSQC Signals
With decades of research directed towards Mycobacteria cell wall lipids, there is no
shortage of structural data concerning cell wall lipids. However, the available information
may not be extrapolated to the 2D-HSQC lipid profiles due to variation in the data
acquisition parameters like the solvent used, acquisition temperature, etc. So before
overlaying old data on the 2D-lipid profile, it has to be assured that the acquisition
parameters for both spectra can be matched or at least accounted for. In some cases like
tracking a specific lipid molecule (as in section 5.2.3.1), it is possible to direct some
effort towards isolating this molecule or a close analogue and develop its standardized
2D-HSQC spectrum for subsequent assignment. Also some advanced NMR experiments
such as 3D-HCCH -TOCSY can help establish relationships between signals in the 2D
spectrum and aid towards establishing a complete assignment.
However, there are also countless reports of lipid species that were isolated from a
single specific strain which make handling of such amount of data a challenging task.
Cooperative efforts between different research groups that include sharing of data and
isolated standards will be necessary to complete signal assignment. A small scale
initiative similar to the whole genome sequencing projects may be a good way to enhance
and organize efforts in that area.

137

6.4.2 Method Standardization and Data Analysis
One of the main challenges of metabolomics and lipidomics methods is to develop a
valid statistical methodology to insure validity of the data and allow for data comparisons
between different research groups. Internal standard has to be added for spectral
alignments and at least three replicates are required to validate the reproducibility of the
data. Raw data have to be normalized to the internal standard and an average of multiple
experiments has to be created. These requirements of multiple experiments and additional
processing steps represent a computational challenge especially with the extraordinary
complexity of the raw data. Statistical software might be necessary for the comparative
analysis between two spectra that may display variability in the background noise or
signal intensity. As it is the case with all “omics” techniques, an arithmetic algorithm is
needed to represent the data in a bioinformatics-friendly manner. For MS and HPLC
methods certain statistical soft wares are now available and some algorithm has been
suggested to facilitate data representation.
6.4.3 Data Depositing and Sharing
The great advancement in science in the past two decades has resulted in the
accumulation of an unprecedented amount of information. For this information to be
handled and put to the maximum use by every researcher, bioinformatics science was
developed. With the introduction of the World Wide Web, bioinformatics has matured,
flourished and become an indispensable tool since then. Bioinformatics offered
researchers the possibility of an instant information sharing and rapid effective data
search. The ultimate result was an explosion of scientific data which in turn necessitated
the creation of organized depository databases and the development of data mining tools
to facilitate navigation through the deposited data.
In the lipidomics and metabolomics fields several depository web sites have been
established. For example for the “human lipidome” there is several initiative and
depository database like LIPIDMAPS for analysis of human lipid pool and biosynthetic
pathways. For maximum utility of any new lipidomics technique, the data generated from
the technique has to be deposited in an organized database that allows researchers to
navigate the information. Such availability of information can encourage researchers to
use the technique and apply this methodology in their own investigation and eventually
deposit more data. Organized data sharing quite often deters duplication of efforts and
speeds up the process of knowledge gain towards the goal of improving our
understanding of the world around us.
6.5 How Metabolomics May Change Life Science
Unlike genomics which deals primarily with macromolecules and utilize molecular
biology tools, metabolomics deals with small organic molecules and utilizes primarily
analytical chemistry tools. Currently, major ideas for the development of lipidomics
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techniques are falling in the foot steps of the proteomics science. Although this may be
considered as a jump start for lipidomics, the different chemical nature of lipids, as
opposed to proteins, will eventually led us to explore new territories in analytical
chemistry. Comprehensive metabolomics are by nature hybrid biological/chemical
experimentation. For example, to investigate the role of certain gene in regulation of cell
metabolism, this gene has to be knocked out first and the elimination of the gene function
has to be validated by the absence of its direct gene products (most likely a cellular
protein ) and its final product (usually a small molecular weight metabolite). Hence the
ultimate goal of establishing a relationship between a certain gene and a certain
metabolite requires knowledge of molecular biology, organic chemistry, analytical
chemistry as well as biostatistics. Such experiments are usually achieved through a team
of scientists from these different science fields but it remains essential that each member
of the team has a basic level of knowledge in all these disciplines to facilitate the process
of communication and flow of data.
For maximum utility of these metabolomics experiments, a generation of scientists is
needed who are trained to develop a thorough understanding of organic and analytical
chemistry and cellular and molecular biology as well. These scientists should be regarded
as the connecting bridges between chemists and molecular biologists who have been
trapped by the lack of communication for so many years because they don’t understand
each other languages. This lack of communication is a result of the pressure on scientists
to develop and adhere to specific specialties and subspecialties because for so long we
held specialists in much higher regards. Not all scientists have to abandon the specialist
culture but at least enough of them should abandon it in order to build bridges between
multiple disciplines. These scientists should also be held in high regards as they
contribute to the common good of our human society.
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APPENDIX A. SUPPLEMENTARY FIGURES FOR CHAPTER 2

Figure A.1 Effect of Different Acquisition Time on the Quality of the 2D-HSQC Lipid
Profiles
2D-HSQC lipid profiles of M. smegmatis acquired for (a), 2 transients, 20 minutes, (b), 4
transients, 40 minutes, (c), 12 transients, 120 minutes and, (d), 60 transients, 10 hours.

168

Figure A.2 Effect of Different Growth Conditions (Liquid Media Versus Solid Media)
Lipid profiles of M. avium growing in Middlebrook 7H9, (a), or growing on Middlebrook
7H11 agar, (b).
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Figure A.3 Lipid Profiles of M. bovis BCG in the Early Exponential Phase
Cells were harvested and extracted at O.Dλ600=0.29.

Figure A.4 Lipid Profiles of M. bovis BCG of Cells in the Late Growth Phase
Cells were harvested and extracted at O.Dλ600=1.2.
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Figure A.5 Effect of 13C-acetate Labeling on the Lipid Profile of M. ulcerans
Cells were grown in Middlebrook 7H9 where 13C6-dextrose and 13C3-glycerol were used,
(a), or in regular Middlebrook 7H9 where 0.2% 13C2 sodium acetate have been added, (b).

171

Figure A.6 Effect of Using Different Culture Volumes for Lipid Extraction
M. bovis BCG were harvested and extracted from 20mls culture, (a), or from 50 mls
culture, (b), to a final extract volume of 600µl. Both profiles were acquired using 5mm
trpfg NMR probe. Low abundance lipids were better represented in the first spectrum due
to the presence of lower amounts of TAG and PL.
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Figure A.7 Lipid Profiles Obtained from the Extraction of 10mls Culture
Lipid profiles were acquired using 3mm IFC NMR probe of M. avium, (a), and M.
tuberculosis , (b).
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Figure A.8 Effect of Different Extraction Time on the Quality of the Lipid Profiles
M. smegmatis cells were harvested and extracted for 20 minutes, (a), 40 minutes, (b), 90
minutes, (c), and 120 minutes, (d). All profiles were acquired for 40 minutes.
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Figure A.9 Lipid Profiles Produced by the Extraction of the Washed Cell Pellet with
Acetone-d6
M. ulcerans cells were extracted for 90 minutes with either acetone-d6, (a) or 2:1 mixture
of CDCl3:CD3OD, (b).

Figure A.10 Effect of Extraction with Benzene-d6
Lipid profile of cells extracted with benzene-d6 included only signals of fatty acids.
Shown above is the lipid profile obtained when a 2:1 mixture of CDCl3:CD3OD was used
for re-extraction of the pellet remaining after extraction with benzene.
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Figure A.11 Effect of Solvent Partition on the Lipid Profiles of M. tuberculosis H37Ra
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Figure A.12 Effect of Solvent Partition on the Lipid Profiles of M. smegmatis
Total lipid profile is shown in (a), apolar lipid profile is shown in (b), and the polar lipid
profile is shown in (c).
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APPENDIX B. SUPPLEMENTARY FIGURES FOR CHAPTER 3

Figure B.1 HR-MAS 2D-HSQC Spectrum of Live M. abscessus
Highlighted in this figure is the presence of low LAM levels (enclosed in a solid-line
box), the presence of phosphoinositol caps (very low intensity signal indicated by a black
arrow) and the presence of high levels of TAG (enclosed in dashed-line circles).
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Figure B.2 HR-MAS 2D-HSQC Spectrum of Live M. avium
Highlighted in this figure is the presence of low LAM levels (enclosed in a solid-line
box), the presence of mannose caps (indicated by a black arrow) and the presence of low
levels of TAG (enclosed in dashed-line circles).
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Figure B.3 HR-MAS 2D-HSQC Spectrum of Live M. bovis BCG
Highlighted in this figure is the presence of high LAM levels (enclosed in a solid-line
box), the presence of mannose caps (indicated by a black arrow) and the presence of low
levels of TAG (enclosed in dashed-line circles).
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Figure B.4 HR-MAS 2D-HSQC Spectrum of Live M. fortitum
Highlighted in this figure is the presence of moderate LAM levels (enclosed in a solidline box), the presence of phosphoinositol caps (indicated by a black arrow) and the
presence of high levels of TAG (enclosed in dashed-line circles).
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Figure B.5 HR-MAS 2D-HSQC Spectrum of Live M. liflandii
Highlighted in this figure is the presence of moderate LAM levels (enclosed in a solidline box), the presence of mannose caps (indicated by a black arrow) and the presence of
low levels of TAG (very weak signal enclosed in dashed-line circles).
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Figure B.6 HR-MAS 2D-HSQC Spectrum of Live M. marinum
Highlighted in this figure is the presence of moderate LAM levels (enclosed in a solidline box), the presence of mannose caps (indicated by a black arrow) and the presence of
low levels of TAG (enclosed in dashed-line circles).
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Figure B.7 HR-MAS 2D-HSQC Spectrum of Live M. phlei
Highlighted in this figure is the presence of low LAM levels (enclosed in a solid-line
box), the presence of phosphoinositol caps (indicated by a black arrow) and the presence
of high levels of TAG (enclosed in dashed-line circles).
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Figure B.8 HR-MAS 2D-HSQC Spectrum of Live M. smegmatis
Highlighted in this figure is the presence of low LAM levels (enclosed in a solid-line
box), the presence of phosphoinositol caps (indicated by a black arrow) and the presence
of high levels of TAG (enclosed in dashed-line circles).
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Figure B.9 HR-MAS 2D-HSQC Spectrum of Live M. tuberculosis H37Ra
Highlighted in this figure is the presence of high LAM levels (enclosed in a solid-line
box), the presence of mannose caps (indicated by a black arrow) and the absence of TAG
(enclosed in dashed-line circles).
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Figure B.10 HR-MAS 2D-HSQC Spectrum of Live M. ulcerans
Highlighted in this figure is the presence of high LAM levels (enclosed in a solid-line
box), the presence of mannose caps (indicated by a black arrow) and the absence of TAG
(enclosed in dashed-line circles).
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Figure B.11 2D-HSQC Lipid Profile of M. avium
Highlighted in the figure are signals of cyclopropyl mycolates (enclosed in a rectangular
box) and signals of the GPL core (enclosed in dashed-line circles).
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Figure B.12 2D-HSQC Lipid Profile of M. abcessus
Highlighted in the figure are signals from the GPL core, enclosed in dashed-line circles.
Also noticeable, is the absence of cyclopropyl signals (as indicated by the rectangular
box) and the presence of low intensity signals of methyl-branched fatty acids, indicated
by a small arrow.
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Figure B.13 2D-HSQC Lipid Profile of M. smegmatis
Highlighted in the figure are signals from the GPL core, enclosed in dashed-line circles.
Also noticeable is the absence of cyclopropyl signals (as indicated by the rectangular
box) and the absence of signals indicative of methyl-branched fatty acids, indicated by a
small arrow.
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Figure B.14 2D-HSQC of Purified Phenol Phthiocerol Isolated from M. ulcerans
Highlighted in the 2D-HSQC spectrum and in the corresponding phenol phthiocerol are
selected biomarker signals from different parts of the molecule.
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Figure B.15 2D-HSQC Lipid Profile of M. ulcerans
Highlighted in the figure are signals of phenol phthiocerol (enclosed in dashed-line
circles). The absence of TAG signal from the lipid profile is indicated by a small arrow.
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Figure B.16 2D-HSQC Lipid Profile of M. liflandii
Highlighted in the figure are signals of phenol phthiocerol and its corresponding PGL
(enclosed in dashed-line circles, the aromatic signals of PGL are recorded at significantly
higher intensities). The presence of low amount of TAG in the lipid profile is indicated
by a small arrow.
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Figure B.17 2D-HSQC Lipid Profile of M. marinum
Highlighted in the figure are signals of phenol phthiocerol and its corresponding PGL
(enclosed in dashed-line circles, the aromatic signals of PGL are recorded at significantly
higher intensities). The presence of high levels of TAG in the lipid profile is indicated by
a small arrow.
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Figure B.18 2D-HSQC Lipid Profile of M. bovis BCG
Highlighted in the figure are signals indicative for cyclopropyl mycolates (in solid-line
rectangle), methyl-branched fatty acids (in solid line circles), Mycoside B (the aromatic
signal in dashed-line circles) and TAG (indicated by a black arrow).
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Figure B.19 2D-HSQC Lipid Profile of M. tubrerculosis H37Rv
Highlighted in the figure are signals indicative for cyclopropyl mycolates (in solid-line
rectangle), highly abundant methyl-branched fatty acids (in solid line circles), and low
levels of TAG (indicated by a black arrow). The absence of mycoside B is indicated by
the absence of its aromatic signal (dashed-line circle).
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Figure B.20 2D-HSQC Lipid Profile of M. phlei
The bottom insert show the area where signals for trehalose phleiates can be observed.
Phleic acid is a polyunsatured fatty acid.
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Figure B.21 2D-HSQC Lipid Profile of M. fortitum
Highlighted in the figure are signals specific to M. fortitum that are likely to be associated
with its unique glycolipid , Mycolactone F.
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Figure B.22 2D-HSQC Lipid Profile of M. tuberculosis H37 Ra
Highlighted in the figure are signals indicative of methyl-branched fatty acids (reported at
relatively low intensity and highlighted in dashed-line circles), and low levels of TAG
(indicated by a black arrow).
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Figure B.23 2D-HSQC Lipid Profile of M. tuberculosis Erdman’s Strain
Highlighted in the figure are signals indicative of methyl-branched fatty acids (reported at
relatively higher intensity and highlighted in dashed-line circles), and low levels of TAG
(indicated by a black arrow).
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Figure B.24 2D-HSQC Lipid Profile of M. tuberculosis CDC1551 Strain
The presence of very low TAG levels is highlighted by a black arrow.
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Figure B.25 2D-HSQC Lipid Profile of M. tuberculosis HN878 Strain
Highlighted in the figure, are signals indicative for M. tuberculosis PGL (signals for PGL
are enclosed in dashed-line circles). Also highlighted by a black arrow are relatively
higher levels of TAG.
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